000168214912/31FALSE2026Q2http://fasb.org/us-gaap/2026#RelatedPartyMemberhttp://fasb.org/us-gaap/2026#RelatedPartyMember0.330.5100xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:puredvlt:segmentiso4217:GBPdvlt:daydvlt:unitdvlt:bitcoindvlt:yeardvlt:monthdvlt:paymentdvlt:tranche00016821492026-01-012026-06-3000016821492026-08-1900016821492026-06-3000016821492025-12-310001682149us-gaap:RelatedPartyMember2026-06-300001682149us-gaap:RelatedPartyMember2025-12-310001682149dvlt:LiveEventsMember2026-04-012026-06-300001682149dvlt:LiveEventsMember2025-04-012025-06-300001682149dvlt:LiveEventsMember2026-01-012026-06-300001682149dvlt:LiveEventsMember2025-01-012025-06-300001682149dvlt:ConsumerAudioProductsComponentsAndOtherNetMemberus-gaap:NonrelatedPartyMember2026-04-012026-06-300001682149dvlt:ConsumerAudioProductsComponentsAndOtherNetMemberus-gaap:NonrelatedPartyMember2025-04-012025-06-300001682149dvlt:ConsumerAudioProductsComponentsAndOtherNetMemberus-gaap:NonrelatedPartyMember2026-01-012026-06-300001682149dvlt:ConsumerAudioProductsComponentsAndOtherNetMemberus-gaap:NonrelatedPartyMember2025-01-012025-06-300001682149dvlt:ConsumerAudioProductsComponentsAndOtherNetMemberus-gaap:RelatedPartyMember2026-04-012026-06-300001682149dvlt:ConsumerAudioProductsComponentsAndOtherNetMemberus-gaap:RelatedPartyMember2025-04-012025-06-300001682149dvlt:ConsumerAudioProductsComponentsAndOtherNetMemberus-gaap:RelatedPartyMember2026-01-012026-06-300001682149dvlt:ConsumerAudioProductsComponentsAndOtherNetMemberus-gaap:RelatedPartyMember2025-01-012025-06-300001682149dvlt:PatentLicenseMember2026-04-012026-06-300001682149dvlt:PatentLicenseMember2025-04-012025-06-300001682149dvlt:PatentLicenseMember2026-01-012026-06-300001682149dvlt:PatentLicenseMember2025-01-012025-06-3000016821492026-04-012026-06-3000016821492025-04-012025-06-3000016821492025-01-012025-06-300001682149dvlt:ConsumerAudioProductsComponentsAndOtherNetMember2026-04-012026-06-300001682149dvlt:ConsumerAudioProductsComponentsAndOtherNetMember2025-04-012025-06-300001682149dvlt:ConsumerAudioProductsComponentsAndOtherNetMember2026-01-012026-06-300001682149dvlt:ConsumerAudioProductsComponentsAndOtherNetMember2025-01-012025-06-300001682149us-gaap:CommonStockMember2025-12-310001682149us-gaap:AdditionalPaidInCapitalMember2025-12-310001682149us-gaap:RetainedEarningsMember2025-12-310001682149us-gaap:CommonStockMember2026-01-012026-03-310001682149us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-3100016821492026-01-012026-03-310001682149us-gaap:CommonStockMemberdvlt:AtMarketOfferingWithMaximMember2026-01-012026-03-310001682149us-gaap:AdditionalPaidInCapitalMemberdvlt:AtMarketOfferingWithMaximMember2026-01-012026-03-310001682149dvlt:AtMarketOfferingWithMaximMember2026-01-012026-03-310001682149us-gaap:RetainedEarningsMember2026-01-012026-03-310001682149us-gaap:CommonStockMember2026-03-310001682149us-gaap:AdditionalPaidInCapitalMember2026-03-310001682149us-gaap:RetainedEarningsMember2026-03-3100016821492026-03-310001682149us-gaap:CommonStockMember2026-04-012026-06-300001682149us-gaap:AdditionalPaidInCapitalMember2026-04-012026-06-300001682149us-gaap:CommonStockMemberdvlt:VivasorInvestmentMember2026-04-012026-06-300001682149us-gaap:AdditionalPaidInCapitalMemberdvlt:VivasorInvestmentMember2026-04-012026-06-300001682149dvlt:VivasorInvestmentMember2026-04-012026-06-300001682149us-gaap:CommonStockMemberdvlt:May2025OfferingMember2026-04-012026-06-300001682149us-gaap:AdditionalPaidInCapitalMemberdvlt:May2025OfferingMember2026-04-012026-06-300001682149dvlt:May2025OfferingMember2026-04-012026-06-300001682149us-gaap:CommonStockMemberdvlt:AtMarketOfferingWithMaximMember2026-04-012026-06-300001682149us-gaap:AdditionalPaidInCapitalMemberdvlt:AtMarketOfferingWithMaximMember2026-04-012026-06-300001682149dvlt:AtMarketOfferingWithMaximMember2026-04-012026-06-300001682149us-gaap:RetainedEarningsMember2026-04-012026-06-300001682149us-gaap:CommonStockMember2026-06-300001682149us-gaap:AdditionalPaidInCapitalMember2026-06-300001682149us-gaap:RetainedEarningsMember2026-06-300001682149us-gaap:CommonStockMember2024-12-310001682149us-gaap:AdditionalPaidInCapitalMember2024-12-310001682149us-gaap:RetainedEarningsMember2024-12-3100016821492024-12-310001682149us-gaap:CommonStockMember2025-01-012025-03-310001682149us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-3100016821492025-01-012025-03-310001682149us-gaap:CommonStockMemberdvlt:February2025OfferingMember2025-01-012025-03-310001682149us-gaap:AdditionalPaidInCapitalMemberdvlt:February2025OfferingMember2025-01-012025-03-310001682149dvlt:February2025OfferingMember2025-01-012025-03-310001682149us-gaap:RetainedEarningsMember2025-01-012025-03-310001682149us-gaap:CommonStockMember2025-03-310001682149us-gaap:AdditionalPaidInCapitalMember2025-03-310001682149us-gaap:RetainedEarningsMember2025-03-3100016821492025-03-310001682149us-gaap:CommonStockMember2025-04-012025-06-300001682149us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-300001682149us-gaap:RetainedEarningsMember2025-04-012025-06-300001682149us-gaap:CommonStockMember2025-06-300001682149us-gaap:AdditionalPaidInCapitalMember2025-06-300001682149us-gaap:RetainedEarningsMember2025-06-3000016821492025-06-300001682149us-gaap:NonrelatedPartyMember2026-01-012026-06-300001682149us-gaap:NonrelatedPartyMember2025-01-012025-06-300001682149us-gaap:RelatedPartyMember2026-01-012026-06-300001682149us-gaap:RelatedPartyMember2025-01-012025-06-300001682149dvlt:APIMediaNetMember2026-01-012026-06-300001682149dvlt:APIMediaNetMember2025-01-012025-06-300001682149dvlt:CSINetMember2026-01-012026-06-300001682149dvlt:CSINetMember2025-01-012025-06-300001682149dvlt:AtTheMarketATMProgramMember2026-01-012026-06-300001682149dvlt:AtTheMarketATMProgramMember2025-01-012025-06-300001682149dvlt:RegisteredDirectOfferingMember2026-01-012026-06-300001682149dvlt:RegisteredDirectOfferingMember2025-01-012025-06-300001682149dvlt:VivasorSubscriptionAgreementMember2026-01-012026-06-300001682149dvlt:VivasorSubscriptionAgreementMember2025-01-012025-06-300001682149us-gaap:CustomerConcentrationRiskMemberdvlt:MajorCustomerNumberOneMemberus-gaap:AccountsReceivableMember2026-01-012026-06-300001682149us-gaap:CustomerConcentrationRiskMemberdvlt:MajorCustomerNumberTwoMemberus-gaap:AccountsReceivableMember2026-01-012026-06-300001682149us-gaap:CustomerConcentrationRiskMemberdvlt:MajorCustomerNumberOneMemberus-gaap:AccountsReceivableMember2025-01-012025-12-310001682149us-gaap:CustomerConcentrationRiskMemberdvlt:MajorCustomerNumberTwoMemberus-gaap:AccountsReceivableMember2025-01-012025-12-310001682149us-gaap:CustomerConcentrationRiskMemberdvlt:MajorCustomerNumberOneMemberus-gaap:RevenueFromContractWithCustomerMember2026-04-012026-06-300001682149us-gaap:CustomerConcentrationRiskMemberdvlt:MajorCustomerNumberTwoMemberus-gaap:RevenueFromContractWithCustomerMember2026-04-012026-06-300001682149us-gaap:CustomerConcentrationRiskMemberdvlt:MajorCustomerNumberOneMemberus-gaap:RevenueFromContractWithCustomerMember2026-01-012026-06-300001682149us-gaap:CustomerConcentrationRiskMemberdvlt:MajorCustomerNumberTwoMemberus-gaap:RevenueFromContractWithCustomerMember2026-01-012026-06-300001682149us-gaap:CustomerConcentrationRiskMemberdvlt:MajorCustomerNumberOneMemberus-gaap:RevenueFromContractWithCustomerMember2025-04-012025-06-300001682149us-gaap:CustomerConcentrationRiskMemberdvlt:MajorCustomerNumberTwoMemberus-gaap:RevenueFromContractWithCustomerMember2025-04-012025-06-300001682149us-gaap:CustomerConcentrationRiskMemberdvlt:MajorCustomerNumberOneMemberus-gaap:RevenueFromContractWithCustomerMember2025-01-012025-06-300001682149us-gaap:CustomerConcentrationRiskMemberdvlt:MajorCustomerNumberTwoMemberus-gaap:RevenueFromContractWithCustomerMember2025-01-012025-06-300001682149srt:MinimumMember2026-06-300001682149srt:MaximumMember2026-06-300001682149dvlt:ConsumerAudioProductsMember2026-04-012026-06-300001682149dvlt:ConsumerAudioProductsMember2025-04-012025-06-300001682149dvlt:ConsumerAudioProductsMember2026-01-012026-06-300001682149dvlt:ConsumerAudioProductsMember2025-01-012025-06-300001682149dvlt:ComponentsMember2026-04-012026-06-300001682149dvlt:ComponentsMember2025-04-012025-06-300001682149dvlt:ComponentsMember2026-01-012026-06-300001682149dvlt:ComponentsMember2025-01-012025-06-300001682149us-gaap:CommonStockMember2026-01-012026-06-300001682149us-gaap:ConvertibleDebtMember2026-01-012026-06-300001682149us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-06-300001682149dvlt:InducementGrantMemberus-gaap:RestrictedStockUnitsRSUMember2026-01-012026-06-300001682149dvlt:RestrictedStockAwardsMember2026-01-012026-06-300001682149us-gaap:CommonStockMember2025-01-012025-06-300001682149us-gaap:RestrictedStockMember2025-01-012025-06-300001682149us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-06-300001682149dvlt:RestrictedStockAwardsMember2025-01-012025-06-300001682149dvlt:InducementGrantMemberus-gaap:RestrictedStockMember2025-01-012025-06-300001682149dvlt:CompuSystemsIncMember2025-05-202025-05-200001682149dvlt:CompuSystemsIncMember2024-10-012024-12-310001682149dvlt:CompuSystemsIncMember2025-01-012025-01-310001682149dvlt:InitialConvertibleNoteMemberdvlt:CompuSystemsIncMember2025-05-202025-05-200001682149dvlt:FirstConvertibleNoteMemberdvlt:CompuSystemsIncMember2025-05-202025-05-200001682149dvlt:SecondConvertibleNoteMemberdvlt:CompuSystemsIncMember2025-05-202025-05-200001682149dvlt:CsiConvertibleNotesMemberdvlt:CompuSystemsIncMember2025-05-200001682149dvlt:CompuSystemsIncMember2024-12-012024-12-310001682149dvlt:CompuSystemsIncMember2025-05-012025-05-310001682149dvlt:CompuSystemsIncMember2025-05-200001682149dvlt:CompuSystemsIncMemberus-gaap:TradeNamesMember2025-05-202025-05-200001682149dvlt:CompuSystemsIncMemberus-gaap:TradeNamesMember2025-05-200001682149dvlt:CompuSystemsIncMemberus-gaap:CustomerRelationshipsMember2025-05-202025-05-200001682149dvlt:CompuSystemsIncMemberus-gaap:CustomerRelationshipsMember2025-05-200001682149dvlt:CompuSystemsIncMemberdvlt:InternalUseTechnologyMember2025-05-202025-05-200001682149dvlt:CompuSystemsIncMemberdvlt:InternalUseTechnologyMember2025-05-200001682149dvlt:APIMediaInnovationsInc.Member2025-10-282026-01-220001682149dvlt:APIMediaInnovationsInc.Member2025-10-282025-10-280001682149dvlt:APIMediaInnovationsInc.Member2026-01-220001682149dvlt:APIMediaInnovationsInc.Memberus-gaap:TradeNamesMember2026-01-222026-01-220001682149dvlt:APIMediaInnovationsInc.Memberus-gaap:TradeNamesMember2026-01-220001682149dvlt:APIMediaInnovationsInc.Memberus-gaap:CustomerRelationshipsMember2026-01-222026-01-220001682149dvlt:APIMediaInnovationsInc.Memberus-gaap:CustomerRelationshipsMember2026-01-220001682149dvlt:APIMediaInnovationsInc.Memberdvlt:InternalUseTechnologyMember2026-01-222026-01-220001682149dvlt:APIMediaInnovationsInc.Memberdvlt:InternalUseTechnologyMember2026-01-220001682149dvlt:APIMediaInnovationsInc.Member2026-01-012026-06-300001682149dvlt:APIMediaInnovationsInc.Member2026-01-222026-01-220001682149dvlt:APIMediaInnovationsInc.Member2026-04-012026-06-300001682149dvlt:APIMediaInnovationsInc.Member2025-04-012025-06-300001682149dvlt:APIMediaInnovationsInc.Member2025-01-012025-06-300001682149us-gaap:PatentsMemberus-gaap:RelatedPartyMember2026-01-012026-06-300001682149dvlt:SalieriPlatformMember2026-01-012026-06-300001682149us-gaap:MachineryAndEquipmentMember2026-06-300001682149us-gaap:MachineryAndEquipmentMember2025-12-310001682149us-gaap:ToolsDiesAndMoldsMember2026-06-300001682149us-gaap:ToolsDiesAndMoldsMember2025-12-310001682149us-gaap:ConstructionInProgressMember2026-06-300001682149us-gaap:ConstructionInProgressMember2025-12-310001682149us-gaap:FurnitureAndFixturesMember2026-06-300001682149us-gaap:FurnitureAndFixturesMember2025-12-310001682149us-gaap:LeaseholdImprovementsMember2026-06-300001682149us-gaap:LeaseholdImprovementsMember2025-12-310001682149us-gaap:PatentsMember2026-06-300001682149us-gaap:TrademarksAndTradeNamesMember2026-06-300001682149us-gaap:CustomerRelationshipsMember2026-06-300001682149dvlt:InternalUseTechnologyMember2026-06-300001682149dvlt:NYIAXIncMemberus-gaap:NotesReceivableMember2026-03-310001682149dvlt:NYIAXIncMemberus-gaap:NotesReceivableMember2026-06-300001682149us-gaap:NotesReceivableMember2026-06-300001682149dvlt:NYIAXIncMemberus-gaap:NotesReceivableMember2026-03-012026-03-310001682149dvlt:DVConvertibleNoteMember2024-12-310001682149us-gaap:ConvertibleDebtMember2024-01-012024-12-310001682149dvlt:DVConvertibleNoteMember2024-01-012024-12-310001682149dvlt:DVConvertibleNoteMember2025-02-142025-02-140001682149dvlt:DVConvertibleNoteMember2026-01-012026-06-300001682149dvlt:DVConvertibleNoteMember2025-12-310001682149dvlt:FirstAndSecondConvertibleNotesMember2025-05-200001682149dvlt:FirstConvertibleNoteMember2026-03-182026-03-180001682149dvlt:FirstConvertibleNoteMember2026-01-012026-03-310001682149dvlt:FirstConvertibleNoteMember2026-04-012026-06-300001682149dvlt:SecondConvertibleNoteMember2025-05-202025-05-200001682149dvlt:FirstAndSecondConvertibleNotesMember2025-05-202025-05-200001682149dvlt:FirstAndSecondConvertibleNotesMembersrt:MinimumMember2025-05-200001682149dvlt:FirstAndSecondConvertibleNotesMembersrt:MaximumMember2025-05-200001682149dvlt:CsiConvertibleNotesMember2026-06-300001682149dvlt:CsiConvertibleNotesMember2026-04-012026-06-300001682149dvlt:CsiConvertibleNotesMember2026-01-012026-06-300001682149us-gaap:LoansPayableMemberdvlt:ShortTermFinancingMember2026-05-050001682149us-gaap:LoansPayableMemberdvlt:ShortTermFinancingMember2026-05-052026-05-050001682149us-gaap:LoansPayableMemberdvlt:ShortTermFinancingMember2026-06-300001682149us-gaap:LoansPayableMemberdvlt:ShortTermFinancingMember2026-04-012026-06-300001682149us-gaap:LoansPayableMemberdvlt:ShortTermFinancingMember2026-01-012026-06-300001682149us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel1Memberdvlt:NYIAXMember2026-06-300001682149us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel2Memberdvlt:NYIAXMember2026-06-300001682149us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberdvlt:NYIAXMember2026-06-300001682149us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel1Memberdvlt:VivasorInc.Member2026-06-300001682149us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel2Memberdvlt:VivasorInc.Member2026-06-300001682149us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Memberdvlt:VivasorInc.Member2026-06-300001682149us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsNonrecurringMember2026-06-300001682149us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsNonrecurringMember2026-06-300001682149us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2026-06-300001682149us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2026-06-300001682149us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2026-06-300001682149us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2026-06-300001682149dvlt:TransactionsWithNyiaxInc.Member2026-06-300001682149dvlt:TransactionsWithNyiaxInc.Memberdvlt:NyiaxInvestmentMember2026-06-300001682149dvlt:TransactionsWithNyiaxInc.Member2026-04-012026-06-300001682149dvlt:TransactionsWithNyiaxInc.Member2026-01-012026-06-300001682149dvlt:VivasorInc.Memberdvlt:VivasorInc.InvestmentMember2026-06-300001682149dvlt:VivasorInc.Member2026-04-012026-06-300001682149dvlt:VivasorInc.Member2026-01-012026-06-300001682149dvlt:VivasorInc.Member2026-06-300001682149dvlt:TritonGT1LLCMemberdvlt:TritonGT1LLCMemberdvlt:TritonGT1LLCInvestmentMember2026-01-012026-06-300001682149dvlt:TritonGT1LLCMember2026-06-300001682149us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsNonrecurringMember2025-12-310001682149us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsNonrecurringMember2025-12-310001682149us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2025-12-310001682149us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001682149us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001682149us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001682149dvlt:ConvertibleNotesExcludingCsiNotesMemberus-gaap:ConvertibleNotesPayableMember2025-12-310001682149dvlt:ConvertibleNotesExcludingCsiNotesMemberus-gaap:ConvertibleNotesPayableMember2024-12-310001682149dvlt:ConvertibleNotesExcludingCsiNotesMemberus-gaap:ConvertibleNotesPayableMember2026-01-012026-06-300001682149dvlt:ConvertibleNotesExcludingCsiNotesMemberus-gaap:ConvertibleNotesPayableMember2025-01-012025-06-300001682149dvlt:SeniorConvertiblePromissoryNotesMemberus-gaap:ConvertibleNotesPayableMember2026-01-012026-06-300001682149dvlt:SeniorConvertiblePromissoryNotesMemberus-gaap:ConvertibleNotesPayableMember2025-01-012025-06-300001682149dvlt:DVConvertibleNoteMemberus-gaap:ConvertibleNotesPayableMember2026-01-012026-06-300001682149dvlt:DVConvertibleNoteMemberus-gaap:ConvertibleNotesPayableMember2025-01-012025-06-300001682149dvlt:ConvertibleNotesExcludingCsiNotesMemberus-gaap:ConvertibleNotesPayableMember2026-06-300001682149dvlt:ConvertibleNotesExcludingCsiNotesMemberus-gaap:ConvertibleNotesPayableMember2025-06-300001682149dvlt:AtMarketOfferingWithMaximMember2026-01-012026-06-300001682149dvlt:AtMarketOfferingWithMaximMember2026-06-300001682149dvlt:CommonStockGrantsMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2026-04-012026-06-300001682149dvlt:CommonStockGrantsMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2026-01-012026-06-300001682149dvlt:CommonStockGrantsMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2026-01-012026-03-3100016821492025-12-290001682149dvlt:WarrantDividendMember2026-02-272026-02-270001682149dvlt:WarrantDividendMember2025-12-290001682149dvlt:WarrantDividendMember2026-01-072026-01-070001682149us-gaap:MeasurementInputSharePriceMember2026-01-070001682149dvlt:WarrantDividendMember2026-01-070001682149us-gaap:MeasurementInputExpectedTermMember2026-01-070001682149us-gaap:MeasurementInputPriceVolatilityMember2026-01-070001682149us-gaap:MeasurementInputRiskFreeInterestRateMember2026-01-070001682149us-gaap:MeasurementInputSharePriceMember2026-02-270001682149dvlt:WarrantDividendMember2026-02-270001682149us-gaap:MeasurementInputExpectedTermMember2026-02-270001682149us-gaap:MeasurementInputPriceVolatilityMember2026-02-270001682149us-gaap:MeasurementInputRiskFreeInterestRateMember2026-02-270001682149dvlt:StockPurchaseAgreementMemberdvlt:EquityInvestmentInVivasorMemberus-gaap:RelatedPartyMember2026-04-162026-04-160001682149dvlt:StockPurchaseAgreementMemberus-gaap:RelatedPartyMember2026-04-162026-04-160001682149dvlt:RegisteredDirectOfferingMember2026-05-032026-05-030001682149dvlt:RegisteredDirectOfferingMember2026-05-030001682149us-gaap:WarrantMemberdvlt:RegisteredDirectOfferingMember2026-05-030001682149us-gaap:CommonStockMemberdvlt:RegisteredDirectOfferingMember2026-05-030001682149us-gaap:WarrantMemberdvlt:RegisteredDirectOfferingMember2026-05-032026-05-030001682149dvlt:WarrantDividendMemberdvlt:RegisteredDirectOfferingMember2026-05-052026-05-050001682149us-gaap:MeasurementInputSharePriceMemberdvlt:RegisteredDirectOfferingMember2026-05-050001682149dvlt:WarrantDividendMemberus-gaap:MeasurementInputExercisePriceMemberdvlt:RegisteredDirectOfferingMember2026-05-050001682149us-gaap:MeasurementInputExpectedTermMemberdvlt:RegisteredDirectOfferingMember2026-05-050001682149us-gaap:MeasurementInputPriceVolatilityMemberdvlt:RegisteredDirectOfferingMember2026-05-050001682149us-gaap:MeasurementInputRiskFreeInterestRateMemberdvlt:RegisteredDirectOfferingMember2026-05-050001682149dvlt:CommonStockWarrantsMemberdvlt:PublicOfferingFebruary2024Member2026-06-300001682149dvlt:CommonStockWarrantsMemberdvlt:PublicOfferingFebruary2024Member2025-12-310001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeOneMember2026-06-300001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeOneMember2026-01-012026-06-300001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeTwoMembersrt:MinimumMember2026-06-300001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeTwoMembersrt:MaximumMember2026-06-300001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeTwoMember2026-06-300001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeTwoMember2026-01-012026-06-300001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeThreeMembersrt:MinimumMember2026-06-300001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeThreeMembersrt:MaximumMember2026-06-300001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeThreeMember2026-06-300001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeThreeMember2026-01-012026-06-300001682149us-gaap:WarrantMember2026-06-300001682149us-gaap:WarrantMember2026-01-012026-06-300001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeOneMembersrt:MinimumMember2025-12-310001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeOneMembersrt:MaximumMember2025-12-310001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeOneMember2025-12-310001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeOneMember2025-01-012025-12-310001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeTwoMembersrt:MinimumMember2025-12-310001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeTwoMembersrt:MaximumMember2025-12-310001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeTwoMember2025-12-310001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeTwoMember2025-01-012025-12-310001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeThreeMembersrt:MinimumMember2025-12-310001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeThreeMembersrt:MaximumMember2025-12-310001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeThreeMember2025-12-310001682149us-gaap:WarrantMemberdvlt:ExercisePriceRangeThreeMember2025-01-012025-12-310001682149us-gaap:WarrantMember2025-12-310001682149us-gaap:WarrantMember2025-01-012025-12-310001682149dvlt:LongTermStockIncentivePlanMember2018-01-300001682149dvlt:LongTermStockIncentivePlanMember2026-06-300001682149dvlt:RestrictedStockWithServiceBasedVestingConditionsMember2025-12-310001682149dvlt:RestrictedStockWithServiceBasedVestingConditionsMember2026-01-012026-06-300001682149dvlt:RestrictedStockWithServiceBasedVestingConditionsMember2026-06-300001682149dvlt:RestrictedStockWithPerformanceBasedVestingConditionsMember2025-12-310001682149dvlt:RestrictedStockWithPerformanceBasedVestingConditionsMember2026-01-012026-06-300001682149dvlt:RestrictedStockWithPerformanceBasedVestingConditionsMember2026-06-300001682149us-gaap:PerformanceSharesMember2026-01-012026-06-300001682149dvlt:LongTermStockIncentivePlanMemberdvlt:RestrictedStockWithPerformanceBasedVestingConditionsMember2026-01-012026-06-300001682149dvlt:LongTermStockIncentivePlanMemberus-gaap:RestrictedStockMember2026-01-012026-06-300001682149dvlt:BradleyInducementGrantMemberus-gaap:RestrictedStockUnitsRSUMember2025-01-022025-01-020001682149dvlt:BradleyInducementGrantMemberdvlt:RestrictedStockWithServiceBasedVestingConditionsMember2025-01-022025-01-020001682149dvlt:BradleyInducementGrantMemberdvlt:RestrictedStockWithPerformanceBasedVestingConditionsMember2025-01-022025-01-020001682149dvlt:BradleyInducementGrantMember2026-01-012026-06-300001682149dvlt:BradleyInducementGrantMember2026-06-300001682149dvlt:LoguiratoInducementGrantMemberus-gaap:RestrictedStockUnitsRSUMember2025-05-202025-05-200001682149dvlt:LoguiratoInducementGrantMemberdvlt:RestrictedStockWithServiceBasedVestingConditionsMember2025-05-202025-05-200001682149dvlt:LoguiratoInducementGrantMemberdvlt:RestrictedStockWithPerformanceBasedVestingConditionsMember2025-05-202025-05-200001682149dvlt:LoguiratoInducementGrantMemberdvlt:RestrictedStockWithPerformanceBasedVestingConditionsMember2026-06-300001682149dvlt:LoguiratoInducementGrantMemberdvlt:RestrictedStockWithPerformanceBasedVestingConditionsMember2026-04-012026-06-300001682149dvlt:ExchangeAgreementMember2025-03-162025-03-160001682149dvlt:ExchangeAgreementMember2025-03-160001682149dvlt:TransactionsWithNyiaxInc.Member2025-04-090001682149dvlt:TransactionsWithNyiaxInc.Member2025-04-092025-04-090001682149dvlt:NyiaxAcquisitionMember2026-03-182026-03-180001682149dvlt:NyiaxAcquisitionMember2026-03-180001682149dvlt:LicenseProgramsMember2025-06-300001682149dvlt:LicenseProgramsMember2025-09-3000016821492025-07-072025-07-070001682149dvlt:LicenseProgramsMember2025-08-080001682149dvlt:LicenseProgramsMemberdvlt:PaymentAtTimeOfAgreementMember2025-09-230001682149dvlt:LicenseProgramsMemberdvlt:PaymentOnDecember232025Member2025-09-230001682149dvlt:LicenseProgramsMemberdvlt:PaymentOnDecember232025Member2025-09-232025-09-230001682149dvlt:LicenseProgramsMemberdvlt:PaymentAfterFiscal2025TillFinalPaymentOnDecember232027Member2025-09-230001682149dvlt:LicenseProgramsMember2026-06-300001682149dvlt:CloudServicesMember2025-07-070001682149dvlt:AgreementWithIBMForTheSanQtumAIEnterpriseUnitInstallationMember2025-11-302025-11-300001682149dvlt:AgreementWithIBMForTheSanQtumAIEnterpriseUnitInstallationMember2026-06-300001682149dvlt:AgreementWithIBMForTheSanQtumAIEnterpriseUnitInstallationMember2026-01-012026-06-300001682149dvlt:MasterPurchaseOrderAgreementMember2026-01-042026-01-040001682149dvlt:MasterPurchaseOrderAgreementMember2026-06-300001682149dvlt:EosTechnologyHoldingsInc.Member2024-01-012024-12-310001682149dvlt:HelmexAgreementMember2026-05-302026-05-300001682149dvlt:EosTechnologyHoldingsInc.Memberus-gaap:RelatedPartyMember2026-01-012026-06-300001682149dvlt:DVConvertibleNoteMemberdvlt:EosTechnologyHoldingsInc.Memberus-gaap:RelatedPartyMember2026-04-012026-06-300001682149dvlt:EosTechnologyHoldingsInc.Memberus-gaap:RelatedPartyMember2026-04-012026-06-300001682149dvlt:EosTechnologyHoldingsInc.Memberus-gaap:RelatedPartyMember2026-06-300001682149dvlt:EosTechnologyHoldingsInc.Memberus-gaap:RelatedPartyMember2025-04-012025-06-300001682149dvlt:EosTechnologyHoldingsInc.Memberus-gaap:RelatedPartyMember2025-01-012025-06-300001682149dvlt:EosTechnologyHoldingsInc.Member2026-01-012026-06-300001682149dvlt:EosTechnologyHoldingsInc.Member2026-04-012026-06-300001682149dvlt:EosTechnologyHoldingsInc.Member2025-04-012025-06-300001682149dvlt:EosTechnologyHoldingsInc.Member2025-01-012025-06-300001682149dvlt:EosTechnologyHoldingsInc.Member2025-01-012025-12-310001682149dvlt:PurchaseFromRelatedPartyMemberdvlt:HansongTechnologyMemberus-gaap:RelatedPartyMember2026-04-012026-06-300001682149dvlt:PurchaseFromRelatedPartyMemberdvlt:HansongTechnologyMemberus-gaap:RelatedPartyMember2025-04-012025-06-300001682149dvlt:PurchaseFromRelatedPartyMemberdvlt:HansongTechnologyMemberus-gaap:RelatedPartyMember2026-06-300001682149dvlt:PurchaseFromRelatedPartyMemberdvlt:HansongTechnologyMemberus-gaap:RelatedPartyMember2025-06-300001682149dvlt:PurchaseFromRelatedPartyMemberdvlt:HansongTechnologyMemberus-gaap:RelatedPartyMember2026-01-012026-06-300001682149dvlt:PurchaseFromRelatedPartyMemberdvlt:HansongTechnologyMemberus-gaap:RelatedPartyMember2025-01-012025-06-300001682149dvlt:SalesToRelatedPartyMemberdvlt:HansongTechnologyMemberus-gaap:RelatedPartyMember2026-04-012026-06-300001682149dvlt:SalesToRelatedPartyMemberdvlt:HansongTechnologyMemberus-gaap:RelatedPartyMember2025-04-012025-06-300001682149dvlt:HansongTechnologyMemberdvlt:HansongTechnologyMember2026-06-300001682149dvlt:HansongTechnologyMemberdvlt:HansongTechnologyMember2025-06-300001682149dvlt:SalesToRelatedPartyMemberdvlt:HansongTechnologyMemberus-gaap:RelatedPartyMember2026-01-012026-06-300001682149dvlt:SalesToRelatedPartyMemberdvlt:HansongTechnologyMemberus-gaap:RelatedPartyMember2025-01-012025-06-300001682149dvlt:DataVaultAiInc.Memberdvlt:HelgeKristensenMemberdvlt:HansongTechnologyMemberus-gaap:RelatedPartyMember2025-12-310001682149dvlt:DataVaultAiInc.Memberdvlt:HelgeKristensenMemberdvlt:HansongTechnologyMemberus-gaap:RelatedPartyMember2026-06-300001682149dvlt:ScilexHoldingCo.Inc.Memberus-gaap:RelatedPartyMember2026-06-300001682149dvlt:ScilexHoldingCo.Inc.Memberus-gaap:RelatedPartyMember2026-01-012026-06-300001682149dvlt:ScilexHoldingCo.Inc.Memberus-gaap:RelatedPartyMember2025-04-012025-06-300001682149dvlt:ScilexHoldingCo.Inc.Memberus-gaap:RelatedPartyMember2025-01-012025-06-300001682149us-gaap:PatentsMemberus-gaap:RelatedPartyMember2026-04-012026-06-300001682149us-gaap:PatentsMemberus-gaap:RelatedPartyMember2025-04-012025-06-300001682149us-gaap:PatentsMemberus-gaap:RelatedPartyMember2025-01-012025-06-300001682149dvlt:VivasorInc.Memberdvlt:VivasorInc.InvestmentMemberus-gaap:RelatedPartyMember2026-06-300001682149dvlt:VivasorInc.Memberus-gaap:RelatedPartyMember2026-06-300001682149dvlt:VivasorInc.Memberus-gaap:RelatedPartyMember2026-04-012026-06-300001682149dvlt:VivasorInc.Memberus-gaap:RelatedPartyMember2026-01-012026-06-300001682149dvlt:SingleReportableSegmentMember2026-04-012026-06-300001682149dvlt:SingleReportableSegmentMember2025-04-012025-06-300001682149dvlt:SingleReportableSegmentMember2026-01-012026-06-300001682149dvlt:SingleReportableSegmentMember2025-01-012025-06-300001682149srt:NorthAmericaMember2026-04-012026-06-300001682149srt:NorthAmericaMember2025-04-012025-06-300001682149srt:NorthAmericaMember2026-01-012026-06-300001682149srt:NorthAmericaMember2025-01-012025-06-300001682149srt:AsiaPacificMember2026-04-012026-06-300001682149srt:AsiaPacificMember2025-04-012025-06-300001682149srt:AsiaPacificMember2026-01-012026-06-300001682149srt:AsiaPacificMember2025-01-012025-06-300001682149srt:EuropeMember2026-04-012026-06-300001682149srt:EuropeMember2025-04-012025-06-300001682149srt:EuropeMember2026-01-012026-06-300001682149srt:EuropeMember2025-01-012025-06-300001682149us-gaap:PerformanceGuaranteeMemberus-gaap:BridgeLoanMemberus-gaap:SubsequentEventMemberdvlt:NYIAXBridgeLoanGuaranteeMember2026-07-170001682149us-gaap:BridgeLoanMemberus-gaap:SubsequentEventMemberdvlt:NYIAXBridgeLoanGuaranteeMemberdvlt:NYIAXMember2026-07-170001682149us-gaap:BridgeLoanMemberus-gaap:SubsequentEventMemberdvlt:NYIAXBridgeLoanGuaranteeMemberdvlt:NYIAXMember2026-07-172026-07-170001682149us-gaap:SubsequentEventMemberdvlt:EosTechnologyHoldingsInc.Member2026-07-292026-07-290001682149us-gaap:SubsequentEventMemberdvlt:CyberCatchHoldingsInc.Member2026-08-140001682149us-gaap:SubsequentEventMemberdvlt:CyberCatchHoldingsInc.Member2026-08-142026-08-140001682149us-gaap:SubsequentEventMemberdvlt:CyberCatchHoldingsInc.Memberus-gaap:PerformanceGuaranteeMemberus-gaap:BridgeLoanMemberdvlt:CyberCatchBridgeLoanGuaranteeMember2026-08-140001682149dvlt:AugustConvertiblePromissoryNotesMemberus-gaap:SubsequentEventMemberdvlt:SecuritiesPurchaseAgreementAugust2026OfferingMember2026-08-180001682149dvlt:AdditionalAugustConvertiblePromissoryNotesMemberus-gaap:SubsequentEventMemberdvlt:SecuritiesPurchaseAgreementAugust2026OfferingMember2026-08-180001682149us-gaap:SubsequentEventMemberdvlt:SecuritiesPurchaseAgreementAugust2026OfferingMember2026-08-182026-08-180001682149dvlt:AugustConvertiblePromissoryNotesMemberus-gaap:SubsequentEventMemberdvlt:SecuritiesPurchaseAgreementAugust2026OfferingMember2026-08-182026-08-180001682149dvlt:AdditionalAugustConvertiblePromissoryNotesMemberus-gaap:SubsequentEventMemberdvlt:SecuritiesPurchaseAgreementAugust2026OfferingMember2026-08-182026-08-180001682149us-gaap:SubsequentEventMemberdvlt:NyiaxAcquisitionMember2026-08-192026-08-190001682149us-gaap:SubsequentEventMemberdvlt:NyiaxAcquisitionMember2026-08-190001682149us-gaap:SubsequentEventMemberdvlt:BankWyseAcquisitionMember2026-08-192026-08-190001682149us-gaap:SubsequentEventMemberdvlt:APCyberWarrantMember2026-07-220001682149us-gaap:SubsequentEventMemberdvlt:APCyberWarrantMemberus-gaap:CommonStockMember2026-07-220001682149us-gaap:SubsequentEventMemberdvlt:APCyberWarrantMember2026-07-222026-07-22
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2026
or
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______________to _______________.
Commission File Number: 001-38608
Datavault AI Inc.
(Exact name of registrant as specified in its charter)
Delaware30-1135279
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
One Commerce Square
2005 Market Street, Suite 2400
Philadelphia, PA 19103
(Address of principal executive offices) (Zip Code)
(408) 627-4716
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common Stock, par value $0.0001 per shareDVLT
The Nasdaq Capital Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
o
Accelerated filer
o
Non-accelerated filer
x
Smaller reporting company
x
Emerging growth company
o
If an emerging growth company, indicate by check-mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
The number of shares of the registrant’s common stock outstanding as of August 19, 2026 is 949,728,605.


Table of Contents
DATAVAULT AI INC. and Subsidiaries
QUARTERLY REPORT ON FORM 10-Q
For the period ended June 30, 2026
Page
Number
2

Table of Contents
PART I: FINANCIAL INFORMATION
Item 1. Financial Statements
DATAVAULT AI INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data)
(unaudited)
June 30, 2026December 31, 2025
Assets
Current Assets:
Cash and cash equivalents$1,400 $2,004 
Accounts receivable3,598 888 
Related party receivable24,040 30,000 
Unbilled accounts receivable621 1,705 
Inventories942 636 
Note receivable1,900 — 
Crypto assets49,016 92,222 
Deferred offering costs5,245 5,500 
Prepaid software license, current8,084 7,759 
Prepaid expenses and other current assets40,115 2,159 
Total current assets134,961 142,873 
Property and equipment, net2,452 606 
Intangible assets, net100,235 94,816 
Goodwill27,285 19,135 
Prepaid software license, noncurrent5,158 6,956 
Investments in non-marketable securities1,892 4,300 
Deposit for business combination— 1,000 
Other assets4,659 5,018 
Total assets$276,642 $274,704 
Liabilities and Stockholders' Equity
Current Liabilities:
Accounts payable$9,705 $10,832 
Accrued liabilities11,549 11,002 
Due to related party788 98 
Short-term convertible note payable, related party3,680 3,936 
Short-term promissory notes1,544 1,013 
Total current liabilities27,266 26,881 
Convertible notes payable— 5,917 
Other liabilities3,482 3,932 
Total liabilities30,748 36,730 
Commitments and contingencies (Note 9)
Common stock, par value $0.0001; 2,000,000,000 shares authorized; 854,456,625 and 573,438,153 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
87 59 
Additional paid-in capital764,408 615,360 
Accumulated deficit(518,601)(377,445)
Total stockholders’ equity245,894 237,974 
Total liabilities and stockholders’ equity$276,642 $274,704 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
3

Table of Contents
DATAVAULT AI INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
For the three and six months ended June 30, 2026 and 2025
(in thousands, except share and per share data)
(unaudited)
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Live event production revenue$2,839 $1,432 $5,338 $1,432 
Consumer audio products, components, and other revenue, net1,053 277 1,829 895 
Consumer audio products and components, related party, net
316 26 457 37 
Patent license revenue
2,509 — 2,509 — 
Total net revenue6,717 1,735 10,133 2,364 
Cost of revenue, live events3,278 1,396 6,073 1,396 
Cost of revenue, consumer audio products, components, and other557 304 1,067 864 
Cost of revenue, patent license
— — 
Total cost of net revenue3,839 1,700 7,144 2,260 
Gross profit2,878 35 2,989 104 
Operating Expenses:
Research and development7,235 4,224 12,964 6,585 
Sales and marketing7,184 1,742 13,820 3,237 
General and administrative14,915 6,528 33,611 12,172 
Total operating expenses29,334 12,494 60,395 21,994 
Loss from operations(26,456)(12,459)(57,406)(21,890)
Interest expense, net(1,000)(17,202)(2,121)(17,322)
Change in fair value of 2025 Notes measured at fair value
— (8,804)— (8,804)
Change in fair value of convertible note to related party measured at fair value
— 1,355 — 1,355 
Loss on Crypto assets
(8,094)— (25,050)— 
Extinguishment of debt— — (1,725)— 
Impairment of investments in non-marketable securities
(56,372)— (58,906)— 
Change in fair value of warrant liabilities
3,866 3,866 19 
Other income/(expense), net31 (3)186 (32)
Loss before provision for income taxes(88,025)(37,111)(141,156)(46,674)
Provision for income taxes— — 
Net loss attributable to common stockholders$(88,025)$(37,116)$(141,156)$(46,679)
Net loss per common share - basic and diluted$(0.12)$(0.54)$(0.22)$(0.77)
Weighted average number of common shares used in computing net loss per common share727,623,511 68,174,418 651,345,981 60,968,158 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
4

Table of Contents
DATAVAULT AI INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
For the three and six months ended June 30, 2026 and 2025
(in thousands, except share and per share data)
(unaudited)
Common SharesAdditional
Paid-in Capital
Accumulated
Deficit
Total
Stockholders’
Equity
SharesAmount
Balance as of December 31, 2025573,438,153$59 $615,360 $(377,445)$237,974 
Stock-based compensation211,131— 5,234 — 5,234 
Equity issuance costs— (250)— (250)
Issuance of common stock for intangible asset acquisition7,500,0005,400 — 5,401 
Issuance of common stock in connection with ATM offering, net of fees36,663,89224,797 — 24,800 
Net loss— — (53,131)(53,131)
Balance as of March 31, 2026
617,813,176$63 $650,541 $(430,576)$220,028 
Stock-based compensation46,094,139— 5,657 — 5,657 
Equity issuance costs— (2,108)— (2,108)
Issuance of common stock with NYIAX transaction2,000,000— — — — 
Issuance of common stock in connection with Vivasor investment75,942,66656,190 — 56,198 
Issuance of common stock in connection with May Offering, net of fees
109,090,91011 55,729 — 55,740 
Issuance of common stock in connection with ATM offering, net of fees3,515,7342,371 — 2,376 
Warrant dividend classified as liability
— (3,972)— (3,972)
Net loss
— — (88,025)(88,025)
Balance as of June 30, 2026854,456,625$87 $764,408 $(518,601)$245,894 
Common SharesAdditional
Paid-in Capital
Accumulated
Deficit
Total
Stockholders’
Equity
SharesAmount
Balance as of December 31, 202452,034,060$$384,172 $(298,451)$85,726 
Stock-based compensation5,986,893— 648 — 648 
Issuance of common stock in connection with the February Offering4,757,1264,859 — 4,860 
Issuance of common stock in connection with warrant exercise3,246,111— — — — 
Conversion of liability warrants to equity warrants— 15 — 15 
Net loss— — (9,563)(9,563)
Balance as of March 31, 202566,024,190$$389,694 $(308,014)$81,686 
Stock-based compensation3,701,197— 1,151 — 1,151 
Issuance of common stock in connection with warrant exercise2,989,887— — — — 
Issuance of common stock for conversions1,845,945— 1,545 — 1,545 
Issuance of common stock with NYIAX transaction1,500,000— — — — 
Issuance of warrants with the 2025 Notes— 16,657 — 16,657 
Issuance of common stock for the acquisition of CompuSystems, Inc.
10,600,00010,282 — 10,283 
Equity Issuance costs— (137)— (137)
Net loss— — (37,116)(37,116)
Balance as of June 30, 202586,661,219$$419,192 $(345,130)$74,069 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
5

Table of Contents
DATAVAULT AI INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the six months ended June 30, 2026 and 2025
(in thousands)
(unaudited)
Six Months Ended June 30,
20262025
Cash flows from operating activities:
Net loss$(141,156)$(46,679)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation10,891 1,799 
Depreciation and amortization6,449 4,825 
Amortization of debt discounts and paid-in-kind interest1,308 520 
Change in fair value of convertible debt— 7,595 
Fair value of equity warrants in interest expense— 16,657 
Loss on digital assets25,050 — 
Debt extinguishment1,725 — 
Impairment of investments in non-marketable securities58,906 — 
Shares payable to NYIAX— 1,088 
Change in fair value of warrant liability(3,866)(19)
Changes in operating assets and liabilities:
Accounts receivable(2,312)(119)
Related party receivable5,960 — 
Unbilled accounts receivable1,084 21 
Inventories(306)416 
Prepaid expenses and other current assets(43,269)182 
Prepaid software1,473 — 
Other assets446 54 
Accounts payable(2,404)962 
Related party payable
146 — 
Accrued liabilities393 (68)
Other liabilities(481)(65)
Net cash used in operating activities(79,963)(12,831)
Cash flows from investing activities:
Issuances of notes receivable(2,000)— 
Repayment of note receivable100 — 
Cash paid for acquisition of API Media, net of cash(12,949)— 
Cash paid for acquisition of CSI, net of cash
— (6,500)
Purchases of property and equipment(582)(52)
Construction in progress(555)— 
Purchases of intangible assets(824)— 
Investment in non-marketable securities(300)— 
Net cash used in investing activities(17,110)(6,552)
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
6

Table of Contents
DATAVAULT AI INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the six months ended June 30, 2026 and 2025
(in thousands)
(unaudited)
Six Months Ended June 30,
20262025
Cash flows from financing activities:
Proceeds from issuance of short-term debt
$2,000 $— 
Proceeds from issuing shares through an At-The-Market (ATM) program
32,363 — 
Proceeds from issuance of common stock in connection with May Offering55,740 — 
Proceeds from issuance of convertible notes, net of issuance costs— 13,698 
Proceeds from issuance of common stock, net of issuance costs— 4,722 
Advances from related party
18,700 — 
Debt issuance costs
(80)— 
Equity issuance costs(1,626)— 
Repayments of notes payable(6,688)— 
Repayments of convertible note payable, related party
(3,940)(1,083)
Repurchase of common stock warrants— (622)
Net cash provided by financing activities96,469 16,715 
Net decrease in cash and cash equivalents
(604)(2,668)
Cash and cash equivalents as of beginning of period2,004 3,330 
Cash and cash equivalents as of end of period$1,400 $662 
Non-cash Investing and Financing Activities:
ATM non-cash offering costs
5,557 — 
Repayment of advances from related party with Bitcoin
18,156 — 
Intangible assets acquired with issuance of common stock5,401 — 
Investment in Vivasor, Inc. through common stock issuance
56,198 — 
Warrant dividend classified as liability
3,972 — 
Capitalized acquisition costs— 117 
CompuSystems, Inc. Convertible Notes issued for CompuSystems, Inc. acquisition
— 9,718 
Non cash common shares issued in CompuSystems, Inc. acquisition
— 10,282 
Deposit paid in December 2024 used in CompuSystems, Inc. acquisition closing
— 1,000 
Shares payable to NYIAX in share exchange agreement— 1,088 
Reclass liability warrant to equity— 15 
May 2025 10% note conversions— 1,545 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

7

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the three and six months ended June 30, 2026 and 2025
(unaudited)

1.    Business and Summary of Significant Accounting Policies
Datavault AI Inc., formerly known as WiSA Technologies, Inc., and before then Summit Wireless Technologies, Inc. (together with its subsidiaries also referred to herein as “we,” “us,” “our,” “Datavault,” “Datavault AI” or the “Company”), was originally formed as a limited liability company in Delaware on July 23, 2010. The Company operates through two synergistic technology platforms, Data Sciences and Acoustic Sciences. The Data Sciences platform is focused on data management, valuation and monetization technologies, while the Acoustic Sciences platform is focused on technologies and solutions involving data-over-sound, spatial and high-definition audio, and live-event data capture and engagement.
On May 20, 2025, the Company completed its previously announced asset purchase of technology assets, customer contracts, trademarks, and other intellectual property (collectively, the “CSI Acquired Assets”) from CompuSystems, Inc. (“CSI”). CSI is a provider of registration, data analytics, and lead management services for live events, offering customer support to clients in the trade, association, corporate, and government event markets. The Company operates the CSI Acquired Assets under the brand name “Event Citadel” as part of its Acoustic Sciences platform. The results of operations attributable to the CSI Acquired Assets are included in the Company’s unaudited condensed consolidated financial statements from May 20, 2025, onward.
On January 22, 2026, the Company completed its previously announced acquisition of all of the outstanding shares of API Media Innovations Inc. (“API Media”). API Media is a technology provider specializing in on-site media capture, data collection, and digital engagement services for live outdoor events, including sporting events and large-scale experiential activations. API Media operates as part of the Company’s Acoustic Sciences platform. The results of operations of API Media are included in the Company’s unaudited condensed consolidated financial statements from January 22, 2026, onward and, accordingly, are included in the Company’s unaudited condensed consolidated financial statements for the three and six months ended June 30, 2026.
Nasdaq Compliance
On February 24, 2026, the Company received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”), because the closing bid price of the Company’s common stock had remained below $1.00 per share for 30 consecutive business days.
Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted an initial compliance period of 180 calendar days, or until August 24, 2026, to regain compliance with the Minimum Bid Price Requirement. If at any time during the compliance period the closing bid price of the Company’s common stock is at least $1.00 per share for a minimum of ten consecutive business days, Nasdaq will provide written confirmation that the Company has regained compliance.
If the Company does not regain compliance by August 24, 2026, the Company may be eligible for an additional 180-calendar day compliance period, provided it satisfies all other continued listing requirements for the Nasdaq Capital Market, other than the Minimum Bid Price Requirement, and provides written notice to Nasdaq of its intention to regain compliance, including, if necessary, by effecting a reverse stock split.
If the Company does not regain compliance within the applicable compliance period(s), including any extensions that may be granted by Nasdaq, Nasdaq would provide notice that the Company’s common stock would be subject to delisting from the Nasdaq Capital Market.
Previously, on May 6, 2025, the Company received notice from Nasdaq that it was not in compliance with the Minimum Bid Price Requirement. The Company subsequently regained compliance on October 10, 2025 after the closing bid price of the Company’s common stock remained at or above $1.00 per share for ten consecutive business days, and Nasdaq confirmed the matter had been closed.
8

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the three and six months ended June 30, 2026 and 2025
(unaudited)

Basis of Presentation
The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and the instructions to Article 8-03 of Regulation S-X and should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2025. The condensed consolidated balance sheet as of June 30, 2026 was derived from the audited annual financial statements as of December 31, 2025 but does not include all information required by U.S. GAAP for annual financial statements. The financial statements include the accounts of the Company, all entities that are wholly owned by the Company, and all entities in which the Company has a controlling financial interest. All adjustments that, in the opinion of management, are necessary for a fair presentation for the periods presented have been reflected by the Company. Such adjustments are of a normal, recurring nature. The results of operations for the three and six months ended June 30, 2026 are not necessarily indicative of the results that may be expected for the entire fiscal year or for any other interim period. All significant intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
Reclassification
Certain reclassifications have been made to prior periods’ consolidated financial statements to conform to the current period presentation. These reclassifications did not result in any change in previously reported net loss, total assets or stockholders’ equity.
Concentration of Credit Risk and Other Risks and Uncertainties
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited in demand and money market accounts with financial institutions. At times, such deposits may be in excess of insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents.
The Company’s accounts receivable are derived from revenue earned from customers located throughout the world. The Company performs credit evaluations of its customers’ financial condition and may, in certain circumstances, require full or partial payment in advance of shipping. As of June 30, 2026 and December 31, 2025, there was no allowance for credit losses. As of June 30, 2026, the Company had two customers accounting for 54% and 32% of accounts receivable. As of December 31, 2025, the Company had two customers accounting for 65% and 32% of accounts receivable. These receivables are with related parties, Vivasor and Scilex. See related party footnote disclosure.
The Company had two customers accounting for 37% and 9% of its net revenue for the three months ended June 30, 2026. The Company had two customers accounting for 25% and 10% of its net revenue for the six months ended June 30, 2026. The Company had two customer accounting for 18% and 10% of its net revenue for the three months ended June 30, 2025. The Company had two customers accounting for 13% and 10% of its net revenue for the six months ended June 30, 2025.
The Company’s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company’s products, competition from substitute products and larger companies, protection of proprietary technology, strategic relationships and dependence on key individuals.
9

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the three and six months ended June 30, 2026 and 2025
(unaudited)

The Company relies on sole-source suppliers to manufacture some of the components used in its product. The Company’s manufacturers and suppliers may encounter problems during manufacturing due to a variety of reasons, any of which could delay or impede their ability to meet demand. The Company is heavily dependent on a single contractor in China for assembly and testing of its products, a single contractor in Japan for the production of its transmit semiconductor chips and a single contractor in China for the production of its receive semiconductor chips.
The Company also generates revenue through the licensing of its proprietary intellectual property and through the provision of live event and media-related services. Revenue derived from intellectual property licensing arrangements may be concentrated among a limited number of counterparties and is subject to risks including the licensee’s ability to commercialize the underlying technology, maintain sufficient funding, and comply with contractual payment terms. Additionally, certain licensing arrangements may include variable consideration or milestone-based payments, which could impact the timing and amount of revenue recognized.
Revenue from the Company’s live event and media services business is dependent on the successful execution of events, customer demand, and the continuation of relationships with key customers and partners. This line of business may be subject to seasonality, event timing, and external factors such as economic conditions, venue availability, and potential disruptions to scheduled events. The Company may also rely on a limited number of significant customers, which could result in revenue concentration and variability in operating results from period to period.
Fair Value of Financial Instruments
Carrying amounts of certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities approximate fair value due to their relatively short maturities. The carrying value of the Company’s borrowings and capital lease liabilities approximates fair value based upon borrowing rates currently available to the Company for loans with similar terms. The Company’s Crypto assets are the only financial instruments that are adjusted to fair value on a recurring basis.
Goodwill and Intangible Assets
The Company's intangible assets include goodwill and other intangible assets. Goodwill is recorded when the purchase price paid for an acquisition exceeds the estimated fair value of the net identified tangible and intangible assets acquired. Other intangible assets include trademarks and trade names, patents and customer-related intangibles. Indefinite-lived intangible assets consist of goodwill. All other intangible assets are definite-lived intangible assets and are amortized over their respective estimated lives, ranging from 3 to 10 years.
The Company is required to perform an impairment review of indefinite-lived intangible assets, including goodwill annually, and more frequently under certain circumstances. Indefinite-lived intangible assets are subjected to this annual impairment test during the fourth quarter of the Company's fiscal year. The Company's impairment evaluation consists of a qualitative impairment assessment in which management evaluates whether it is more likely than not that the indefinite-lived intangible assets are impaired. If it is determined that it is more likely than not, the Company performs a quantitative impairment test, which compares the fair value of the reporting unit or indefinite-lived intangible asset to its carrying value. If the Company determines through the impairment process that the indefinite-lived intangible asset has been impaired, the Company will record the impairment charge in its results of operation. In the event that facts and circumstances indicate definite-lived intangible assets may be impaired, the Company evaluates the recoverability and estimated useful lives of such assets. If such indicators are present, recoverability is evaluated based on whether the sum of the estimated undiscounted cash flows attributable to the asset (group) in question is less than their carrying value. If less, the Company measures the fair value of the asset (group) and recognizes an impairment loss if the carrying amount of the assets exceeds their respective fair values.
Business Combinations
We account for acquisitions of entities or asset groups that qualify as businesses using the acquisition method of accounting. Purchase consideration is allocated to the tangible and intangible assets acquired and liabilities assumed
10

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the three and six months ended June 30, 2026 and 2025
(unaudited)

based on the estimated fair values as of the acquisition date, which are measured in accordance with fair value measurement accounting principles. The determination of fair value requires management to make estimates about discount rates, future expected cash flows, market conditions and other future events that are highly subjective in nature. The excess of the total purchase consideration over the fair value of the identified net assets acquired is recognized as goodwill. The results of the acquired businesses are included in our results of operations beginning from the date of acquisition. Acquisition-related costs are expensed as incurred.
During the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the allocation of purchase consideration and to the fair values of assets acquired and liabilities assumed to the extent that additional information becomes available. After this period, any subsequent adjustments are recorded in the consolidated statements of operations.
Asset Acquisitions
We account for acquisitions of assets or groups of assets that do not meet the definition of a business as asset acquisitions. The cost of an asset acquisition, including transaction costs, is allocated to the individual assets acquired and liabilities assumed based on their relative fair values. No goodwill is recognized in an asset acquisition. Acquired intangible assets are amortized over their estimated useful lives when finite-lived and are evaluated for impairment in accordance with the applicable accounting guidance.
Revenue Recognition
The Company generates revenue from the sale of consumer audio products and components (“Consumer Audio and Components”), registration, data analytics, and lead management services for live events (“Event Citadel Live Events”), event-based media and broadcasting services (“API Media”), and licensing patents. The Company recognizes revenue in accordance with Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers, using the following five-step model: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when, or as, performance obligations are satisfied.
Consumer Audio and Components
Customer purchase orders are considered contracts with customers for Consumer Audio and Components. Revenue, net of expected discounts and allowances, is recognized when control of the promised goods transfers to the customer, which typically occurs upon shipment. The products have been determined to represent the only distinct performance obligations within these arrangements.
Sales to certain distributors may include price adjustments, price protection, stock rotation, and other allowances under certain circumstances. These items are accounted for as variable consideration and are estimated at contract inception based on the expected amount to be provided to customers, which reduces the amount of revenue recognized. Although the Company does not provide customers with a contractual right of return, limited returns may be accepted on a case-by-case basis and are also accounted for as variable consideration. The Company does not expect significant changes to its estimates of variable consideration. Expected costs associated with assurance warranties and claims are recognized as expense as incurred. Taxes assessed by governmental authorities that are both imposed on and concurrent with specific revenue-producing transactions, and that are collected from customers and remitted to governmental authorities, are excluded from revenue.
Event Citadel Live Events
Event Citadel Live Events contracts generally relate to registration, data analytics, lead management, and event preparation and management services provided for trade shows, conferences, and other live events in both the corporate and government sectors. Contracts are generally multi-year arrangements with terms of approximately three years and typically terminate upon completion of the final event specified within the agreement, unless extended by
11

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the three and six months ended June 30, 2026 and 2025
(unaudited)

mutual written consent. Event Citadel contracts generally do not contain termination-for-convenience provisions. Contracts may only be terminated for breach or non-performance, in which case the Company is entitled to compensation for services performed through the termination date.
The Company has concluded that Event Citadel contracts generally contain a single performance obligation consisting of integrated event preparation and management services, as the services are highly interrelated and are not separately identifiable within the context of the contract. The transaction price generally includes fixed service fees, pass-through costs, and other reimbursable expenses, including personnel and supply-related costs incurred on behalf of clients. The Company has concluded it acts as principal in these arrangements and therefore recognizes pass-through and reimbursable costs on a gross basis within revenue, with the corresponding expenses recognized within cost of services. Certain contracts also include rebates payable to customers, which are estimated as variable consideration using the most likely amount method and reduce the transaction price.
Revenue is recognized over time as services are rendered because the customer simultaneously receives and consumes the benefits provided by the Company’s performance. The Company measures progress toward satisfaction of the performance obligation using an input method based on labor hours incurred, which management believes best depicts the transfer of services to the customer.
API Media
API Media provides event-based broadcasting, media, and data services for live sporting events, exhibitions, and other large-scale gatherings. Customer contracts generally contain a single integrated performance obligation consisting of on-site event services. Contracts typically require an upfront deposit, with the remaining balance invoiced upon completion of the event. Amounts billed or collected in advance are recorded as contract liabilities until the related services are performed. Revenue is recognized at a point in time upon completion of services at the event, which represents the point at which control of the promised services transfers to the customer and the Company’s performance obligation is satisfied. The Company’s revenue arrangements do not contain significant financing components.
Patent and Intellectual Property Licensing
Revenues generated from patent and intellectual property licensing arrangements are derived from granting customers rights to use the Company’s patented technologies and related intellectual property. The Company evaluates each arrangement to determine whether the license represents (i) a right-to-use intellectual property at a point in time or (ii) a right-to-access intellectual property over time in accordance with ASC 606-10-55-58 through 55-64.
Licenses that provide customers with a right-to-use functional intellectual property, where the underlying intellectual property is not expected to be significantly modified or enhanced by the Company during the license term, are recognized at a point in time when control of the license transfers to the customer. Control generally transfers upon execution of the agreement, at which point the customer has the right and ability to use, and obtain substantially all of the remaining benefits from, the licensed intellectual property.
Certain arrangements include fixed upfront license fees, sales-based or usage-based royalties, or a combination of both. Fixed consideration is recognized in accordance with the timing of the underlying license (point in time or over time). Sales-based or usage-based royalties promised in exchange for a license of intellectual property are recognized in the period in which the subsequent sales or usage occurs in accordance with the sales- or usage-based royalty exception under ASC 606-10-55-65.
12

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the three and six months ended June 30, 2026 and 2025
(unaudited)

During the three and six months ended June 30, 2026 and 2025, net revenue consisted of the following:
For the Three Months Ended June 30,For the Six Months Ended June 30,
(in thousands)2026202520262025
Live Events$2,839 $1,432 $5,338 $1,432 
Consumer Audio Products10 45 24 182 
Components1,359 258 2,262 750 
Patent License2,509 — 2,509 — 
Total$6,717 $1,735 $10,133 $2,364 
Contract Balances
The Company receives payments from customers based on a billing schedule as established in our contracts to partially offset prepayments required by our vendors on long lead time materials as well as for Live Events. Amounts collected prior to the fulfillment of the performance obligation are considered contract liabilities and classified as customer advances within accrued liabilities on the condensed consolidated balance sheets. Contract assets are recorded when the Company has a conditional right to consideration for our completed performance under the contracts. Accounts receivables are recorded when the right to this consideration becomes unconditional. The Company has $0.6 million and $1.7 million of contract assets as of June 30, 2026 and December 31, 2025, respectively, which are recorded in the current assets section on the condensed consolidated balance sheets. The Company expects to collect 100% of the contract assets as of June 30, 2026 in the next twelve months. During the six months ended June 30, 2026, the Company recognized $1,535,000 of revenue from contract liabilities that were included in accrued liabilities on the condensed consolidated balance sheets as of December 31, 2025.
(in thousands)June 30,
2026
December 31,
2025
Contract Liabilities$1,281 $1,883 
Revenue by Geographic Area
In general, revenue disaggregated by geography (See Note 11) is aligned according to the nature and economic characteristics of our business and provides meaningful disaggregation of our results of operations. Since we operate in one segment, all financial segment and product line information can be found in the condensed consolidated financial statements.
Practical Expedients and Exemptions
As part of our adoption of ASC 606, Revenue from Contracts with Customers, the Company elected to use the following practical expedients: (i) not to adjust the promised amount of consideration for the effects of a significant financing component when the Company expects, at contract inception, that the period between our transfer of a promised product or service to a customer and when the customer pays for that product or service will be one year or less; (ii) to expense costs as incurred for costs to obtain a contract when the amortization period would have been one year or less; and (iii) not to assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.
In addition, the Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.
Crypto Assets
The Company accounts for cryto assets as indefinite-lived intangible assets in accordance with ASC 350-60, Intangibles—Goodwill and Other—Crypto Assets. Crypto assets are initially measured at cost and subsequently
13

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the three and six months ended June 30, 2026 and 2025
(unaudited)

measured at fair value, with changes in fair value recognized in earnings. Fair value is measured using quoted prices in the Company’s principal market for the applicable digital assets as of the measurement date. The Company assigns cost to crypto assets sold using the first-in, first-out (“FIFO”) method. The Company holds crypto assets primarily for operational purposes and to support short-term liquidity needs within its normal operating cycle. The Company reasonably expects to convert such assets to cash or utilize them in operations within a short period of time, typically within one year. Consistent with this intent and realization pattern, the Company classifies its crypto assets as current assets in its consolidated balance sheets. The Company does not hold crypto assets for long-term investment, speculative, or collateral purposes and does not engage in trading activities involving crypto assets.
Advertising Costs
Advertising costs are charged to sales and marketing expenses as incurred. Advertising costs for the three and six months ended June 30, 2026 were $3.3 million and $5.0 million respectively. Advertising costs for the three and six months ended June 30, 2025 were $29 thousand and $175 thousand respectively.
Net Loss Per Share
For the six months ended June 30, 2026, warrants to purchase 17,864,830 shares of common stock, 3,571,429 shares of common stock issuable upon conversion of convertible notes, 6 shares underlying shares of restricted stock units, 1,000,000 shares underlying shares of restricted stock units issued under an inducement grant, and 61,890,038 shares underlying restricted stock awards have been excluded from the calculation of diluted net loss per common share because the inclusion would be antidilutive.
For the six months ended June 30, 2025, warrants to purchase 31,232,173 shares of common stock, 12 shares of restricted stock, 1,200,000 shares underlying shares of restricted stock units issued under an inducement grant, 10,108,368 shares underlying restricted stock awards, and 564,183 shares of two grants of restricted stock under inducement grants have been excluded from the calculation of diluted net loss per common share because the inclusion would be antidilutive.
Equity Investments
The Company accounts for equity investments in accordance with ASC 321, Investments—Equity Securities. Equity investments with readily determinable fair values are measured at fair value, with changes in fair value recognized in earnings. For equity investments without readily determinable fair values for which the Company has not elected to apply the practical expedient to estimate fair value using net asset value, the Company may elect the measurement alternative and measure such investments at cost, less impairment, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer.
At each reporting period, the Company evaluates investments accounted for under the measurement alternative for impairment and considers whether observable transactions indicate a change in the carrying value of the investment. If an impairment exists, the investment is written down to its fair value, with the impairment loss recognized in earnings.
Costs to Fulfill Contracts
The Company capitalizes certain pre-show indirect costs that are incurred to fulfill customer contracts when those costs relate directly to the contract, generate or enhance resources that will be used to satisfy future performance obligations, and are expected to be recoverable. Capitalized costs primarily include indirect pre-show setup activities, such as venue deposits, equipment preparation, design and technical pre-production efforts, and other pre-show fulfillment activities. The Company expenses all direct costs related to the execution of the show and all post-show costs as incurred, as those activities do not meet the criteria for capitalization under ASC 340-40.
14

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

Capitalized pre-show costs are amortized on a systematic basis that is consistent with the transfer of the related services to the customer, which the Company determines based on the percentage of completion of each contract. For example, if a contract is 20% complete as of the reporting date, 20% of the associated capitalized indirect pre-show costs are amortized. Amortization of costs to fulfill a contract is recorded in cost of sales in the condensed consolidated statements of operations.
At June 30, 2026, the balance of capitalized costs to fulfill contracts was $0.5 million, all of which is classified as a current asset. During the three and six months ended June 30, 2026, the Company recognized amortization related to capitalized contract fulfillment costs of $0.6 million and $1.2 million, respectively. No impairment losses were recognized during the period.
Recently Adopted Accounting Pronouncements
In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which simplifies the measurement of expected credit losses for accounts receivable and contract assets arising from transactions accounted for under ASC 606. The Company adopted the guidance effective January 1, 2026. The adoption of ASU 2025-05 did not have a material impact on the Company’s condensed consolidated financial statements.
In November 2024, the FASB issued ASU 2024-04, Debt—Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, which clarifies the accounting for induced conversions of convertible debt instruments. The Company adopted the guidance effective January 1, 2026. The adoption of ASU 2024-04 did not have a material impact on the Company’s condensed consolidated financial statements.
Recently Issued and Not Yet Adopted Accounting Pronouncements
ASU 2025-06 Internal-use software issued in September 2025, ASU 2025-06 updates guidance in Subtopic 350-40 to streamline accounting for internal-use software, particularly for agile development methods. This change was a priority for stakeholders who found it difficult to differentiate project stages for capitalizing development costs in iterative environments. The amendments are effective for annual reporting periods beginning after December 15, 2027, including interim periods within those annual periods, with early adoption permitted. We do not expect the pronouncement to have a material impact on our condensed consolidated financial statements.
ASU 2024-03 Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses: The amendments in this Update are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The interim effective date was amended by Update 2025-01 “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures: Clarifying the Effective Date” (“ASU 2025-01”), clarifying the interim reporting date when an entity must adopt ASU 2024-03. According to ASU 2025-01, ASU 2024-03 is effective for interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact of the adoption of this standard on its condensed consolidated financial statements.
The Company has reviewed other recent accounting pronouncements and concluded they are either not applicable to the business, or no material effect is expected on the consolidated financial statements as a result of future adoption.
15

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the three and six months ended June 30, 2026 and 2025
(unaudited)




2.    Going Concern
The condensed consolidated financial statements of the Company have been prepared on a going concern basis, which contemplates the realization of assets and the discharge of liabilities in the normal course of business. As of June 30, 2026, the Company had cash and cash equivalents of $1.4 million, crypto assets of $49 million and reported net cash used in operations of $80 million during the six months ended June 30, 2026. The Company expects operating losses to continue in the foreseeable future because of additional costs and expenses related to research and development activities, plans to expand its product portfolio, and increase its market share. The Company’s ability to attain profitable operations is dependent upon achieving a level of revenues adequate to support its cost structure.
Based on current operating levels, the Company will need to raise additional funds in the next 12 months by selling additional equity or incurring debt. To date, the Company has funded its operations primarily through sales of its securities in public and private markets, proceeds from the exercise of warrants to purchase common stock and the sale of convertible notes. Additionally, future capital requirements will depend on many factors, including the rate of revenue growth, the selling price of the Company’s products, the expansion of sales and marketing activities, the timing and extent of spending on research and development efforts and the continuing market acceptance of the Company’s products. These factors raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months from the date that the financial statements are issued.
Management of the Company intends to raise additional funds through the issuance of equity securities or debt. There can be no assurance that, in the event the Company requires additional financing, such financing will be available at terms acceptable to the Company, if at all. Failure to generate sufficient cash flows from operations, raise additional capital and reduce discretionary spending could have a material adverse effect on the Company’s ability to achieve its intended business objectives. As a result, the substantial doubt about the Company’s ability to continue as a going concern has not been alleviated. The accompanying condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
16

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

3.    Business Combination and Asset Purchase
On May 20, 2025, the Company completed its previously announced asset purchase of technology assets, customer contracts, trademarks, and other intellectual property (collectively, the “CSI Acquired Assets”) from CompuSystems, Inc. (“CSI”). At the closing (the “CSI Closing”), pursuant to an asset purchase agreement, by and between the Company and CSI, dated as of December 19, 2024, as amended by that certain amendment to the asset purchase agreement, dated as of December 30, 2024, and as further amended by that certain second amendment to the asset purchase agreement, dated as of February 25, 2025, and as further amended by that certain third amendment to the asset purchase agreement, dated March 31, 2025, and as further amended by that certain fourth amendment to the asset purchase agreement, dated May 14, 2025 (the “CSI Asset Purchase Agreement”), the Company acquired the CSI Acquired Assets for an aggregate purchase consideration of $32.8 million consisting of (i) exclusivity fee of $1.0 million paid in the fourth fiscal quarter of 2024 (the “Exclusivity Fee”), (ii) amount in cash of $1.0 million paid to an escrow account in January 2025 (the “Escrow Amount”) (iii) an amount in cash equal to $5.0 million, (iv) 10,600,000 validly issued, fully paid and nonassessable shares of restricted common stock of the Company, (the “Closing Stock Consideration”), (v) $5.0 million payable in the form of the convertible note (the “Initial Convertible Note”) issued by the Company to CSI, (vi) $5.0 million payable in the form of the convertible note (the “First Convertible Note”) issued by the Company to CSI, (vii) $5.0 million payable in the form of convertible note (the “Second Convertible Note”, and together with the Initial Convertible Note and First Convertible Note, the “CSI Convertible Notes”) issued by the Company to CSI, (viii) $500,000 for the reimbursement of fees incurred by CSI due to the acquisition, and (ix) the assumption of certain transferred liabilities, as described in the CSI Asset Purchase Agreement.
The fair values assigned to the identifiable intangible assets acquired were estimated using valuation techniques consistent with the income and cost approaches described in ASC 820. Customer relationships were valued using the multi-period excess earnings method, which incorporates significant assumptions including projected revenue growth, customer attrition, operating margins, contributory asset charges, and discount rates. Trade names and trademarks were valued using the relief-from-royalty method, which incorporates assumptions regarding estimated royalty rates, projected revenues, expected useful life, and discount rates. Developed technology was valued using the cost approach, which incorporates assumptions regarding the estimated time and cost to recreate the technology, entrepreneurial profit, economic obsolescence, and the expected remaining useful life of the technology. These estimates are based on management's assumptions regarding future operating performance and market participant assumptions and are inherently subject to uncertainty.
Pursuant to the CSI Asset Purchase Agreement, in connection with the CSI Closing, the Company issued the CSI Convertible Notes in an aggregate principal amount of $15.0 million, each due on the second anniversary of the closing (the “Maturity Date”). For additional information on the CSI Convertible Notes, refer to Note 5, Borrowings.
The acquisition was accounted for under ASC 805, Business Combinations and uses preliminary purchase price allocations, with adjustments permitted within the measurement period (not exceeding one year). Adjustments beyond the measurement period are recorded in earnings.
A summary of the purchase consideration follows:
Cash$7,500 
Closing Stock Consideration10,283 
Convertible Notes9,717 
Total purchase price consideration$27,500 
Cash of $7.5 million includes initial cash paid of $1.0 million as Exclusivity Fee in December 2024, $1.0 million escrow amount paid in January 2025, and cash paid at closing in May 2025 amounting to $5.5 million
17

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

The final purchase price and purchase price allocation of assets acquired and liabilities assumed follows:
Unbilled receivable$300 
Inventory163 
Other assets202 
Equipment275 
Intangible assets8,870 
Goodwill19,135 
Accrued expenses(104)
Loan for purchase of equipment (141)
Deferred revenue(1,200)
Total purchase consideration$27,500 
The acquired intangible assets values were estimated using the discounted cash flow method and estimated discount rate. The useful lives are based on estimates of benefits derived from the future cash flows.
The acquired intangible assets, useful lives and a final estimate of fair value at the acquisition date follows:
Useful Life (years)Fair Value
Tradename10$900 
Customer relationships105,160 
Internal use technology42,810 
Total$8,870 
API Media Innovations
On January 22, 2026, the Company completed its previously announced acquisition of all of the outstanding shares of API Media Innovations Inc. (“API Media”) pursuant to a Stock Purchase Agreement dated October 28, 2025, by and among the Company, API Media, and its shareholders. The aggregate purchase price was $14 million paid in cash, including a $1 million non-refundable deposit paid upon execution of the agreement, which was credited toward the purchase price at closing. The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations. The purchase price allocation is preliminary and subject to adjustment during the measurement period (not to exceed one year from the acquisition date). Any such adjustments will be recorded in the period in which they are identified.
The fair values assigned to the identifiable intangible assets acquired were estimated using valuation techniques consistent with the income and cost approaches described in ASC 820. Customer relationships were valued using the multi-period excess earnings method, which incorporates assumptions regarding projected revenue growth, customer attrition, operating margins, contributory asset charges, and discount rates. The trade name was valued using the relief-from-royalty method, which incorporates assumptions regarding estimated royalty rates, projected revenues, useful life, and discount rates. Developed technology was valued using the cost approach, which incorporates assumptions regarding the estimated time and cost to recreate the technology, entrepreneurial profit, and economic obsolescence. These estimates are based on management's assumptions regarding future operating performance and market participant assumptions and are inherently subject to uncertainty.
18

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

The following table summarizes the preliminary allocation of the purchase price to the estimated fair values of assets acquired and liabilities assumed at the acquisition date:
Cash$51 
Accounts receivable396 
Prepaid expenses39 
Other receivable
Right of use asset87 
Property and equipment231 
Intangible assets5,490 
Goodwill8,150 
Accrued expenses(271)
Right of use liability(87)
Accounts payable(88)
Total$14,000 
The acquired intangible assets, useful lives and a final estimate of fair value at the acquisition date follows:
Useful Life (years)Fair Value
Tradename5$170 
Customer relationships54,080 
Internal use technology31,240 
Total$5,490 
The Company expects to derive synergy from the acquired intangibles from API with it's own intellectual property. The goodwill recorded in the API acquisition is not deductible for tax purposes. The Company recorded fees in the six months ended June 30, 2026 of $84,000.
Supplemental Pro Forma Information:
The revenue and net loss of API included in consolidated statement of operations since the acquisition date were $1.2 million and $0.1 million, respectively. Revenue and net income for the 3 months ended June 30, 2026 were $1.0 million and $0.4 million, respectively. Had the acquisition occurred on January 1, 2025, consolidated pro forma revenue, net loss and net loss per common share, basic and diluted would have been as follows:
Pro Forma (Unaudited) for the three months ended June 30,
Pro Forma (Unaudited) for the six months ended June 30,
2026202520262025
Net revenue$5,701 $2,792 $9,170 $3,675 
Net loss(88,228)(37,494)(140,943)(47,881)
Other Intangible Asset Acquisitions
During the six months ended June 30, 2026, the Company acquired an additional patent from three inventors for an aggregate fair value of $5.4 million and a useful life of 10 years, based on expected future economic benefit, in exchange for the issuance of 7,500,000 shares of common stock. This transaction was considered a related party transaction as described in the related party note.
19

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

Salieri Platform Acquisition
During the six months ended June 30, 2026, the Company acquired the Salieri platform, including related developed technology, software, source code, documentation, algorithms, and associated intellectual property, pursuant to an agreement with an individual developer for an aggregate purchase price of £0.6 million (approximately $0.8 million). The acquired technology was capitalized as an intangible asset and is being amortized over its estimated useful life based on the expected period of future economic benefit. The Company also entered into a separate four-year consulting agreement with the seller for ongoing platform support, maintenance, and development, which is accounted for separately as services are received.
4.    Balance Sheet Components
Property and equipment, net (in thousands):
June 30,
2026
December 31,
2025
Machinery and equipment$2,333 $1,825 
Tooling
Construction in progress1,142 — 
Furniture and fixtures265 114 
Leasehold improvements309 280 
4,052 2,222 
Less: Accumulated depreciation(1,600)(1,616)
Property and equipment, net2,452 606 
Depreciation expense for property and equipment for the three months ended June 30, 2026 and 2025 were approximately of $80,000 and $26,000, respectively. Depreciation expense for the six months ended June 30, 2026 and 2025 were approximately $154,000 and $38,000, respectively.
Intangible assets, net consisted of the following at June 30, 2026.
Gross Carrying
Amount
Accumulated
Amortization
Net Carrying
Amount
Patents$99,202 $(14,129)$85,073 
Trade names and trademarks3,457 (473)2,984 
Customer relationships9,240 (936)8,304 
Internal use technology4,862 (988)3,874 
$116,761 $(16,526)$100,235 
As of June 30, 2026, the future amortization of the intangibles acquired is as follows:
2026 remainder$6,501 
202713,001 
202813,001 
202912,023 
203011,615 
203110,813 
Thereafter33,281 
$100,235 
20

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

The Company recognized amortization expense related to intangibles of $3.2 million and $2.5 million for the three months ended June 30, 2026 and 2025, respectively. The Company recognized amortization expense related to intangibles of $6.3 million and $4.8 million for the six months ended June 30, 2026 and 2025, respectively.
Notes Receivable
In March 2026 and June 2026, the Company entered into promissory note agreements with NYIAX, Inc. (“NYIAX”), pursuant to which the Company advanced $0.4 million and $1.5 million, respectively, for aggregate advances of $1.9 million. Each note bears interest at an annual rate of 5% and matured on the earlier of (i) June 9, 2026 (in the case of the March note) or June 30, 2026 (in the case of the June note) or (ii) the closing of a merger among NYIAX, the Company, and DVLT Merger Sub Inc. The notes are unsecured and may be prepaid without penalty. The notes contains customary events of default, including nonpayment, covenant breaches, insolvency events, and certain change-in-control transactions. Upon an event of default, the outstanding balance may become immediately due and payable, and a default penalty of 6% per month may accrue. As of June 30, 2026, neither note had been repaid at maturity and both are therefore in default. The Company does not intend to seek remedy for the default at this time. The aggregate outstanding principal balance of $1.9 million is immediately due and payable, and the default penalty rate of 6% per month has begun to accrue. The default penalties are de minimis and not accrued for as of June 30, 2026. The Company evaluates collectability of the note and records an allowance for credit losses, if necessary. As of June 30, 2026, no allowance for credit losses was recorded.
Accrued liabilities (in thousands):
June 30,
2026
December 31,
2025
Accrued compensation$3,118 $3,448 
Accrued vacation788 459 
Accrued audit fees80 332 
Accrued escrow liability2,550 2,550 
Accrued interest— 210 
Accrued lease liability, current portion967 640 
Accrued legal fees1,329 — 
Accrued royalty payable to related party814 810 
Accrued other622 670 
Customer advances1,281 1,883 
Total accrued liabilities$11,549 $11,002 
5.    Borrowings
DV Convertible Note
In connection with the acquisition of certain assets (the "EOS Acquired Assets") from EOS Technologies Holdings Inc (f/k/a Data Vault Holdings Inc.) ("EOS Holdings"), which closed on December 31, 2024 (the "EOS" Asset Acquisition"), the Company issued a convertible note to EOS Holdings in the principal amount of $10.0 million due on the third anniversary of the closing on December 31, 2027 (the "EOS Convertible Note"). The Company agreed to pay interest to EOS Holdings on the aggregate unconverted and then outstanding principal amount of the note at the rate of five and twelve hundredths percent (5.12%) per annum, accruing from the closing.
The EOS Convertible Note could be converted at EOS Holdings' option, partially or entirely, into shares of common stock, any time after the maturity date until the EOS Convertible Note is fully paid off. The EOS Convertible Note uses a conversion price equaling to seventy-five percent (75%) of the average VWAP (as defined in the EOS Convertible Note) during the ten (10) consecutive trading days ending on the trading day that is immediately prior to the conversion date subject to a floor price of $1.116 per share. At EOS Holding’s sole discretion, upon a change of
21

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

control (as defined in the EOS Convertible Note), the Company shall (i) cause any successor entity to assume in writing all of the obligations of the Company under the EOS Convertible Note, (ii) pay or cause to be paid to EOS Holdings the outstanding balance under the EOS Convertible Note in cash, or (iii) pay, at the closing of such change of control, in full satisfaction of the Company’s obligations under the EOS Convertible Note, an amount in cash or equivalent common stock to the amount EOS Holdings would have been paid if it had converted the outstanding balance under the EOS Convertible Note into shares of common stock immediately prior to such closing, at the conversion price.
When the Company entered into capital raising or financing transactions, including the issuance by the Company of shares of common stock or common stock equivalents (as defined in the EOS Convertible Note) for cash consideration, indebtedness or a combination of units thereof (each, a “Subsequent Financing”), then the Company was required first to pay to EOS Holdings at least 10% of the gross proceeds of such Subsequent Financing to redeem all or a portion of the EOS Convertible Note, plus accrued but unpaid interest, plus liquidated damages, if any, and any other amounts then owing to EOS Holdings.
On February 14, 2025, the Company paid a portion of principal and interest of $0.4 million, net, as a result of the February 2025 public offering. For the six months ended June 30, 2026, the Company paid an aggregate of $3.9 million in cash resulting in the EOS Convertible Note being paid in full. The ending balance and fair value as of December 31, 2025 was $3.9 million.
In January 2026, the Company fully repaid the outstanding balance of the EOS Convertible Note. The repayment satisfied the remaining principal and any accrued interest outstanding under the note as of the repayment date. Following the payoff, the EOS Convertible Note was extinguished and no further amounts remain outstanding under the agreement.
The Company elected the fair value method for the EOS Convertible Note at issuance of $10.0 million as of December 31, 2025 due to the embedded derivatives identified within the agreement requiring recurring fair value measurements. The note is valued using level 3 inputs. See Note 6, Fair Value Measurements for further information on inputs.
CSI Convertible Notes
As of December 31, 2025, the Company's outstanding debt included two convertible notes issued in connection with the acquisition of CSI which closed on May 20, 2025. Interest on the First Convertible Note and principal on the Second Convertible Note was accrued at the rate of five percent (5%) per annum. Interest began accruing from the six-month anniversary of the closing on the First Convertible Note and from the nine-month anniversary of the closing on the Second Convertible Note on the principal balance no less frequently than quarterly per calendar quarter. The payment of the accrued interest shall occur on the last business day of each calendar quarter.
On March 18, 2026, the Company entered into the settlement agreement with the holders of the First Convertible Note to settle the debt including accrued interest in the aggregate amount of $5.2 million. The Company has paid $2.0 million in the three months ended March 31, 2026 and $3.2 million in the three months ended June 30, 2026 of the principal in payments scheduled in the settlement agreement. The balance has been fully paid off as of June 30, 2026. The Company recorded a debt extinguishment expense of $1.7 million for the three months ended March 31, 2026 equal to the difference of the settlement amount due and the carrying value of the First Convertible Note at the settlement date. The extinguishment expense is recorded on the condensed consolidated statement of operations for the six months ended June 30, 2026.
The Second Convertible Note can be converted, partially or entirely, into shares of common stock, any time after the nine-month anniversary of the closing until the Second Convertible Note is fully paid off. The Second Convertible Note use a conversion price equaling to the average VWAP during the thirty (30) consecutive trading days ending on the trading day that is immediately prior to the conversion date subject to a floor price of $1.40 per share and ceiling
22

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

price of $2.50 per share (the “Conversion Price”). The entire outstanding principal and accrued interest shall automatically be converted into shares of common stock on the maturity date at the Conversion Price.
The CSI Convertible Notes carrying value at June 30, 2026 was $3.7 million, net of a discount of $1.4 million. Discount accretion expense was $0.3 million and $0.9 million for the three and six months ended June 30, 2026, respectively.
Short Term Financing
On May 5, 2026, the Company entered into an agreement for a loan in the amount of $2.0 million and received proceeds of $1.9 million net of $80,000 origination fees. The loan has weekly payments of $125,000 until the maturity date October 16, 2026. The effective interest rate on the loan is 183.5% per annum. There is no prepayment penalty. The loan is guaranteed by both the Chief Executive Officer and the Chief Financial Officer. The carrying amount of $1.5 million is included in short term notes payable on the condensed consolidated balance sheet as of June 30, 2026. The interest expense recognized in the three and six months ended June 30, 2026 is $0.6 million.
6.    Fair Value Measurements
The Company measures the fair value of financial instruments using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. Each level of input has different levels of subjectivity and difficulty involved in determining fair value.
Level 1 – Inputs used to measure fair value are unadjusted quoted prices that are available in active markets for the identical assets or liabilities as of the reporting date. Therefore, determining fair value for Level 1 investments generally does not require significant judgment, and the estimation is not difficult.
Level 2 – Pricing is provided by third-party sources of market information obtained through investment advisors. The Company does not adjust for or apply any additional assumptions or estimates to the pricing information received from its advisors.
Level 3 – Inputs used to measure fair value are unobservable inputs that are supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models for which the assumptions utilize management’s estimates of market participant assumptions. The determination of fair value for Level 3 instruments involves the most management judgment and subjectivity.








23

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

The Company’s financial assets and liabilities that are measured at fair value on a nonrecurring and recurring basis as of June 30, 2026 and December 31, 2025 by level within the fair value hierarchy, are as follows:
June 30, 2026
Quoted prices in active marketsSignificant other observable inputsSignificant unobservable inputs
(in thousands)(Level 1)(Level 2)(Level 3)
Nonrecurring fair value measurements:
Assets:
NYIAX
$— $— $792 
Vivasor, Inc.
$— $— $800 
Total non recurring fair value measurements
$— $— $1,592 
Recurring fair value measurements:
Assets:
Bitcoin$49,016 $— $— 
Liabilities:
Warrant liabilities$— $115 $— 
NYIAX Investment
The Company's investment in NYIAX consists of 2,150,000 shares of NYIAX common stock, which represents approximately 3% ownership, accounted for at cost less impairments. See Note 9 for further details. The investment in NYIAX had a historical cost of $4.3 million and is carried at cost less impairment and has a carrying amount of $0.8 million. During the three and six months ended June 30, 2026, the Company recorded an impairment of the NYIAX investment of $1.0 million and $3.5 million which is recorded in the Impairment of investment in nonmarketable security line on the condensed consolidated statement of operations for the three and six months ended June 30, 2026.
Vivasor, Inc. Investment
The Company's investment in Vivasor Inc. consists of an approximate 2% ownership interest in the privately held company and is accounted for under the measurement alternative in accordance with ASC 321. During the three and six months ended June 30, 2026, the Company recognized an impairment on the investment of $55.4 million as it was determined the carrying amount was not recoverable. The investment's cost was $56.2 million and is carried at cost less impairment and has a carrying balance of $0.8 million on the condensed consolidated balance sheet as of June 30, 2026. Vivasor, Inc. is a related party of the Company, see Note 10 for related party details.
Triton GT 1 LLC Investment
The Company's investment in Triton GT 1 LLC consists of an approximate 2% membership interest in the privately held limited liability company and is accounted for under the measurement alternative in accordance with ASC 321. During the three and six months ended June 30, 2026, the Company recognized no impairment or observable price adjustments related to the investment. The investment continues to be carried at its initial cost of approximately $0.3 million, as no qualifying observable transactions or impairment indicators requiring adjustment were identified during the period.
24

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

December 31, 2025
Quoted prices in active marketsSignificant other observable inputsSignificant unobservable inputs
(in thousands)(Level 1)(Level 2)(Level 3)
Assets:
Equity investment - NYIAX$— $— $4,300 
Bitcoin$92,222 $— $— 
Liabilities:
Convertible note payable$— $— $3,936 
Warrant liabilities$— $— $
There were no transfers between Level 1, 2 or 3 during the three and six months ended June 30, 2026 or 2025.
Convertible Notes
As described in Note 5, the Company elected the fair value option on the EOS Convertible Note issued on December 31, 2024. The Company uses level 3 inputs to measure the fair value in subsequent periods. The Company paid off the EOS Convertible Note during the six months ended June 30, 2026. See Note 5, Borrowings, for more details.
The following table includes a summary of changes in fair value of the EOS Convertible Notes.
For the six months ended June 30,
(in thousands)20262025
Beginning balance$3,936 $10,000 
Additions
— 13,942 
Change in fair value recorded in interest expense7,456 
Amounts settled on DV note
— (1,524)
Conversion of 10% notes
— (1,545)
Payoff on DV note(3,939)— 
Ending balance$— $28,329 
Fair Value of Crypto Assets
The following table summarizes Crypto assets held for operations (in thousands, except units):
June 30, 2026
BTCCost BasisFair Value
Bitcoin837 $73,108 $49,016 
December 31, 2025
BTCCost BasisFair Value
Bitcoin1,054 $92,051 $92,222 
25

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

For the six months ended June 30, 2026
BTC
Cost BasisFair Value
Beginning balance1,054 $92,051 $92,222 
Additions— — — 
Disposals(217)(18,943)(18,978)
Fair value remeasurement— — (24,228)
Ending balance 837 $73,108 $49,016 

During the six months ended June 30, 2026, the Company repaid $18.1 million of cash advances previously received from Scilex Holding Company (“Scilex”), a related party, by transferring 217 Bitcoin to Scilex in satisfaction of the related liability. The Bitcoin used to settle the liability had a cost basis of $18.9 million, resulting in a realized loss of $0.8 million and is recorded in Loss on digital assets in the condensed consolidated statements of operations. The Company had no transfers of Bitcoin during the three months ended June 30, 2026.
For the three and six months ended June 30, 2026, the Company recognized a fair value remeasurement loss of $8.1 million and $24.2 million, respectively. Realized gains and losses and fair value remeasurement gains and losses from Crypto assets are recorded in Loss on digital assets in the condensed consolidated statements of operations. The Company accounts for disposals of Bitcoin using the first-in, first-out (“FIFO”) method.
7.    Stockholders’ Equity
A summary of the common stock and warrant activity and related information for the six months ended June 30, 2026 is provided as follows.
Maxim ATM
The Company sold 40,179,626 in shares of common stock under the Maxim ATM for net proceeds of $32.4 million for the six months ended June 30, 2026. Maxim receives a fee of 3% of gross proceeds or $1.0 million. Gross proceeds net of fees is recorded in additional paid-in capital on the statement of stockholders' net of non-cash offering costs of $5.5 million which were previously capitalized and reclassified to equity upon raising the funds.
Consultant Equity Awards
In the three and six months ended June 30, 2026, the Company recognized $0.2 million and $1.2 million of compensation expense for equity awards granted to consultants outside of the 2018 LTIP plan in the aggregate of 1,409,427 shares of common stock. The shares vest immediately or after six months.
Meme Coin II Dividend
On December 29, 2025, the board of directors of the Company declared a conditional dividend of Dream Bowl Meme Coin II digital collectibles (the “Meme Coins”) to eligible holders of the Company’s common stock and certain other equity securities. The Meme Coins were payable to holders of record as of January 7, 2026 and were distributed beginning on February 27, 2026.
The distribution was made on the basis of one Meme Coin for every sixty shares of common stock held, or, with respect to eligible equity securities other than common stock, for every sixty shares of common stock underlying such securities, in each case held as of the record date, with fractional entitlements rounded down. Holders with fewer than sixty shares of common stock or common stock equivalents were not be entitled to receive any Meme Coins.
The Meme Coins are digital collectibles intended solely for personal, non-commercial use in connection with the Dream Bowl XIV event and do not represent or confer any equity, voting, dividend, profit-sharing, or ownership rights
26

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)
in the Company or any other entity, nor do they provide any right to receive cash or other monetary consideration. The Meme Coins are not designed or intended to function as an investment, currency, or financial product.
Warrant Dividend
On December 29, 2025, the Company’s board of directors also declared a conditional dividend of warrants to purchase shares of the Company’s common stock to eligible holders of the Company’s common stock and certain other equity securities. The warrants were payable to holders of record as of January 7, 2026 and were distributed on February 27, 2026. The number of warrants distributed was 9,665,079.
The distribution was made on the basis of one warrant for every sixty shares of common stock held, or, with respect to eligible equity securities other than common stock, for every sixty shares of common stock underlying such securities, in each case held as of the record date, with fractional entitlements rounded down. Holders with fewer than sixty shares of common stock or common stock equivalents were not be entitled to receive any warrants.
Each warrant entitles the holder to purchase one share of the Company’s common stock at an exercise price of $5.00 per share (subject to adjustment for recapitalizations, stock splits, stock dividends and similar types of transactions) and will expire on the first anniversary of the distribution date. The exercise of each warrant is subject to certain conditions, including a requirement that the applicable beneficial owner possess a corresponding Meme Coin at the time of exercise.
The warrants were recorded as liability classified for their aggregate fair value of $4.0 million as of the record date of January 7, 2026. The fair value of the common stock warrants uses significant observable inputs (Level 2). The fair value of the common warrants was determined using the Black-Scholes Model based on the following key inputs and assumptions: stock price on January 7, 2026 of $1.16, exercise price of $5.00, term of 1 year, volatility of 179.0% and risk-free rate of 3.48%. On the distribution date of February 27, 2026 the Company adjusted the fair value to it's distribution date fair value of $1.9 million for which the adjustment was to the warrant liability. The fair value of the common warrants was determined using the Black-Scholes Model based on the following key inputs and assumptions: stock price on February 27, 2026 of $0.71, exercise price of $5.00, term of 1 year, volatility of 183.7% and risk-free rate of 3.48%.
Vivasor Subscription Agreement
On April 16, 2026, the Company entered into a subscription agreement with Vivasor, Inc. (Vivasor), a related party, pursuant to which the Company acquired 8,163,265 shares of Vivasor’s Series A common stock, at a purchase price of $6.125 per share for aggregate consideration of $50 million. In exchange for the Vivasor shares, the Company issued 75,942,666 shares of its common stock to Vivasor. The transaction closed on April 23, 2026.
Registered Direct Offering
On May 3, 2026, the Company entered into a Securities Purchase Agreement (the "May Purchase Agreement") with certain institutional investors, pursuant to which the Company agreed to sell and issue in a registered direct offering (the "May Offering") an aggregate of 109,090,910 shares of common stock at an offering price of $0.55 per share for aggregate gross proceeds to the Company from the May Offering of approximately $60.0 million, before deducting the May Placement Agent’s (as defined below) fees and offering expenses payable by the Company. The Company intends to use the net proceeds from the Offering for the deployment of its quantum-ready graphics processing unit edge network, including build-out and equipment, as well as working capital and general corporate purposes. The May Offering closed on May 5, 2026.
Pursuant to the May Purchase Agreement, the Company has agreed that, subject to certain exceptions, from the date of the prospectus supplement until forty-five (45) days after the closing of the Offering, (i) neither it nor any of its subsidiaries shall (a) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any
27

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)
common stock or common stock equivalents or (b) file any registration statement or any amendment or supplement thereto, and (ii) it shall not enter into a variable rate transactions.
In connection with the May Offering, the Company entered into a Placement Agency Agreement, dated as of May 3, 2026, with Titan Partners Group LLC, a division of American Capital Partners, LLC (the “May Placement Agent”), pursuant to which the May Placement Agent agreed to serve as the sole placement agent for the issuance and sale of securities of the Company pursuant to the May Purchase Agreement. As compensation for such services, the Company agreed to pay the May Placement Agent a cash fee of $4.2 million and issue to the May Placement Agent, or its designees, warrants to purchase up to 5,454,545 shares of common stock (the “May Placement Agent Warrants”) at the closing of the May Offering. The May Placement Agent Warrants have a term of five years from the date of the prospectus supplement and have an exercise price of $0.6325 per share. The Company also agreed to reimburse the May Placement Agent for legal and other expenses incurred by it in connection with the offering in an aggregate amount up to $60,000. The shares, the May Placement Agent Warrants and the shares of common stock issuable upon exercise of the May Placement Agent Warrants (the “Placement Agent Warrant Shares”) were offered and sold by the Company pursuant to an effective shelf registration statement on Form S-3 (File No. 333-294502), which was originally filed with the SEC on March 20, 2026, and was declared effective on March 25, 2026, a base prospectus forming a part of the effective registration statement dated March 25, 2026 and a prospectus supplement dated May 3, 2026.
In connection with the May Offering, the Company issued 2,727,272 warrants for the issuance of common stock to Maxim and paid a cash fee of $1.0 million for the participation requirement of the Maxim ATM (the "Participation Warrants"). The warrants have a term of five years from the date of the prospectus supplement and have an exercise price of $0.6325 per share. The warrants are accounted for as equity issuance costs and are classified as equity instruments. They are recorded at their grant date fair value of $1.0 million.
The May Placement Agent Warrants were recorded to equity with an aggregate fair value of $2.9 million as of the issuance date of May 5, 2026. The fair value of the common stock warrants uses significant observable inputs (Level 2). The fair value of the common warrants was determined using the Black-Scholes Model based on the following key inputs and assumptions: stock price on May 5, 2026 of $0.57, exercise price of $0.63, term of 5 years, volatility of 160.2% and risk-free rate of 4.08%.
Warrants exercisable as of June 30, 2026 exclude warrants to purchase 12,068 shares of common stock issued to investors that participated in the February 2024 Public Offering that requires shareholder approval prior to the warrants being exercisable.
Information regarding warrants for common stock outstanding and exercisable as of June 30, 2026 is as follows:
Exercise
Price
Warrants
Outstanding as of
June 30, 2026
Weighted Average
Remaining
Life (years)
Warrants
Exercisable as of
June 30, 2026
$0.638,181,817 4.88,181,817 
$1.83 - $5.00
9,677,612 0.79,665,544 
$1,574.00 - $22,800.00
5,401 1.65,401 
$3.48*
17,864,830 2.617,852,762 
________________________________________
*Weighted average
28

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)
Information regarding warrants for common stock outstanding and exercisable as of December 31, 2025 is as follows:
Exercise
Price
Warrants
Outstanding as of
December 31, 2025
Weighted Average
Remaining
Life (years)
Warrants
Exercisable as of
December 31, 2025
$1.83 - $3.20
12,207 3.4139 
$1,574.00 - $22,800.00
5,401 2.15,401 
$38,250.00 - $66,900.00
403 1.6402 
$692.23*
18,011 2.95,942 
________________________________________
*Weighted average
Warrants exercisable as of December 31, 2025 exclude warrants to purchase 1 share of common stock issued to a marketing firm, which vest upon the achievement of certain milestones and warrants to purchase 12,068 shares of common stock issued to investors that participated in the February 2024 Public Offering that requires shareholder approval prior to the warrants being exercisable.
8.    Stock-Based Compensation
2018 Long Term Stock Incentive Plan
On January 30, 2018, the Company’s board of directors approved the establishment of the Company’s 2018 Long-Term Stock Incentive Plan (the “LTIP”) and termination of its Carve-Out Plan. Under the LTIP, the aggregate maximum number of shares of common stock (including shares underlying options) that may be issued under the LTIP pursuant to awards of Restricted Shares or Options will be limited to 15% of the outstanding shares of common stock, which calculation shall be made on the first trading day of each fiscal quarter. As of June 30, 2026, up to 21,755,186 shares of common stock are available for grants to participants under the LTIP.
A summary of activity related to restricted stock awards with service-based vesting conditions for the six months ended June 30, 2026 is presented below:
Stock AwardsSharesWeighted-Average
Grant Date Fair Value
Non-vested as of January 1, 202620,180,686 $1.81 
Granted48,001,214 $0.74 
Vested(4,018,986)$1.64 
Forfeited(2,517,876)$0.95 
Non-vested as of June 30, 202661,645,038 $1.00 
29

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

A summary of activity related to restricted stock awards with performance-based vesting conditions for the six months ended June 30, 2026 is presented below:
Stock AwardsSharesWeighted-Average
Grant Date Fair Value
Non-vested as of January 1, 20261,925,000 $0.99 
Granted— $— 
Vested(1,480,000)$1.04 
Forfeited(200,000)$0.96 
Non-vested as of June 30, 2026245,000 $0.70 
As of June 30, 2026, the unamortized compensation costs related to the unvested restricted stock awards with service based vesting conditions was approximately $61.1 million which is to be amortized on a straight-line basis over a weighted-average period of approximately 2.6. In the three months ended March 31, 2026, 1,480,000 performance awards granted in February 2025 met their vesting criteria and the Company recognized $0.6 million in compensation cost. These performance awards vested upon the achievement of the Company’s aggregate revenue equaling or exceeding $40.0 million over a trailing 12 calendar month period ending on or prior to the date that is 5 years from the grant date. As of June 30, 2026, the unamortized compensation costs related to the unvested restricted stock awards with performance based vesting criteria was $0.1 million which is to be amortized on a straight-line basis over a weighted-average period of approximately 1.5. These performance awards vest upon the achievement of revenue equaling or exceeding certain a threshold over a trailing 12 calendar month period ending on or prior to the date that is 5 years from the grant date. The performance awards are assigned a 100% probability to achieve the performance conditions.
For the six months ended June 30, 2026, 2,230,017 shares of restricted stock awards were released under the LTIP with an intrinsic value of $1.5 million.
Inducement Grants
On January 2, 2025, the Company issued 1,200,000 units of restricted stock at a fair value per share of $2.04, to Nathaniel Bradley, the Company’s Chief Executive Officer, as an inducement grant (“Bradley Inducement Grant”) pursuant to an inducement award agreement dated December 31, 2025. Of this grant, 600,000 units have service-based conditions and vest in 3-month equal installments over a 36-month period, while the other 600,000 units have performance-based condition and vest upon the Company’s aggregate revenue equaling or exceeding $40,000,000 over the trailing 12 calendar month period ending on or prior to the date that is 5 years from the grant date. The performance-based vesting criteria was met in the three months ended March 31, 2026 and the Company recognized $0.5 million of the remaining expense for acheiving the milestone in compensation cost. As of June 30, 2026, the unamortized compensation cost for the time-based award related to the Bradley Inducement Grant was approximately $0.7 million which is being amortized on a straight-line basis over a period of 1.72 years.
On May 20, 2025, the Company issued 500,000 units of restricted stock at a fair value per share of $0.97, to Mark LoGuirato, as an inducement grant (“LoGuirato Inducement Grant”) pursuant to an inducement award agreement dated May 20, 2025. Of this grant, 250,000 awards have service-based conditions and vest in 3-month equal installments over a 36-month period, while the other 250,000 awards have performance-based condition and vest upon the Company’s CSI revenue equaling or exceeding $25,000,000 over trailing 12 calendar month period ending on or prior to the date that is 5 years from the grant date. LoGuirato's employment terminated in the three months ended June 30, 2026 and there is no unamortized compensation cost as of June 30, 2026. The Company reversed $132,000 of compensation in the three months ended June 30, 2026 as a result of the termination.

30

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

9.    Commitments and Contingencies
Contingencies
In the normal course of business, the Company may become involved in legal proceedings. The Company will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of a possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. The accrual for a litigation loss contingency might include, for example, estimates of potential damages, outside legal fees and other directly related costs expected to be incurred.
On March 13, 2026, the Company was named as a defendant in a lawsuit captioned, Li et al v. Datavault AI, Inc., Case No. 1:26-cv-02091, filed in the U.S. District Court for the Southern District of New York. The complaint alleges breach of contract, conversion and that Datavault violated Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder, seeking monetary damages. The Company filed a motion to dismiss the complaint on May 15, 2026. Plaintiffs filed an opposition to that motion on June 12, 2026, and the Company filed its reply brief on June 26, 2026. The motion to dismiss is thus fully briefed and awaiting decision from the Court. If denied, the Company intends to continue to defend this action vigorously. At this time, we are unable to predict the outcome of this action or reasonably estimate the range of possible losses.
Class Action Lawsuit
On August 5, 2026, a class action lawsuit was filed against the Company and certain of its current officers in the Eastern District of Pennsylvania, by plaintiff Carla Aramouni seeking to represent a class of all persons who purchased the Company’s securities between September 4, 2024 and October 30, 2025, alleging violations of Section 10(b) and 20(a) of the Exchange Act. The matter is styled Aramouni v. Datavault AI Inc., et al., Case No. 2:26-cv-05548-JS (E.D. Pa Aug. 5, 2026). The complaint alleges that the Company made false and/or misleading statements and/or failed to disclose material information about the Company’s business, customer contracts, operations, and commercialization prospects in its public statements and SEC filings. The plaintiff seeks unspecified monetary damages on behalf of a purported class of stockholders plus attorney’s fees and costs. The Company believes the claims asserted in the complaint are without merit and intends to vigorously defend against them. The matter is in its early stages, and the Company is unable to predict the outcome of the litigation or to reasonably estimate the range of possible loss, if any, that may result from the matter.
The Company’s management does not believe that any such matters, individually or in the aggregate, will have a materially adverse effect on the Company’s condensed consolidated financial statements.
NYIAX Agreements
Exchange Agreement
On March 16, 2025, the Company entered into a share exchange agreement (the “Exchange Agreement”) with NYIAX, Inc., a Delaware corporation (“NYIAX”), pursuant to which NYIAX exchanged 900,000 shares (the “NYIAX Shares”) of NYIAX’s common stock, par value $0.0001 per share (the “NYIAX Common Stock”), for aggregate consideration of up to 5,000,000 shares of common stock (collectively, the “Exchange”). The Exchange Agreement closed on April 9, 2025.
As full consideration for the sale, assignment, transfer and delivery of the NYIAX Shares by NYIAX to the Company, the Company agreed to issue to NYIAX (i) 3,000,000 shares of common stock (such shares of common stock, the “NYIAX Closing Shares”), and (ii) 2,000,000 shares of common stock (such shares of common stock, the “NYIAX Additional Shares”), The NYIAX Closing Shares will be issued in four equal quarterly tranches starting from the closing. The 2,000,000 of Additional Shares were issued to NYIAX on April 1, 2026.
31

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

The Company accounted for the NYIAX transactions as a collaborative arrangement and allocated fair values of exchanged assets on their relative fair value. The common stock consideration of aggregate of 7,530,000 shares, including the 2,000,000 contingently issuance shares which are considered probable to be issued, was measured at the closing date of April 9, 2025 for an aggregate fair value of $4.9 million and is recorded to additional paid-in capital on the condensed consolidated balance sheet. The NYIAX common shares received in the aggregate of 2,150,000 were valued at $4.3 million and are recorded as an investment at fair value under the measurement alternative of ASC 321 at the close date fair value of $2 per share on the condensed consolidated balance sheet. The Company recognized an impairment on the investment of $3.5 million in the six months ended June 30, 2026. See Note 6 for details. The Company accounts for the NYIAX investment under ASC 321 measurement alternative, which accounts for the investment as cost less impairment, due to the Company not having significant influence over NYIAX.
NYIAX Agreement and Plan of Merger
On March 18, 2026, the Company, DVLT Merger Sub, Inc., a wholly owned subsidiary of the Company (“Merger Sub”), and NYIAX entered into an Agreement and Plan of Merger (the “NYIAX Merger Agreement”), dated March 18, 2026. Pursuant to the provisions of the NYIAX Merger Agreement, on the closing date (the “Closing Date”), (i) Merger Sub will merge with and into NYIAX (the “Merger”), the separate corporate existence of Merger Sub will cease and NYIAX will continue as the surviving company and a wholly owned subsidiary of the Company, and (ii) the Company will pay to NYIAX equity holders aggregate consideration (“Merger Consideration”) of 78,947,368 shares of the Company’s common stock. The Company estimates the Merger Consideration to be $61.6 million based on an aggregate fair value using the closing stock price on March 17, 2026 of $0.78 per share. See Note 6 for discussion of impairment of the NYIAX investment.
Pursuant to the terms of the NYIAX Merger Agreement, at the effective time of the Merger (the “Effective Time”), by virtue of the Merger and without any action on the part of the stockholders of NYIAX (the “Merger Partner Stockholders”), (i) each outstanding share of NYIAX’s common stock, par value $0.0001 per share (the “NYIAX Common Stock”), other than any shares of NYIAX Common Stock held in the treasury of NYIAX will be converted into the right to receive (i) a number of shares of common stock equal to the Exchange Ratio (as defined in ther Merger Agreement), or (ii) each share of NYIAX Common Stock held immediately prior to the Effective Time by a Merger Partner Stockholder that is an Unaccredited Investor (as defined in the Merger Agreement) will be converted into the right to receive the unaccredited investor cash consideration, which will be the higher of (i) price per share equal to the VWAP (as defined in the NYIAX Merger Agreement) of the common stock for the five (5) consecutive trading days ending on the trading day immediately preceding the date of the NYIAX Merger Agreement, or (ii) price per share equal to the VWAP of the common stock for the five (5) consecutive trading days ending on the trading day immediately preceding the Closing Date.
Pursuant to the NYIAX Merger Agreement, if the Company effects or announces an intent to effect a reverse stock split of the common stock at any time within one hundred twenty (120) days following the date of the NYIAX Merger Agreement, then the Company will issue to the Merger Partner Stockholders, on a pro rata basis in accordance with their respective entitlements to the Merger Consideration, an aggregate of 10,000,000 duly authorized, validly issued, fully paid and nonassessable additional shares of common stock.
Pursuant to the terms of the NYIAX Merger Agreement, the Company has also agreed to appoint two new members to the board of directors of the Company, nominated by NYIAX and subject to such nominees being acceptable to the Company, effective as of the Closing Date.
The NYIAX Merger Agreement contains representations and warranties from both the Company and Merger Sub, on the one hand, and NYIAX, on the other hand, customary for a transaction of this nature. The NYIAX Merger Agreement also contains customary covenants and agreements, including with respect to the operations of the business of NYIAX and the Company between the date of the NYIAX Merger Agreement and Effective Time. The completion of the Merger will also be subject to closing conditions, customary for a transaction of this nature. NYIAX will be subject to customary “no-shop” restrictions on its ability to solicit alternative acquisition proposals from third parties and to provide information to, and continue or participate in discussions and engage in negotiations with, third parties
32

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

regarding any alternative acquisition proposals, subject to a customary “fiduciary out” provision that allows the Company, under certain specified circumstances and subject to other terms and conditions in the NYIAX Merger Agreement, to provide information to, and continue or participate in discussions and engage in negotiations with, third parties with respect to an alternative acquisition proposal if the board of directors of NYIAX (the “NYIAX Board”) (or a committee thereof) determines in good faith (after consultation with its financial advisor and outside legal counsel) that such alternative acquisition proposal either constitutes a superior proposal or is reasonably likely to lead to a superior proposal, and the NYIAX Board (or a committee thereof) has determined in good faith (after consultation with its financial advisor and outside legal counsel) that the failure to take such actions could reasonably be expected to be inconsistent with its fiduciary duties pursuant to applicable law.
Pursuant to the NYIAX Merger Agreement if, at any time during the period beginning on the Closing Date and ending on the date that is twelve (12) months following the Closing Date, the surviving corporation (as defined in the NYIAX Merger Agreement), or the Company, executed and announced a definitive commercial, strategic, joint venture, licensing, partnership, or other bona fide revenue generating or value enhancing agreement with a trading market (a “Trading Market Transaction”), approved by the the board of directors of the Company, then the Company shall issue to the Merger Partner Stockholders, on a pro rata basis in accordance with their respective ownership immediately prior to the Effective Time, an aggregate of 13,000,000 duly authorized, validly issued, fully paid and nonassessable restricted shares of common stock (the “Earn-Out Shares”). In lieu thereof, each unaccredited investor shall be entitled to receive, with respect to each share of NYIAX Common Stock held immediately prior to the Effective Time, a cash payment equal to the higher of (i) price per share equal to the VWAP of the common stock for the five (5) consecutive trading days ending on the trading day immediately preceding the Closing Date, or (ii) price per share equal to the VWAP of the common stock for the five (5) consecutive trading days ending on the trading day immediately preceding the execution and announcement of Trading Market Transaction, without interest and subject to applicable tax withholding.
From the closing, NYIAX and for a period of twelve (12) months thereafter has agreed to a special indemnity, pursuant to which NYIAX will indemnify, defend and hold harmless the Company, the surviving corporation from and against any and all losses (as defined in the NYIAX Merger Agreement) arising out of, relating to, or resulting from certain specific, enumerated claims, actions, suits, proceedings, investigations or demands against NYIAX set forth in the NYIAX Merger Agreement, including any continuation, amendment, extension or escalation thereof. Any and all losses for which indemnification is required under the NYIAX Merger Agreement will be satisfied solely by a reduction in the number of Trading Market Transaction earn-out shares otherwise issuable to the Merger Partner Stockholders pursuant to NYIAX Merger Agreement. In no event shall the aggregate number of Trading Market Transaction earn-out shares subject to reduction pursuant to the NYIAX Merger Agreement exceed 5,000,000 shares of common stock.
Pursuant to the Merger Agreement, the Company has agreed to file with the Securities and Exchange Commission a registration statement on Form S-3 (or, if the Company is not then eligible to use Form S-3, on Form S-1), within thirty (30) calendar days following the closing date, covering the resale of all shares of common stock issued to Merger Partner Stockholders as Merger Consideration pursuant to Merger Agreement. The Earn-Out Shares will have similar registration rights upon issuance of such shares.
The NYIAX Merger Agreement contains customary termination rights for both the Company and Merger Sub, on the one hand, and NYIAX, on the other hand, including, among others, for failure to consummate the Merger within 90 days from the signing of the NYIAX Merger Agreement.
IBM Purchase Commitment for Programs
On July 7, 2025, the Company entered into a purchase commitment for programs (the “IBM Purchase Commitment”) with International Business Machines Corporation (“IBM”), to purchase certain subscriptions from IBM program offerings (the “Programs”). IBM agreed to license the Programs to the Company for two payments of $18.9 million on June 30, 2025 and $4.8 million on September 30, 2025, respectively (the “Program Payments”). According to an Embedded Solution Agreement (the “Base Agreement”), of which the Purchase Commitment and the Cloud Services
33

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

Agreement (as defined below) form a part, the Program Payments become due once an invoice is sent from IBM to the Company and are due within 30 days of receipt of the invoice.
On September 23, 2025, the Company entered into an amendment to the IBM Purchase Commitment (the “Amendment 1”), revising the total commitment to $25.9 million, payable according to the following schedule: $2.5 million paid at the signing of the agreement, $3.3 million on December 23, 2025, followed by eight quarterly payments of $2.2 million each, with the final payment due on December 23, 2027.
Under the IBM Purchase Commitment, the Company must send a report to IBM every 90 days summarizing the use of each Program. The Company may license the Programs to end-users, subject to certain limitations, restrictions, and requirements. The Company must use its own intellectual property to add value to the Programs and describe this value to IBM as well as bundle it within the Programs when licensing to end-users.
The IBM Purchase Commitment includes customary representations and warranties and various customary covenants and closing conditions that are subject to certain limitations, including in the Base Agreement.
Payments under the IBM Purchase Commitment are capitalized to prepaid expenses and are amortized on a straight-line basis over the contractual term, which ends on June 29, 2028, with amortization recorded to research and development expense in the same manner as the related hosting fees. As of June 30, 2026, the Company had approximately $15.2 million of remaining purchase commitments payable under the agreement.
Cloud Services Subscription Agreement
On July 7, 2025, the Company entered into a cloud services subscription agreement (the “Cloud Services Agreement”) with IBM, pursuant to which the Company has agreed to purchase certain subscriptions to IBM cloud services (the “Cloud Services”).
The Company has selected their Cloud Services, with the minimum value of the Cloud Services actually purchased within each annual period being (i) $0.1 in the first year, (ii) $2.1 in the second year, and (iii) $4.1 in the third year. If the Cloud Services purchased in an annual period exceed the minimum, that surplus amount can be removed from the required minimum for the following year. If the Cloud Services purchased in an annual period are below the minimum, the Company must place an order covering the additional amount within seven days of the end of the applicable annual period. If the Company does not place that additional order, IBM may invoice the Company and require the Company to pay that additional amount to reach the minimum for the applicable annual period.
Pursuant to the Cloud Services Agreement, the Company must use its own intellectual property to add value to the Cloud Services for end-users of the Cloud Services.
The Cloud Services Agreement includes customary representations and warranties and various customary covenants and closing conditions that are subject to certain limitations, including in the Base Agreement.
The Company is recording the expense as subscription licenses expense in the research and development line item on the condensed consolidated statement of operations.
SanQtum AI Enterprise Unit Agreement
On November 30, 2025, the Company entered into a three-year subscription agreement with IBM for the SanQtum AI Enterprise Unit Installation (the “SanQtum Agreement”). The agreement has a contractual term beginning November 30, 2025 and ending November 29, 2028.
Pursuant to the SanQtum Agreement, the Company committed to purchase a minimum contract value of $10.0 million over the three-year term. In connection with the agreement, the Company made an initial payment of $10.0 million
34

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

upon execution. If the Company does not place purchase orders sufficient to meet the committed contract value during the term, IBM may invoice the Company for the remaining balance of the commitment.
The Company accounts for the arrangement as a prepaid software and amortizes the related expense on a straight line basis within research and development expense over the contractual term. As of June 30, 2026, the unamortized portion of the initial payment is recorded under prepaid software license on the condensed consolidated balance sheet.
Master Purchase Order Agreement - SanQtum
On January 4, 2026, the Company entered into a Master Purchase Order Agreement with AP Global Holdings LLC (d/b/a Available Infrastructure) pursuant to which the Company agreed to purchase SanQtum™ infrastructure and cybersecurity services under a services-based delivery model. The agreement provides for an upfront payment of $250,000 and has an initial term of twelve months, subject to earlier termination in accordance with its terms. During quarter ended June 30, 2026 we paid an upfront deposit of $32.4 million which relieves the Company of the commitment to AP Global Holdings LLC.
Earnout Agreement
In connection with the closing of the EOS Asset Acquisition, the Company and EOS Holdings entered into the Earnout Agreement, dated as of December 31, 2024, pursuant to which the Company shall pay an amount equal to three percent (3%) of the net revenue of the Company generated from or otherwise attributable to any patents and patent applications included in the EOS Acquired Assets, subject to customary deductions calculated in accordance with U.S. GAAP, and as further set forth in the Earnout Agreement. The earnout period commenced on the closing date of the EOS Asset Acquisition and will end upon the expiration of the last to expire of the patents included in the EOS Acquired Assets (the “Term”). The Company shall make the earnout payments to EOS Holdings on a quarterly basis during the Term. The Earnout Agreement includes customary covenants regarding how the Company can operate its business during the term of the Earnout Agreement.
On July 29, 2026, the Company and EOS Holdings entered into a letter agreement that amended the settlement provisions of the Earnout Agreement to permit EOS Holdings, in its sole discretion, to elect to receive all or any portion of an earnout payment in shares of the Company’s common stock in lieu of cash. Any shares issued pursuant to such election are subject to certain limitations, including an exchange cap, with any portion that cannot be settled in shares payable in cash.
Helmex Agreement
On May 30, 2026, the Company entered into a term sheet with Helmex Global LLP and certain affiliated parties (collectively, “Helmex”) in connection with a proposed financing transaction. The contemplated transaction provides for an aggregate investment of up to $2.0 billion through four successive tranches of $500.0 million each, with the initial tranche expected to consist of an investment of $500.0 million in exchange for shares of the Company’s common stock and/or preferred stock, subject to the execution of definitive agreements and satisfaction of applicable closing conditions.
In connection with the proposed initial tranche, the Company agreed to fund $25.0 million of administrative, operational and structuring costs associated with establishing the investment fund and facilitating the proposed financing. The transaction fee provision represents a binding obligation under the term sheet. As of June 30, 2026, the Company had paid $5.0 million toward the $25.0 million transaction fee.
The proposed financing remains subject to significant conditions, including completion of due diligence, execution of definitive transaction agreements, receipt of required regulatory and stockholder approvals, completion and acceptance of an independent valuation of the preferred units, satisfaction of applicable collateral and other documentation requirements, and the Company’s determination that it will be able to monetize the preferred units received in the transaction. Accordingly, there can be no assurance that the proposed financing will be completed on the contemplated
35

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

terms or at all. Amounts paid toward the transaction fee are non-refundable and therefore are subject to significant risk of loss if the proposed financing is not consummated.
10.    Related Parties
Nathaniel Bradley and EOS Holdings
Nathaniel Bradley, the Chief Executive Officer (“CEO”) of the Company, is a control person of EOS Holdings which became a related party of the Company at the close of the EOS Asset Acquisition on December 31, 2024. In addition, Sonia Choi, the Company’s Chief Marketing Officer is the spouse of the Company’s CEO and holds the position of Chief Marketing Officer of EOS Holdings, a related party of the Company. EOS Holdings received 3,999,911 shares of common stock of the Company at the close of the transaction. As described in Note 5 Borrowings, the Company fully paid the EOS Convertible Note to EOS Holdings during the first quarter of 2026. In the third quarter of 2025, EOS Holdings exercised its conversion right under the EOS Convertible Note, converting approximately $3.2 million of the principal balance into shares of the Company’s common stock.
In addition to the EOS Convertible Note, on January 16, 2025, the Company entered into a Transition Services Agreement (“Transition Services Agreement”) to receive from EOS Holdings, employees to provide transition services in connection with the EOS Acquired Assets for a period of up to three months. For the three and six months ended June 30, 2026, the Company has paid $0 and $11,431, respectively, to EOS Holdings and has a balance due to EOS as of June 30, 2026 of $0.5 million. $0.4 million and $0.5 million was paid to EOS Holdings for the three and six months ended June 30, 2025.
Pursuant to the asset acquisition agreement with EOS Holdings, the Company is obligated to pay an earnout equal to 3% of Net Revenue (as defined in the agreement) generated from products and/or services utilizing the acquired Patent Rights. For the three and six months ended June 30, 2026, the Company recorded $4,050 earnout expense. There was no earnout expense or associated revenue for the three and six months ended June 30, 2025. As of June 30, 2026, the Company had accrued approximately $0.8 million in earnout payable to EOS Holdings which is included in the accrued liabilities section of the balance sheet. As of December 31, 2025, the Company had accrued approximately $0.8 million in earnout payable. This transaction is expected to be settled with the issuance of stock. No payments or stock issuances were made during the six months ended June 30, 2026.
Helge Kristensen
Mr. Kristensen has served as a member of the Company’s board of directors since 2010. Mr. Kristensen serves as vice president of Hansong Technology, an original device manufacturer of audio products based in China, president of Platin Gate Aps, a company with focus on service-branding in lifestyle products as well as pro line products based in Denmark and co-founder and director of Inizio Capital, an investment company based in the Cayman Islands.
For the three months ended June 30, 2026 and 2025, Hansong Technology purchased modules from the Company and was assessed fees of approximately $316,000 and $26,000, respectively, and made no payments for the three months ended June 30, 2026 and 2025. At June 30, 2026 and 2025, Hansong Technology owed the Company $290,000 and $42,000, respectively.
For the six months ended June 30, 2026 and 2025, Hansong Technology purchased modules from the Company and was assessed fees of approximately $457,000 and $37,000, respectively, and made no payments to the company for the six months ended June 30, 2026 and 2025.
For the three months ended June 30, 2026 and 2025, Hansong Technology sold speaker products to the Company of approximately $4,000 and $1,000, respectively, and the Company made zero and $2,000 payments to Hansong Technology for the three months ended June 30, 2026 and 2025. At June 30, 2026 and 2025, the Company owed Hansong approximately zero and $42,000, respectively.
36

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

For the six months ended June 30, 2026 and 2025, Hansong Technology sold speaker products to the Company of approximately $4,000 and $1,000, respectively, and the Company made no and $2,000 payments to Hansong Technology for the six months ended June 30, 2026 and 2025.
As of June 30, 2026 and December 31, 2025, Mr. Kristensen owned less than 1.0% of the outstanding shares of the Company’s common stock.
Scilex Advances and Bitcoin Transactions
During the six months ended June 30, 2026, Scilex, a related party and significant shareholder of the Company, provided short-term cash advances to the Company to support working capital and operating needs. The advances bore interest at an annual rate of 15.42%. During the six months ended June 30, 2026, the Company received aggregate cash advances from Scilex of approximately $18.7 million and repaid approximately $18.1 million of principal and $0.1 million of accrued interest through transfers of Bitcoin. There were no advances or repayments during the three months ended June 30, 2026. As of June 30, 2026, amounts outstanding under the advances totaled approximately $0.7 million of principal and $28,000 of accrued interest. There were no Scilex advances for the three or six months ended June 30, 2025.
Other Intangible Asset Acquisitions
During the six months ended June 30, 2026, the Company acquired an additional patent from three inventors, including Dr. Henry Ji and Stephen Ma, both related parties, for an aggregate fair value of approximately $5.4 million. Dr. Ji is a related party of the Company, and Mr. Ma serves as Chief Financial Officer of Scilex, Inc., a significant shareholder and related party of the Company. The patent was assigned a useful life of 10 years based on the estimated period of expected future economic benefit. As consideration for the acquisition, the Company agreed to issue an aggregate of 7,500,000 shares of common stock, consisting of 2,500,000 initial closing shares and 5,000,000 contingent shares issuable upon achievement of specified milestones. The contingent shares were issued during the six months ended June 30, 2026. The Company recorded amortization expense related to the acquired patent of approximately $0.1 million and $0.2 million for the three and six months ended June 30, 2026, respectively. There was no amortization expense related to the acquired patent for the three and six months ended June 30, 2025.
Investment in Vivasor, Inc.
Vivasor, Inc. (“Vivasor”) is a related party of the Company. Dr. Henry Ji, a related party of the Company, serves as Chief Executive Officer of Vivasor. During the six months ended June 30, 2026, the Company acquired an approximately 2% ownership interest in Vivasor for aggregate consideration of approximately $56.2 million, which was paid in the Company's common stock. The investment is accounted for as an equity security without a readily determinable fair value under the measurement alternative in accordance with ASC 321, Investments—Equity Securities. During the three and six months ended June 30, 2026, the Company recognized an impairment loss of approximately $55.4 million related to its investment in Vivasor. As a result, the carrying value of the investment was approximately $0.8 million as of June 30, 2026. See Note 6, Investments, for additional information regarding the Company’s investment in Vivasor and the related impairment.
11.    Segment Information
The Company operates in one business segment. Our chief decision-maker, the President and Chief Executive Officer, evaluates our performance based on company-wide condensed consolidated results.
Operating segments have been identified based on the financial information utilized by the Company’s Chief Executive Officer, the chief operating decision maker (“CODM”). The CODM uses net income as a measure of profitability to assess segment performance and deciding on how to allocate resources such as capital investments, share repurchases, and acquisitions. The CODM does not use or receive total assets by segment to make decisions regarding resources; therefore, the total asset disclosure by segment has not been included.
37

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)


The following table reflects results of operations of the Company’s reportable segment (in thousands):
For the Three Months Ended June 30,For the Six Months Ended June 30,
2026202520262025
Net revenue$6,717 $1,735 $10,133 $2,364 
Cost of net revenue3,839 1,700 7,144 2,260 
Salaries, benefits, and stock based compensation expense11,208 4,664 20,676 8,223 
Depreciation and amortization expense3,287 2,500 6,449 4,825 
Other segment expenses14,839 5,335 33,270 8,951 
Interest (expense), net(1,000)(24,646)(2,121)(24,766)
Other (expense), net(60,569)(1)(81,629)(13)
Income tax expense— — 
Net loss$(88,025)$(37,116)$(141,156)$(46,679)
Net revenue from customers is designated based on the geographic region to which the product is delivered. Net revenue by geographic region for the three and six months ended June 30, 2026 and 2025 was as follows:
For the Three Months Ended June 30,For the Six Months Ended June 30,
(in thousands)2026202520262025
North America$5,357 $1,477 $7,871 $1,615 
Asia Pacific731 199 1,155 565 
Europe629 59 1,107 184 
Total$6,717 $1,735 $10,133 $2,364 
Substantially all of our long-lived assets are located in the United States.
12.    Subsequent Events
NYIAX Bridge Loan Guarantee
On July 17, 2026, subsequent to the reporting period, the Company entered into a Guarantee Bridge Loan Agreement with Abri Capital LTD. and NYIAX, Inc. in connection with the pending acquisition of NYIAX. Under the agreement, the Company serves as guarantor of a short-term bridge loan facility providing NYIAX with borrowings of up to $0.8 million. The proceeds of the facility are intended to fund transaction-related expenses, legal and regulatory costs, employee obligations, and working capital requirements associated with the proposed merger. Amounts borrowed under the facility bear interest at 13% per annum, are issued at a 10% original issue discount, and mature on September 11, 2026, unless earlier repaid upon the closing of the proposed merger, at which time all outstanding principal and accrued interest become due within three days. The Bridge Loan Agreement contains customary representations, warranties, covenants, and events of default. The guarantee and related financing arrangement are subject to customary funding conditions. As of the date these condensed consolidated financial statements were issued, the proposed merger had not been completed.
EOS Technology Holdings
On July 29, 2026, subsequent to the reporting period, the Company entered into a letter agreement with EOS Technology Holdings Inc. amending certain terms of the Earnout Agreement dated December 31, 2024. Under the letter agreement, EOS Technology Holdings Inc. may elect, in its sole discretion, to receive all or a portion of future earnout payments in shares of the Company's common stock in lieu of cash. Shares issued pursuant to such elections will generally be valued based on the volume-weighted average price of the Company's common stock for the five
38

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

consecutive trading days immediately preceding the applicable payment due date, subject to certain specified terms. The issuance of shares under the letter agreement is subject to an exchange cap equal to 19.99% of the Company's outstanding common stock as of the date of the agreement, unless stockholder approval or another applicable Nasdaq exception is obtained. Any earnout payments that cannot be satisfied with shares due to the exchange cap will continue to be settled in cash. The Company also agreed to file registration statements covering the resale of shares issued pursuant to the agreement, subject to the terms and limitations set forth therein. The Company is evaluating the accounting implications of the amendment to the Earnout Agreement, including its impact, if any, on the related earnout liability.
CyberCatch Acquisition
On August 14, 2026, the Company entered into a definitive agreement to acquire 100% of the issued and outstanding common shares of CyberCatch Holdings, Inc. (“CyberCatch”), a provider of AI-enabled cybersecurity compliance and cyber risk mitigation solutions, in an all-cash transaction structured as a court-approved plan of arrangement under the Business Corporations Act (British Columbia). Under the terms of the agreement, the Company will acquire approximately 26.8 million outstanding common shares of CyberCatch for aggregate cash consideration of approximately $86.2 million, or $3.22 per share. Outstanding dilutive securities of CyberCatch will be exchanged on a cashless-exercise basis. The transaction is subject to customary closing conditions, including approval by CyberCatch shareholders, court approval of the plan of arrangement, applicable stock exchange and regulatory approvals, and other customary closing conditions. Upon completion of the transaction, CyberCatch is expected to become a wholly owned subsidiary of the Company. As the transaction had not closed as of the date the financial statements were issued, the Company has not recorded the acquisition in the accompanying financial statements. In connection with the transaction, the Company is also obligated to provide CyberCatch with an additional bridge loan of $0.5 million within seven days following execution of the definitive agreement.
August 2026 Offering
On August 18, 2026, the Company entered into the Securities Purchase Agreement for the issuance and sale of convertible promissory notes with an aggregate principal value of $25.0 million (the "August Convertible Promissory Notes"), with up to $25.0 million in aggregate principal amount of additional convertible promissory notes (the "Additional August Convertible Promissory Notes") issuable from time to time upon exercise of the Reinvestment Right (as defined below). In addition, the Company is issuing 15,000,000 shares of common stock, to be used as pre-delivery shares (the "Pre-Delivery Shares"). The August Convertible Promissory Notes and the Additional August Convertible Promissory Notes are convertible into shares of common stock. The August Convertible Promissory Note and Additional August Convertible Promissory Notes bears simple interest at a rate of 8% per annum and has no original issue discount with a term of 30 months. The investor may convert all or any part of the outstanding balance of any August Convertible Promissory Note or Additional August Convertible Promissory Note, at a fixed conversion price of $1.55 per share, into shares of the Company's common stock.
The investor has the right (the “Reinvestment Right”), but not the obligation, to invest up to $25.0 million in Additional Convertible Promissory Notes on the same terms and conditions as the August Convertible Promissory Note at any time during the 12-month period following August 18, 2026 (the “Closing Date”). Any August Convertible Promissory Notes issued pursuant to the Reinvestment Right will have new 30-month maturity periods from their respective issuance dates. In addition to the conversion rights described above, the August Convertible Promissory Note grants the investor additional conversion rights that permit it to convert specified portions of the August Convertible Promissory Note at a variable market price.
In addition to the fixed-price conversion right described above, the August Convertible Promissory Note grants the investor the right to convert at a variable market price (each, a "Market Price Conversion"). For each Market Price Conversion, the number of conversion shares issuable equals the conversion amount divided by the market price, where "Market Price" means 92% of the lowest daily VWAP of the Company's common stock during the seven (7) trading day period immediately preceding the applicable conversion date. Each conversion amount includes make-whole interest calculated as if the converted amount had been held to maturity. The Market Price Conversion rights are
39

Table of Contents
DATAVAULT AI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended June 30, 2026 and 2025
(unaudited)

structured as follows: Limited market price conversion (the "Limited Market Price Conversions"). During the period beginning September 1, 2026 and ending December 31, 2026, if a Limited Redemption Event (defined below) occurs, the investor may submit a conversion notice to effect a Market Price Conversion during the applicable limited redemption window. A "Limited Redemption Event" occurs on any trading day on which the Company's common stock trades at a price at least 5% greater than the Nasdaq minimum price for such trading day. A "Limited Redemption Window" begins on the date a Limited Redemption Event occurs and ends five (5) Trading Days later, and more than one Limited Redemption Window may be open at the same time. The amount the investor may convert pursuant to any such Conversion is capped at the maximum limited conversion amount, which equals 10% of the cumulative daily dollar trading volume of the Company's common stock on the trading day on which the Limited Redemption Event occurs, plus make-whole interest.
The unrestricted market price conversions (the "Unrestricted Market Price Conversions") begins January 1, 2027 and continues until the August Convertible Promissory Note has been repaid in full, and allows the investor to submit a conversion notice to convert all or any portion of the outstanding balance of the August Convertible Promissory Note at the market price, without regard to the limited redemption event condition or the maximum limited conversion amount cap.
NYIAX Acquisition
On August 19, 2026, the Company completed its acquisition of NYIAX, Inc. (“NYIAX”), a provider of blockchain-enabled exchange and contract management technology, through the merger of a wholly owned subsidiary of the Company with and into NYIAX, with NYIAX surviving the merger as a wholly owned subsidiary of the Company. The Company issued approximately 78,947,368 shares of its common stock in connection with the acquisition, with an estimated fair value of approximately $30.8 million based on the closing price of the Company’s common stock immediately preceding the acquisition date. The Company is currently evaluating the accounting for the acquisition in accordance with ASC 805, Business Combinations. As the acquisition was completed subsequent to June 30, 2026, the transaction has not been reflected in the Company’s condensed consolidated financial statements as of and for the three and six months ended June 30, 2026. The initial accounting for the business combination, including the allocation of the purchase consideration to the identifiable assets acquired and liabilities assumed, has not yet been completed.
BankWyse Acquisition
On August 19, 2026, the Company entered into a definitive agreement to acquire BankWyse, a Wyoming-chartered Special Purpose Depository Institution that provides digital asset custody, commercial banking and related services. The acquisition is subject to regulatory approval and other customary closing conditions, including approvals associated with the change of control of BankWyse and its continued operation under its Wyoming Special Purpose Depository Institution charter. The merger consideration is $22 million, consisting of approximately $14.7 million in DVLT common stock and $7.3 million in cash, plus contingent earnout consideration of up to $10 million. Upon completion of the transaction, BankWyse is expected to become a wholly owned subsidiary of the Company. As the transaction had not closed as of the date the financial statements were issued, the Company has not recorded the acquisition in the accompanying condensed consolidated financial statements.
AP Cyber Warrant
On July 22, 2026, the Company issued a warrant to AP Cyber LLC (“AP Cyber”) as partial consideration for services to be provided pursuant to a mutual services agreement entered into between the Company and AP Cyber on July 16, 2026. The warrant provides AP Cyber with the right to purchase up to 24,000,000 shares of the Company’s common stock at an initial exercise price of $0.40 per share, subject to adjustment in accordance with the terms of the warrant. The warrant expires on July 22, 2036. The warrant becomes exercisable based upon the achievement of specified sales thresholds for Qestral Coin. One-third of the warrant shares become exercisable when net proceeds from sales of Qestral Coin equal or exceed $100 million, one-half of the warrant shares become exercisable when net proceeds equal or exceed $1 billion, and all warrant shares become exercisable when net proceeds equal or exceed $2.5 billion.
40

Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Cautionary Notice Regarding Forward Looking Statements
This Quarterly Report on Form 10-Q (this “Report”) contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements discuss matters that are not historical facts. Because they discuss future events or conditions, forward-looking statements may include words such as “anticipate,” “believe,” “estimate,” “intend,” “could,” “should,” “would,” “may,” “seek,” “plan,” “might,” “will,” “expect,” “predict,” “project,” “forecast,” “potential,” “continue,” negatives thereof or similar expressions. These forward-looking statements are found at various places throughout this Report and include information concerning possible or assumed future results of Datavault AI Inc.’s (“Datavault”, the “Company”, “our”, “us” or “we”) operations; business strategies; future cash flows; financing plans; plans and objectives of management; any other statements regarding future operations, future cash needs, business plans and future financial results, and any other statements that are not historical facts.
From time to time, forward-looking statements also are included in our other periodic reports on Forms 10-Q and 8-K, in our press releases, in our presentations, on our website and in other materials released to the public. Any or all of the forward-looking statements included in this Report and in any other reports or public statements made by us are not guarantees of future performance and may turn out to be inaccurate. These forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to risks, uncertainties and other factors, including risks related to Datavault’s ability to remain listed on the Nasdaq Capital Market; Datavault’s need for financing in the near term to support its ongoing operations; the volatility of the market price for Datavault’s common stock; market, economic and other conditions; Datavault’s ability to manage costs and execute on its operational and budget plans; risks related to mergers and acquisitions activity, including our ability to close certain acquisitions and realize the anticipated benefits from those acquisitions; our ability to realize the anticipated benefits from the acquisitions of CompuSystems, Inc. (“CSI”), API Media Innovations Inc. and NYIAX, Inc. (“NYIAX”); our ability to complete the acquisition of NYIAX; and Datavault’s ability to achieve its financial goals. Many of those factors are outside of our control and could cause actual results to differ materially from the results expressed or implied by those forward-looking statements. In light of these risks, uncertainties and assumptions, the events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this Report. All subsequent written and oral forward-looking statements concerning other matters addressed in this Report and attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this Report.

Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise.
Overview
Datavault AI Inc. (“Datavault,” the “Company,” “us,” “our,” or “we”) is an artificial intelligence platform ("AIP") company focused on transforming data and real-world assets into monetizable digital assets. The Company is developing an integrated licensing and technology ecosystem that combines artificial intelligence, blockchain, data valuation, tokenization, cybersecurity, high-performance computing and exchange infrastructure to support the lifecycle of data and digital assets..
Part of the Datavault platform is an AI-driven inference layer that operates beneath the Company’s user-facing applications, exchanges and monetization technologies. This inference layer is designed to analyze and contextualize data, identify relationships and patterns, generate insights, establish attributes and valuation signals, and support automated decision-making across the platform.
The Company’s proprietary technologies include AI-driven agents and patented technologies designed to enable data ownership, observability, valuation and monetization. These technologies are intended to work together rather than operate as independent products, creating an integrated ecosystem through which enterprises, institutions and other asset owners can identify previously underutilized data, establish its value and ownership, protect it, create digital representations of the
41

Table of Contents
underlying rights or assets, and access mechanisms for commercialization. Datavault has two synergistic platforms-Data Sciences and Acoustic Sciences.
Our Data Sciences division is focused on the delivery of cyber-secure AIP, privacy-protected data management and monetization technologies, which include artificial intelligence-driven agents branded as Data Vault®, DataValue®, DataScore®, and Data Vault Bank®. The Company’s cybersecurity capabilities are intended to provide security across this architecture, protecting data and digital assets as they move through the lifecycle from ingestion and inference through valuation, tokenization and exchange. The Company’s exchange technologies are designed to provide the commercialization layer of the platform. These technologies are intended to connect asset and data owners with markets through which digitally represented assets, rights and data may ultimately be transacted, licensed or otherwise monetized.
Datavault also operates an Acoustic Sciences platform that combines the Company’s patented audio and data-over-sound technologies with its events and experiential media business. The Acoustic Sciences platform includes WiSA®, ADIO® and related technologies designed for wireless audio transmission, spatial and immersive audio experiences, data-over-sound applications and digital engagement. The division also includes the Company’s live event capabilities, including CompuSystems, Inc. (“CSI”), operating under the Event Citadel brand, and API Media Innovations Inc. (“API Media”). Event Citadel provides event registration, lead retrieval, data analytics and related services for trade shows, conferences and other live events, while API Media provides media infrastructure, on-site media capture, data collection and digital engagement services for sporting events, entertainment venues and other large-scale experiential activations. The Company believes its events business provides both an established commercial revenue base and a real-world environment in which Datavault technologies can be deployed. By integrating event registration, audience engagement, media infrastructure and experiential data with technologies such as ADIO®, the Company believes it can capture and authenticate interactions occurring at physical events and venues and connect those interactions to its broader Data Sciences platform. This integration is designed to transform event-generated data into potentially monetizable digital assets while creating additional opportunities for audience engagement, credentialing, data analytics and tokenization.
Together, these capabilities form an integrated artificial intelligence platform designed to connect data, intelligence, value and markets. The Company is building infrastructure intended to support the complete lifecycle of digital assets, with its AI inference layer providing the underlying intelligence that connects the Company’s data, valuation, security, tokenization and monetization technologies.
Comparison of the Three and Six Months Ended June 30, 2026 and June 30, 2025
Revenue
Revenue for the three months ended June 30, 2026 was $6.7 million, an increase of $5.0 million or 287% compared to the revenue for the three months ended June 30, 2025 of $1.7 million. The increase was primarily a result of the acquisition of CSI and API Media along with an increase in patent license revenue. The CSI acquisition generated approximately $1.8 million in revenue and the API Media acquisition generated approximately $1.0 million in revenue for the three months ended June 30, 2026.
Revenue for the six months ended June 30, 2026 was $10.1 million, an increase of $7.7 million or 329% compared to the revenue for the six months ended June 30, 2025 of $2.4 million. The increase was primarily a result of the acquisition of CSI and API Media along with an increase in patent license revenue. The CSI acquisition generated approximately $4.1 million in revenue and the API Media acquisition generated approximately $1.2 million in revenue for the six months ended June 30, 2026.
Gross Profit and Operating Expenses
Gross Profit
Gross profit for three months ended June 30, 2026 was $2.9 million compared to a gross profit of $35,000 for the three months ended June 30, 2025. The gross profit as a percent of sales was 43% for the three months ended June 30, 2026, compared to the gross profit of 2% for the three months ended June 30, 2025. The increase in gross profit is due to the inclusion of higher-margin revenue as a result of the acquisition of API Media, an increase in higher margin audio product sales, and an increase in high-margin patent license sales.
42

Table of Contents
Gross profit for the six months ended June 30, 2026 was $3.0 million compared to a gross profit of $0.1 million for the six months ended June 30, 2025. The gross profit as a percent of sales was 30% for the six months ended June 30, 2026, compared to the gross profit of 4% for the six months ended June 30, 2025. The increase in gross profit is due to the inclusion of higher-margin revenue as a result of the acquisition of API Media, an increase in higher margin audio product sales, and an increase in high-margin patent license sales.
Research and Development
Research and development expenses for the three months ended June 30, 2026 were $7.2 million, an increase of $3.0 million, compared to the research and development expenses for the three months ended June 30, 2025 of $4.2 million. The increase in research and development expenses is primarily driven by IBM Watsonx AI and SanQtum AI subscription licenses of $3.1 million and higher legal expenses of $0.2 million.
Research and development expenses for the six months ended June 30, 2026 were $13.0 million, an increase of $6.4 million, compared to the research and development expenses for the six months ended June 30, 2025 of $6.6 million. The increase in research and development expenses is primarily driven by IBM Watsonx AI and SanQtum AI subscription licenses of $6.2 million and higher legal expenses of $0.5 million.
Sales and Marketing
Sales and marketing expenses for the three months ended June 30, 2026 were $7.2 million, an increase of $5.5 million compared to the sales and marketing expenses for the three months ended June 30, 2025 of $1.7 million. The increase in sales and marketing expenses is primarily related to an increase in headcount resulting in increased salaries and wages, benefits and stock-based compensation of $2.1 million, an increase in advertising and sponsorship projects of $2.4 million and legal and consulting expenses of $0.3 million.
Sales and marketing expenses for the six months ended June 30, 2026 were $13.8 million, an increase of $10.6 million compared to the sales and marketing expenses for the six months ended June 30, 2025 of $3.2 million. The increase in sales and marketing expenses is primarily related to an increase in headcount resulting in increased salaries and wages, benefits and stock-based compensation of $3.6 million, an increase in advertising and sponsorship projects of $4.9 million and legal and consulting expenses of $0.8 million.
General and Administrative
General and administrative expenses for the three months ended June 30, 2026 were $14.9 million, an increase of $8.4 million compared to general and administrative expenses for the three months ended June 30, 2025 of $6.5 million. The increase in general and administrative expenses is primarily driven by higher headcount, resulting in additional salaries, wages, commissions, benefits, and stock-based compensation of $3.3 million; legal and consulting expenses of $2.1 million; higher amortization of intangibles assets of $0.7 million related to the CSI acquisition closed on May 20, 2025, the IP acquisitions from Turner Global Media LLC and Web Access LLC closed in July 2025, the IP acquisition closed on January 04, 2026 the API acquisition closed on January 22, 2026, and the Saleri acquisition closed in Q2 2026. The increase also reflects higher acquisition-related expenses of $0.8 million and lease expense of $0.5 million.
General and administrative expenses for the six months ended June 30, 2026 were $33.6 million, an increase of $21.4 million compared to general and administrative expenses for the six months ended June 30, 2025 of $12.2 million. The increase in general and administrative expenses is primarily driven by higher headcount, resulting in additional salaries, wages, commissions, benefits, and stock-based compensation of $7.8 million; legal and consulting expenses of $6.8 million; higher amortization of intangibles assets of $1.5 million related to the CSI acquisition closed on May 20, 2025, the IP acquisitions from Turner Global Media LLC and Web Access LLC closed in July 2025, the IP acquisition closed on January 04, 2026 the API acquisition closed on January 22, 2026, and the Saleri acquisition closed in Q2 2026. The increase also reflects higher acquisition-related expenses, investor relations costs, and lease expense of $1.5 million, $0.6 million and, $0.9 million, respectively.
Interest Expense, net
Interest expense, net for the three months ended June 30, 2026 was $1.0 million, a decrease of $16.2 million compared to the interest expense, net for the three months ended June 30, 2025 of $17.2 million. Interest expense decreased due to an increase in short-term borrowings.
43

Table of Contents
Interest expense, net for the six months ended June 30, 2026 was $2.1 million, a decrease of $15.2 million compared to the interest expense, net for the six months ended June 30, 2025 of $17.3 million. Interest expense decreased due to an overall decrease in borrowings.
Debt Extinguishment
Debt extinguishment expense for the six months ended June 30, 2026 was $1.7 million, representing the difference between the settlement amount due and the carrying value of the First Convertible Note on the settlement date.
Crypto Assets
Loss on crypto assets was $8.1 million for the three months ended June 30, 2026, compared to no loss for the three months ended June 30, 2025. For the six months ended June 30, 2026, loss on crypto assets was $25.1 million, compared to no loss for the six months ended June 30, 2025. The losses during the 2026 periods were primarily attributable to decreases in the fair value of the Company’s crypto asset holdings resulting from fluctuations in market prices. The Company did not hold crypto assets during the comparable 2025 periods.
Change in Fair Value of Warrant Liability
Change in fair value of warrant liability for the three months ended June 30, 2026 was $3.9 million compared to $2,000 of income for the three months ended June 30, 2025.
Change in fair value of warrant liability for the six months ended June 30, 2026 was $3.9 million compared to $19,000 of income for the six months ended June 30, 2025.
Impairment of Investments in Non-Marketable Securities
Impairment of investment in marketable security for the three months ended June 30, 2026 was $56.4 million compared to none for the three months ended June 30, 2025. This impairment increase was primarily due to the decline in value of our investment in Vivasor, Inc.
Impairment of investment in marketable security for the six months ended June 30, 2026 was $58.9 million compared to none for the six months ended June 30, 2025. This impairment increase was primarily due to the decline in value of our investment in Vivasor, Inc.
Other Income and Expense, net
Other income, net for the three months ended June 30, 2026 was $31,000 income compared to $3,000 expense for the three months ended June 30, 2025.
Other income, net for the six months ended June 30, 2026 was $186,000 income compared to $32,000 expense for the six months ended June 30, 2025.
Liquidity and Capital Resources
Cash and cash equivalents as of June 30, 2026 were $1.4 million compared to $2.0 million, as of December 31, 2025.
We recorded a net loss of $88.0 million and $141.2 million for the three and six months ended June 30, 2026, respectively and used net cash in operating activities of $80.0 million for the six months ended June 30, 2026 compared to $12.8 million for the six months ended June 30, 2025. Excluding non-cash adjustments, the primary reasons for the increase in the use of net cash from operating activities during the six months ended June 30, 2026, was related to an increase in the net loss.
Cash used in investing activities for the six months ended June 30, 2026 and June 30, 2025 totaled approximately $17.1 million and $6.6 million, respectively. The increase was due to the acquisition of API on January 22, 2026.
Cash provided by financing activities for the six months ended June 30, 2026 and June 30, 2025 totaled approximately $96.5 million and $16.7 million, respectively. The increase of $79.8 million of cash provided by financing activities is
44

Table of Contents
primarily attributable to an increase of $32.4 million provided by proceeds from equity offerings at-the-market, and $55.7 million registered direct equity offering, offset by an increase of debt payments of $10.6 million.
In addition to our ongoing operating requirements, we have significant contractual and other commitments that may require substantial cash resources over the next twelve months. These obligations include approximately $20.0 million of remaining transaction fee commitments related to the Helmex transaction, remaining purchase commitments under our agreements with IBM, potential earnout payments to EOS, and weekly payment obligations under our May 5, 2026 short-term loan. In addition, in August 2026, we entered into a definitive agreement to acquire CyberCatch Holdings, Inc. in an all-cash transaction. Based on approximately 26.8 million CyberCatch common shares outstanding and consideration of $3.22 per share, approximately $86.2 million of cash consideration would be payable to holders of CyberCatch common shares, in addition to amounts that may be payable in respect of outstanding options and warrants, subject to the terms of the arrangement agreement. The CyberCatch acquisition remains subject to shareholder, court, regulatory and other customary closing conditions. We expect to fund our operating requirements and these commitments through existing cash and cash equivalents and other available resources, together with additional capital raised through equity and/or debt financings. Our ability to satisfy these obligations and continue to fund operations will depend, in part, on our ability to obtain additional financing on acceptable terms.
We have financed our operations to date primarily through the issuance of equity securities, proceeds from the exercise of warrants to purchase common stock, the issuance of debt instruments, and the sale of Bitcoin. As of August 15, 2026, we utilized our ATM offering to sell common stock for net proceeds of $32.4 million. In addition, on May 5, 2026, we raised net proceeds of $55.8 million through a registered direct offering. We intend to utilize our existing cash and cash equivalents, Bitcoin, and other available resources to fund our operations; however, these resources are not expected to be sufficient to fund our operations and other cash requirements for the next 12 months. Accordingly, we will need to raise additional capital through the issuance of equity securities and/or debt instruments to fund our operations and satisfy our anticipated cash requirements.

Off-Balance Sheet Arrangements
On July 17, 2026, we entered into a guarantee in connection with a bridge loan facility provided to NYIAX, Inc. Under the guarantee, we may be required to satisfy NYIAX's obligations under the bridge loan facility in the event NYIAX fails to perform its repayment obligations, subject to a maximum guaranteed amount of approximately $0.8 million. Accordingly, the guarantee represents a contingent obligation of the Company. As of the date of this Quarterly Report, no amounts have been paid by the Company pursuant to the guarantee.
Other than the NYIAX guarantee described above, we do not have any material off-balance sheet arrangements.
Critical Accounting Estimates
The preparation of our unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors that we believe to be reasonable under the circumstances. Actual results may differ from these estimates. We consider an accounting policy or estimate to be critical when it requires significant judgment or estimation and when changes in the underlying assumptions or estimates could have a material effect on our consolidated financial statements.
Business Combinations
We account for acquisitions that meet the definition of a business using the acquisition method of accounting. The application of acquisition accounting requires significant judgment in determining the fair value of consideration transferred and the identifiable assets acquired and liabilities assumed. The determination of fair value may involve the use of significant estimates and assumptions, including projected revenues and cash flows, expected growth rates, customer attrition rates, royalty rates, discount rates and the estimated useful lives of acquired intangible assets. The excess of the purchase consideration over the fair value of identifiable net assets acquired is recorded as goodwill. Changes in the assumptions and estimates used in determining the fair values of acquired assets and liabilities could materially affect the amounts recognized in connection with a business combination and subsequent periods.
45

Table of Contents
Goodwill and Intangible Assets
Our intangible assets primarily consist of acquired technology, patents and patent rights, customer relationships, trademarks and other acquired intellectual property. Intangible assets with finite useful lives are amortized over their estimated useful lives and are reviewed for impairment when events or changes in circumstances indicate that their carrying amounts may not be recoverable. Determining the useful lives and recoverability of intangible assets requires management to make judgments regarding the expected period over which the assets will generate economic benefits and estimates of future cash flows attributable to those assets.
Goodwill is not amortized but is evaluated for impairment at least annually and whenever events or circumstances indicate that its carrying value may not be recoverable. Our impairment assessments require management to make significant estimates and assumptions regarding future operating performance, revenue growth, cash flows, discount rates and other market and economic factors. Changes in these assumptions or deterioration in expected operating results could result in the recognition of an impairment charge.
Revenue Recognition – Percentage of Completion
For certain arrangements for which revenue is recognized over time, we measure progress toward satisfaction of the performance obligation using an input method based on costs incurred relative to total estimated costs required to complete the performance obligation. Revenue recognized under this method is dependent upon estimates of total expected contract costs and the extent of progress toward completion.
The estimation of total contract costs requires significant management judgment and is affected by a variety of factors, including the nature and complexity of the work to be performed, labor and other resource requirements, project timelines, changes in scope and other contractual or operational factors. We review our estimates of contract performance and total expected costs on an ongoing basis and recognize changes in estimates in the period in which they become known. Accordingly, revisions to estimated costs to complete or the estimated measure of progress could result in increases or decreases to revenue and earnings recognized in a particular period.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
As a smaller reporting company, as defined in Rule 12b-2 of the Exchange Act, we are not required to provide the information required by this Item.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures that are designed to ensure that material information required to be disclosed in our periodic reports filed under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission (“SEC”) rules and forms and to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer as appropriate, to allow timely decisions regarding required disclosure. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures. Based on the foregoing evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of June 30, 2026, our disclosure controls and procedures were effective to provide reasonable assurance that the information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), does not expect that our disclosure controls and procedures will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our Company have been detected. These inherent limitations include, but are not limited to, the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by
46

Table of Contents
the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Changes in Internal Controls
There were no changes in the Company’s internal control over financial reporting that occurred during the six months ended June 30, 2026 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.
47

Table of Contents
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
The information set forth in Note 9, “Commitments and Contingencies”, to our accompanying condensed consolidated financial statements under the caption “Contingencies” included in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated herein by reference.

Item 1A. Risk Factors
In addition to the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025, the following risk factors reflect material developments during the quarter ended June 30, 2026 and through the date of this filing that have changed the nature or magnitude of certain previously disclosed risks or that present new material risks to an investment in our securities. These risk factors should be read in conjunction with, and supplement, the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025. In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, which could materially affect the Company’s business, financial condition or future results. The risks described in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2025 are not the only risks facing the Company. Additional risks and uncertainties not currently known to the Company or that the Company currently deems to be immaterial also may materially adversely affect the Company’s business, financial condition and/or operating results.
We have a history of operating losses and may not be profitable in the future.
We have incurred net losses since inception and had an accumulated deficit of approximately $377.4 million as of December 31, 2025. For the six months ended June 30, 2026, we incurred a net loss of $145.0 million and used $80.0 million of cash in operating activities. As of June 30, 2026, we had $1.4 million in cash and cash equivalents, compared to $2.0 million at December 31, 2025.
While we have experienced revenue growth in recent periods, we are not certain whether or when we will obtain a high enough volume of sales to sustain or increase our growth or to achieve profitability in the future. We also expect our costs and expenses to increase in future periods, which could negatively affect our future results of operations if our revenue does not increase. In particular, we intend to continue to expend significant funds to further develop our platform, including by introducing new products and functionality, and to expand our inside and field sales teams and customer success team to drive new customer adoption, expand use cases and integrations, and support international expansion. We will also face increased compliance costs associated with growth and the expansion of our customer base. Our efforts to grow our business may be costlier than we expect, or the rate of our growth in revenue may be slower than we expect, and we may not be able to increase our revenue enough to offset our increased operating expenses. We may incur significant losses in the future for a number of reasons, including the other risks described herein, and unforeseen expenses, difficulties, complications or delays, and other unknown events. If we are unsuccessful in implementing any initiatives to improve our revenues to achieve profitability, it will have a material adverse impact on our business, prospects, operating results and financial condition. There can be no assurance that the revenue that we generate will be able to support our operations or meet our working capital needs.
On May 5, 2026, we entered into a short-term loan agreement in the amount of $2.0 million with an effective interest rate of approximately 183.5% per annum. The loan is guaranteed by both our Chief Executive Officer and our Chief Financial Officer in their personal capacities. The terms of this borrowing, including the extremely high effective interest rate and the requirement of personal officer guarantees, reflect our limited ability to access conventional credit markets and capital on commercially reasonable terms. Our reliance on such high-cost, short-term borrowings may accelerate cash depletion, reduce funds available for operations, and signal financial distress to investors, business partners and potential counterparties. In addition, the personal guarantees by our Chief Executive Officer and Chief Financial Officer create potential conflicts of interest, as these officers may have personal financial incentives related to the Company’s ability to service or repay this debt that differ from or compete with the interests of our stockholders. While we believe the loan was entered into on the best terms available to the Company at the time, there can be no assurance that the existence of such guarantees will not influence management decision-making in ways that are not aligned with stockholder interests.
48

Table of Contents
We may continue to need to rely on similar high-cost financing arrangements in the future if our cash resources are insufficient to fund operations and we are unable to access the capital markets on more favorable terms. Any future borrowings on similar or more onerous terms would further increase our cost of capital and reduce the resources available for our business.
We are subject to a securities class action lawsuit that could result in substantial costs and divert management’s attention from our business.
On August 5, 2026, a class action lawsuit was filed against the Company and certain of its current officers in the Eastern District of Pennsylvania, by plaintiff Carla Aramouni seeking to represent a class of all persons who purchased the Company’s securities between September 4, 2024 and October 30, 2025, alleging violations of Sections 10(b) and 20(a) of the Exchange Act. The matter is styled Aramouni v. Datavault AI Inc., et al., Case No. 2:26-cv-05548-JS (E.D. Pa Aug. 5, 2026). The complaint alleges that the Company made false and/or misleading statements and/or failed to disclose material information about the Company’s business, customer contracts, operations, and commercialization prospects in its public statements and SEC filings. The plaintiff seeks unspecified monetary damages on behalf of a purported class of stockholders plus attorneys’ fees and costs. The Company believes the claims asserted in the complaint are without merit and intends to vigorously defend against them. The matter is in its early stages, and the Company is unable to predict the outcome of the litigation or to reasonably estimate the range of possible loss, if any, that may result from the matter. However, securities class action litigation is often expensive and time-consuming, regardless of the outcome. We may be required to expend significant resources to defend ourselves, which could divert management’s attention from our business operations. Any adverse determination could result in substantial monetary damages that are not covered, or not fully covered, by our directors’ and officers’ liability insurance. In addition, the pendency of the litigation may adversely affect the market price of our common stock and our ability to raise capital.
Additionally, similar lawsuits could be filed against us and our officers and directors, which would increase costs and management distraction. The outcome of this litigation is inherently uncertain, and we are unable to predict the outcome or reasonably estimate the range of possible losses, if any, that may result from this matter.
We have committed to pay $25.0 million in non-refundable transaction fees in connection with a proposed financing that may not be consummated, and amounts paid to date are subject to significant risk of total loss.
On May 30, 2026, we entered into a term sheet with Helmex Global LLP and certain affiliated parties in connection with a proposed financing transaction for an aggregate investment of up to $2.0 billion. In connection with the proposed initial tranche, we agreed to fund $25.0 million of administrative, operational, and structuring costs associated with establishing the investment fund and facilitating the proposed financing. As of June 30, 2026, we had paid $5.0 million toward this commitment.
The proposed financing remains subject to significant conditions, including: (i) completion of due diligence satisfactory to both parties; (ii) negotiation and execution of definitive agreements; (iii) receipt of required regulatory and stockholder approvals, including antitrust clearance and any required clearance from the Committee on Foreign Investment in the United States (CFIUS); (iv) completion and acceptance of an independent valuation of the preferred units; and (v) our determination that we will be able to monetize the preferred units received in the transaction. There can be no assurance that these conditions will be satisfied or that the proposed financing will be completed on the contemplated terms or at all.
All amounts paid toward the transaction fee are non-refundable regardless of whether the proposed financing is consummated. Accordingly, if the proposed financing is not completed, we will lose the entirety of any amounts paid toward the $25.0 million fee, which would have a material adverse effect on our already limited cash resources and financial condition. The commitment to pay additional amounts under the fee obligation may further strain our liquidity at a time when our cash resources are severely limited.
We have entered into several term sheets and a letter of intent relating to proposed strategic transactions, but we may not execute definitive agreements with respect to one or more of such transactions, and any such transaction may not be completed on the terms contemplated by such term sheets or at all.
Since March 31, 2026, we have entered into several term sheets relating to proposed strategic transactions, including (i) a binding term sheet with Scilex Holding Company (“Scilex”), a significant stockholder of the Company and a related party, dated April 26, 2026, regarding a proposed $120.0 million cash contribution by Scilex to us and a revenue participation arrangement pursuant to which Scilex would be entitled to a specified percentage of the gross revenues we recognize
49

Table of Contents
attributable exclusively to our Quantum-Edge Network, (ii) a binding term sheet with Scilex, dated June 24, 2026, regarding our proposed sale to Scilex of 837 Bitcoin for an aggregate purchase price of $50.0 million, payable to us in multiple tranches through December 31, 2028, and (iii) a term sheet with Helmex, dated May 30, 2026, regarding a proposed financing transaction for an aggregate investment in the Company of up to $2.0 billion through four successive tranches of $500.0 million each (the term sheets referenced in the preceding clauses (i) through (iii), collectively, the “Term Sheets” and the transactions contemplated thereby, the “Proposed Transactions”). See Note 8, Commitments and Contingencies, to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for additional information regarding the Helmex term sheet, and the risk factor above for a description of the non-refundable transaction fee we have committed to pay in connection with the proposed Helmex financing.
The Term Sheets contemplate the execution of definitive agreements with respect to the applicable transactions, which are expected to include customary representations, warranties, covenants, indemnification provisions and closing conditions for transactions of their type. The Proposed Transactions remain subject to further negotiation, the completion of due diligence, receipt of required regulatory, corporate and, in certain cases, stockholder approvals, market conditions and other customary conditions outside our control. As of the date of this Quarterly Report on Form 10-Q, no definitive agreement for any of the Proposed Transactions has been entered into, and there can be no assurance that definitive agreements for such transactions will be executed or that the Proposed Transactions will be consummated on the terms set forth in the applicable Term Sheet or at all.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On July 22, 2026, we issued to AP Cyber LLC (“AP Cyber”), a Delaware limited liability company, a warrant to purchase up to 24,000,000 shares of our common stock at an initial exercise price of $0.40 per share, subject to adjustment (the “AP Cyber Warrant”). The AP Cyber Warrant was issued as partial consideration for services to be provided by AP Cyber under a mutual services agreement between the Company and AP Cyber, dated July 16, 2026 (the “Mutual Services Agreement”). The AP Cyber Warrant has a term of ten years and expires on July 22, 2036. The AP Cyber Warrant becomes exercisable in tranches upon the achievement of specified revenue milestones relating to sales of a digital asset product under the Mutual Services Agreement. The AP Cyber Warrant and the shares of our common stock issuable upon exercise thereof have not been registered under the Securities Act. The issuance of the AP Cyber Warrant was made in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act as a transaction by an issuer not involving a public offering. AP Cyber represented to the Company that it is an accredited investor within the meaning of Rule 501(a) of Regulation D promulgated under the Securities Act and that it is acquiring the warrant for investment purposes and not with a view to distribution.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
During the fiscal quarter ended June 30, 2026, no director or officer of the Company adopted, modified or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement, as such terms are defined in Item 408 of Regulation S-K.
50

Table of Contents
Item 6. Exhibits
Exhibit
Number
Description
2.1
2.2
2.3
3.1(i)(a)
3.1(i)(b)
3.1(i)(c)
3.1(i)(d)
3.1(i)(e)
3.1(i)(f)
3.1(i)(g)
3.1(i)(h)
3.1(i)(i)
3.1(i)(j)
3.1(i)(k)
3.1(i)(l)
3.1(ii)(a)
3.1(ii)(b)
4.1
51

Table of Contents
4.2*


4.3*
10.1*
10.2*
10.3*
10.4
10.5*
10.6*
10.7
10.8
10.9
31.1*
31.2*
32.1*
32.2*
101Interactive Data Files (embedded within the Inline XBRL document)
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
52

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Datavault AI Inc.
Date: August 19, 2026
By:/s/ Nathaniel Bradley
Name: Nathaniel Bradley
Chief Executive Officer
(Duly Authorized Officer and Principal Executive Officer)
Date: August 19, 2026
By:/s/ Brett Moyer
Name: Brett Moyer
Title: Chief Financial Officer
(Principal Financial Officer)
53
LEGAL_AMERICAS # 602343320.8 THIS WARRANT AND THE WARRANT SHARES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS, AND MAY NOT BE PLEDGED, HYPOTHECATED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS SO REGISTERED OR AN EXEMPTION THEREFROM IS AVAILABLE. WARRANT TO PURCHASE COMMON STOCK OF DATAVAULT AI INC. Date: July 22, 2026 THIS WARRANT TO PURCHASE COMMON STOCK certifies that, for value received, and as partial consideration for the services to be provided by AP Cyber LLC, a Delaware limited liability company (“AP Cyber”), under that certain Mutual Services Agreement, entered into between to DATAVAULT AI INC., a Delaware corporation (the “Company”), and AP Cyber, dated as of July 16, 2026 (as may be amended from time to time in accordance with its terms, the “MSA”), the Company, subject to the terms set forth in Section 1(d) hereof, promises to issue to AP Cyber, as the holder of this Warrant, its nominees, successors or assigns (collectively, the “Holder”), up to an aggregate of 24,000,000 nonassessable shares of common stock, par value $0.0001 per share, of the Company (“Common Stock”), upon the payment by the Holder to the Company of the Exercise Price (as defined herein) and to deliver to the Holder a certificate or certificates (or to deliver by book entry evidence) representing the Common Stock issued upon exercise of this Warrant pursuant to its terms. The number of shares of Common Stock issuable upon exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time as provided herein. The initial exercise price per share of Common Stock under this Warrant shall be equal to $0.40 per share (the “Exercise Price”), subject to adjustment as provided herein. For the purpose of this Warrant, the term “Common Stock” shall mean (i) the common stock, par value $0.0001 per share, of the Company, or (ii) any other class or classes of stock resulting from successive changes, reclassifications or capital reorganizations of such class of stock, and the term “Business Day” shall mean any day other than a Saturday or Sunday or a day on which commercial banks in New York, New York are required or authorized to be closed. Section 1. Term of Warrant, Exercise of Warrant. (a) Subject to the terms of this Warrant, the Holder shall have the right, at its option, which may be exercised in whole or in part, at any time, and from time to time, commencing at the time of the issuance of this Warrant and until 5:00 p.m. Eastern Time on July 22, 2036 to purchase from the Company the number of fully paid and nonassessable shares of Common Stock which the Holder may at the time be entitled to purchase on exercise of this Warrant (the “Warrant Shares”). Notwithstanding the foregoing, if the Holder shall have given the Company written notice of its intention to exercise this Warrant on or before 5:00 p.m. Eastern Time on July 22, 2036, the Holder may exercise this Warrant at any time through (and including) the next Business Day following the date that all applicable required regulatory holding periods


 
LEGAL_AMERICAS # 602343320.8 - 2 - have expired and all applicable required governmental approvals have been obtained in connection with such exercise of this Warrant by the Holder, if such Business Day is later than on July 22, 2036 (July 22, 2036 or such later date being herein referred to as the “Warrant Expiration Date”). After the Warrant Expiration Date, this Warrant will be void. (b) This Warrant shall be exercisable by the Holder surrendering this Warrant, with the form of Exhibit A hereof duly executed by the Holder, to the Company at its office located at One Commerce Square, 2005 Market Street, Suite 2400, Philadelphia, PA 19103 (or, in the event the Company’s principal office is no longer located thereat, its then principal office in the United States (the “Principal Office”)), accompanied by payment, of an amount (the “Exercise Payment”) equal to the Exercise Price multiplied by the number of Warrant Shares for which the Warrant is being exercised, payable as follows: (i) by payment to the Company in cash, by certified or official bank check, or by wire transfer of the Exercise Payment, (ii) by surrender to the Company for cancellation shares of Common Stock of the Company having a Market Price (as hereinafter defined) on the date of exercise equal to the Exercise Payment; or (iii) by a combination of the methods described in clauses (i) and (ii) above. In lieu of paying the Exercise Payment, pursuant to the immediately preceding sentence, when exercising the Warrant, the Holder may elect to receive a payment equal to the difference between (A) the Market Price on the date of exercise of this Warrant multiplied by the number of Warrant Shares for which this Warrant is being exercised and (B) the Exercise Price with respect to such number of Warrant Shares for which this Warrant is being exercised, payable by the Company to the Holder only in shares of Common Stock valued at the Market Price on the date of exercise. For purposes hereof, the term “Market Price” shall mean, with respect to any day, the average closing price of a share of Common Stock for the 15 consecutive trading days preceding such day on the principal national securities exchange on which the shares of Common Stock or securities are listed or admitted to trading or, if not listed or admitted to trading on any national securities exchange, the average of the reported bid and ask prices during such 15 trading day period on the Nasdaq Stock Market LLC (“Nasdaq”) or, if the shares are not listed on Nasdaq, in the over-the- counter market or, if the shares of Common Stock or securities are not publicly traded, the Market Price for such day shall be the fair market value thereof determined jointly by the Company and the Holder; provided, however, that if such parties fail to reach agreement within 30 days after the date of such exercise of this Warrant, the Market Price shall be determined in good faith by an independent investment banking firm selected jointly by the Company and the Holder or, if that selection fails to be made within 15 days, by an independent investment banking firm selected by the American Arbitration Association in accordance with its rules. All costs and expenses incurred in connection with the determination of Market Price shall be borne by the Company. (c) Upon any exercise of this Warrant, the Company shall issue and cause to be delivered with all reasonable dispatch, but in any event within three Business Days, to or upon the written order of the Holder and, subject to Section 2, in such name or names as the Holder may designate, a certificate or certificates (or reasonable evidence of book entry) for the number of Warrant Shares issuable upon such exercise together with any other property, including cash, which may be deliverable upon such exercise. If fewer than all of the Warrant Shares represented by this Warrant are purchased, a new Warrant of the same tenor as this Warrant,


 
LEGAL_AMERICAS # 602343320.8 - 3 - evidencing the remaining Warrant Shares for which this Warrant was not exercised, will be issued and delivered by the Company at the Company’s expense. (d) This Warrant shall be exercisable for Warrant Shares as follows: (i) Upon such time that net proceeds of sales of “Qestral Coin” (as defined in the MSA) shall equal or exceed $100,000,000, this Warrant shall automatically (and without any further act or deed on the part of any party) become exercisable with respect to one-third of the Warrant Shares then issuable under this Warrant; (ii) Upon such time that net proceeds of sales of “Qestral Coin” (as defined in the MSA) shall equal or exceed $1,000,000,000, this Warrant shall automatically (and without any further act or deed on the part of any party) become exercisable with respect to one-half of the Warrant Shares then issuable under this Warrant; and (iii) Upon such time that net proceeds of sales of “Qestral Coin” (as defined in the MSA) shall equal or exceed $2,500,000,000, this Warrant shall automatically (and without any further act or deed on the part of any party) become exercisable with respect to all Warrant Shares then issuable under this Warrant. Section 2. Warrant Register, Registration of Transfers. Section 2.1. Warrant Register. The Company shall keep at its Principal Office, a register (the “Warrant Register”) in which the Company shall record the name and address of the Holder from time to time and all transfers and exchanges of this Warrant. The Company shall give the Holder prior written notice of any change of the address at which such register is kept. Section 2.2. Registration of Transfers, Exchanges or Assignment of Warrants. The Holder shall be entitled to assign its interest in this Warrant in whole or in part to any person upon surrender thereof accompanied by a written instrument or instruments of transfer in the form of Exhibit B hereof duly executed by the Holder. This Warrant may be exchanged for or combined with another Warrant or Warrants of like tenor, representing in the aggregate the right to exercise the Warrant or Warrants, as applicable, for the remaining number of Warrant Shares underlying this Warrant upon presentation thereof to the Company at its Principal Office together with a written notice signed by the Holder specifying the denominations in which the new Warrant is or the new Warrants are to be issued. Upon surrender for transfer or exchange of this Warrant to the Company at its Principal Office for transfer or exchange, in accordance with this Section 2, the Company shall, without charge (subject to Section 3), execute and deliver a new Warrant or Warrants of like tenor and of a like aggregate amount of Warrant Shares in the name of the assignee named in such instrument of assignment and, if the Holder’s entire interest is not being assigned, in the name of the Holder with respect to that portion not transferred, and this Warrant shall promptly be canceled. Section 3. Payment of Taxes. The Company shall pay all documentary stamp taxes, if any, attributable to the initial issuance of any Warrant Shares upon the exercise of this Warrant; provided, however, that the Company shall not be required to pay any tax or taxes which may be


 
LEGAL_AMERICAS # 602343320.8 - 4 - payable in respect of any transfer involved in the issue or delivery of any Warrant or certificate for Warrant Shares in a name other than that of the Holder as such name is then shown on the books of the Company. Section 4. Certain Covenants. Section 4.1. Reservation of Warrant Shares. The Company shall reserve and shall at all times keep reserved, out of its authorized but unissued shares of Common Stock, free from any preemptive rights, rights of first refusal or other restrictions (other than pursuant to the Securities Act of 1933, as amended (the “Act”)), a number of shares of Common Stock sufficient to provide for the exercise of this Warrant. The transfer agent, if any, of the Company, and every subsequent transfer agent of the Company for any shares of the Common Stock issuable upon the exercise of this Warrant, shall be irrevocably authorized and directed at all times to reserve such number of authorized shares as shall be requisite for such purpose. Section 4.2. No Impairment. The Company shall not by any action, including, without limitation, amending its certificate of incorporation or any other organizational document, any reorganization, transfer of assets, consolidation, merger, dissolution or issue or sale of securities or otherwise, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but shall at all times in good faith assist in the carrying out of all such terms and in the taking of all such action, as may be necessary or appropriate to protect the rights of the Holder against impairment. Without limiting the generality of the foregoing, the Company shall take all such action as may be necessary or appropriate so that the Company may validly issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant at the then Exercise Price therefor. Section 4.3. Notice of Certain Corporate Action. In case the Company shall propose (a) to offer to the holders of its Common Stock rights to subscribe for or to purchase any shares of Common Stock or shares of stock of any class or any other securities, rights or options, or (b) to effect any reclassification of its Common Stock (other than a reclassification involving only the subdivision, or combination, of outstanding shares of Common Stock), or (c) to effect any capital reorganization, or (d) to effect any consolidation, merger or sale, transfer or other disposition of all or substantially all of its property, assets or business, or (e) to effect the liquidation, dissolution or winding up of the Company, or (f) to offer to the holders of its Common Stock the right to have their shares of Common Stock repurchased or redeemed or otherwise acquired by the Company, or (g) to take any other action which would require the adjustment of the Exercise Price and/or the number of Warrant Shares issuable upon exercise of this Warrant, then in each such case (but without limiting the provisions of Section 5), the Company shall give to the Holder, a notice of such proposed action, which shall specify the date on which a record is to be taken for purposes of such dividend, distribution or offer of rights, or the date on which such reclassification, reorganization, consolidation, merger, sale, transfer, disposition, liquidation, dissolution, or winding up is to take place and the date of participation therein by the holders of Common Stock, if any such date is to be fixed and shall also set forth such facts with respect thereto as shall be reasonably necessary to indicate the effect of such action on the Common Stock. Such notice shall be so given at least 10 Business Days prior to the record date for determining holders of the Common Stock for purposes of participating in or


 
LEGAL_AMERICAS # 602343320.8 - 5 - voting on such action, or at least 10 Business Days prior to the date of the taking of such proposed action or the date of participation therein by the holders of Common Stock, whichever shall be the earlier. Such notice shall specify, in the case of any subscription or repurchase rights, the date on which the holders of Common Stock shall be entitled thereto, or the date on which the holders of Common Stock shall be entitled to exchange their Common Stock for securities or other property deliverable upon any reorganization, reclassification, consolidation, merger, sale or other action, as the case may be. Such notice shall also state whether the action in question or the record date is subject to the effectiveness of a registration statement under the Act or to a favorable vote of security holders, if either is required, and the adjustment in Exercise Price and/or number of Warrant Shares issuable upon exercise of this Warrant as a result of such reorganization, reclassification, consolidation, merger, sale or other action. Section 5. Adjustment of Exercise Price. Section 5.1. Subdivision or Combination of Stock. In case the Company shall at any time (a) issue a dividend payable in Common Stock, or securities convertible into or exercisable or exchangeable for Common Stock (“Convertible Securities”), or any rights to subscribe for or to purchase, or any options for the purchase of, Common Stock or Convertible Securities or (b) subdivide its outstanding shares of Common Stock into a greater number of shares or combine its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect immediately prior to such subdivision or combination shall be adjusted to an amount that bears the same relationship to the Exercise Price in effect immediately prior to such action as the total amount of shares of Common Stock outstanding immediately prior to such action bears to the total number of shares of Common Stock outstanding immediately after such action, and the number of shares of Common Stock purchasable upon the exercise of any Warrant shall be that number of shares of Common Stock obtained by multiplying the number of shares of Common Stock purchasable immediately prior to such adjustment upon the exercise of such Warrant by the Exercise Price in effect immediately prior to such adjustment and dividing the product so obtained by the Exercise Price in effect after such adjustment. Section 5.2. Reorganization, Reclassification, Consolidation, Merger or Sale. (a) If any capital reorganization or reclassification of the capital stock of the Company, or any consolidation or merger of the Company with another corporation, or the sale of all or substantially all of its assets to another corporation shall be effected in such a way that holders of Common Stock shall be entitled to receive stock, securities or assets with respect to or in exchange for Common Stock, then, as a condition of such reorganization, reclassification, consolidation, exercise, merger or sale, lawful and adequate provision shall be made whereby the Holder shall thereafter have the right to receive upon the basis and upon the terms and conditions specified herein and in lieu of the shares of Common Stock immediately theretofore receivable upon the exercise of this Warrant, the amount of shares of stock, securities or assets (including cash) as may be issued or payable with respect to or in exchange for a number of outstanding shares of such Common Stock equal to the number of Warrant Shares for which this Warrant could have been exercised immediately prior to such reorganization, reclassification, consolidation, merger or sale, and in any such case appropriate provision shall be made with respect to the rights and interests of such Holder to the end that the provisions hereof shall


 
LEGAL_AMERICAS # 602343320.8 - 6 - thereafter be applicable, as nearly as may be, in relation to any shares of stock, securities or assets (including cash) thereafter deliverable upon the exercise of this Warrant. The Company will not effect any consolidation, merger or sale, unless prior to the consummation thereof the successor corporation (if other than the Company) resulting from such consolidation or merger or the corporation purchasing such assets shall assume, by written instrument executed and mailed or delivered to the Holder at the last address of such Holder appearing on the books of the Company, the obligation to deliver to such Holder such shares of stock, securities or assets (including cash) as, in accordance with the foregoing provisions, the Holder may be entitled to receive. (b) Notwithstanding the foregoing: (i) In the event of a merger or consolidation of the Company in which the consideration otherwise receivable in such merger or consolidation by the Holder upon exercise of the Warrant consists of anything other than cash or securities of an issuer whose equity securities are registered under the Securities Exchange Act of 1934, as amended (the “1934 Act”), the Holder shall be entitled to receive, upon exercise hereof, the consideration the Holder would be entitled to receive pursuant to Section 5.2(a). (ii) In the event of a merger or consolidation of the Company in which the consideration otherwise receivable in such merger or consolidation by the Holder upon exercise of the Warrant consists solely of securities of an issuer whose equity securities are registered under the 1934 Act (a “Public Issuer”), this Warrant may, at the option of the corporation surviving the merger or consolidation, be converted into either (i) the right to receive an amount in cash equal to the number of Warrant Shares for which the Warrant is then being exercised, multiplied by the Market Price of a share of Common Stock, or (ii) a warrant to acquire common stock of the Public Issuer. In the event the corporation surviving the merger or consolidation elects to convert this Warrant into the right to acquire common stock of the Public Issuer, the Exercise Price in effect immediately following such merger or consolidation shall equal the Exercise Price in effect immediately prior to such merger or consolidation, multiplied by a fraction, the numerator of which shall be the Market Price of a share of common stock of the Public Issuer and the denominator of which shall be the Market Price of a share of Common Stock, and the number of shares of common stock of the Public Issuer for which this Warrant shall be exercisable shall equal the number of Warrant Shares represented by this Warrant immediately prior to such merger or consolidation, multiplied by a fraction, the numerator of which shall equal the Market Price of a share of Common Stock and the denominator of which shall equal the Market Price of a share of common stock of the Public Issuer. Section 5.3. No Adjustment for Exercise of Certain Options, Warrants, Etc. The provisions of this Section 5 shall not apply to any Common Stock issued, issuable or deemed outstanding under Sections 5.1 to 5.2 inclusive: (i) to any person pursuant to any stock option, stock purchase or similar plan or arrangement for the benefit of employees, consultants or directors of the Company or its subsidiaries in effect on the date of issuance of this Warrant; or


 
LEGAL_AMERICAS # 602343320.8 - 7 - (ii) pursuant to options, warrants and conversion rights in existence on (or issued after) the date of issuance hereof. Section 5.4. Fractional Shares. The Company shall not issue fractions of shares of Common Stock upon exercise of this Warrant or scrip in lieu thereof. If any fraction of a share of Common Stock would, except for the provisions of this Section 5.4, be issuable upon exercise of this Warrant, the Company shall (or shall cause the Warrant Agent to), in lieu thereof, pay to the person entitled thereto an amount in cash equal to the current value of such fraction, calculated to the nearest one-hundredth (1/100) of a share, to be computed on the basis of the Fair Market Value for a share of Common Stock as of the date of exercise. The term “Fair Market Value” shall mean the closing price of a share of Common Stock or other security on the date of the issuance or sale on the principal national securities exchange on which the Common Stock is listed or admitted to trading or, if the Common Stock or such other security is not listed or admitted to trading on any national securities exchange, the average of the reported bid and ask prices on the date of the issuance or sale on Nasdaq or, if the Common Stock or such other security is not listed on the Nasdaq, in the over-the-counter market or, if the Common Stock or such other security is not publicly traded, the Fair Market Value for such day shall be the fair market value thereof determined jointly by the Company and the Holder; provided, however, that if such parties are unable to reach agreement within five Business Days of the date of issuance or sale. Fair Market Value shall be determined in good faith by an independent investment banking firm selected jointly by the Company and the Holder or, if that selection cannot be made within 15 days, by an independent investment banking firm selected by the American Arbitration Association in accordance with its rules. All fees and expenses of such independent investment banking firm that are incurred in connection with the determination of Fair Market Value shall be borne by the Company. Notwithstanding the foregoing, in the event of issuances of Common Stock in settlement of obligations of the Company, including without limitation the settlement of any pending action, suit or proceeding, the determination of Fair Market Value shall be made as of the date of the applicable settlement agreement and not the date of issuance as long as the relevant issuance occurs within 30 days of the date of such agreement. In the event the issuance occurs more than 30 days after the date of such agreement, Fair Market Value shall be determined as of the date of such issuance. Section 5.5. Notice of Adjustment. Upon any adjustment of the Exercise Price, and from time to time upon the request of the Holder, the Company shall furnish to the Holder a notice setting forth the amount of the Exercise Price resulting from such adjustment or otherwise in effect and the number of Warrant Shares then available for purchase under this Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Section 5.6. Certain Events. If any event occurs as to which, in the good faith judgment of the board of directors of the Company the other provisions of this Section 5 are not strictly applicable or if strictly applicable would not fairly protect the exercise rights of the Holder in accordance with the essential intent and principles of such provisions, then the board of directors of the Company in the good faith, reasonable exercise of its business judgment shall make an adjustment in the application of such provisions, in accordance with such essential intent and principles so as to protect such exercise rights as aforesaid.


 
LEGAL_AMERICAS # 602343320.8 - 8 - Section 6. No Rights as a Stockholder; Notice to Holder. Nothing contained in this Warrant shall be construed as conferring upon the Holder the right to vote or to consent or to receive notice as a stockholder in respect of any meeting of stockholders for the election of directors of the Company or any other matter, or any rights whatsoever as a stockholder of the Company. Section 7. Replacement of Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and (in the case of loss, theft or destruction) upon delivery of an indemnity agreement (with, in the case of a Holder which is not a qualified institutional buyer within the meaning of Rule 144A under the Act, surety) in an amount reasonably satisfactory to it, or (in the case of mutilation) upon surrender and cancellation thereof, the Company will issue, in lieu thereof, a new Warrant of like tenor. Section 8. Representations and Warranties of the Company. The Company hereby represents and warrants to the Holder as follows: (a) The Company is duly incorporated or organized and validly existing under the laws of the State of Delaware. The Company has the right, power and capacity to execute, deliver and perform this Warrant and to consummate the transactions contemplated hereby (including, without limitation, the issuance of the Warrant Shares). This Warrant has been duly and validly executed and delivered by the Company and constitutes valid and legally binding obligations of the Company, enforceable against the Company in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors’ rights generally, or (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies. (b) The execution, delivery and performance by the Company of this Warrant (including, without limitation, the issuance of the Warrant Shares) does not and will not conflict with, violate or result in a breach of, or constitute a default under, any mortgage, indenture, contract, agreement, instrument, judgment, decree or order to which the Company is a party, by which the Company is bound or to which the Company’s properties or assets are subject or any statute, rule or regulation applicable to the Company, or result in the creation of any lien or other encumbrance upon the material properties or assets of the Company pursuant to the foregoing. (c) The Warrant Shares, when issued as provided in this Warrant, will be duly authorized and validly issued, fully paid and non-assessable. Section 9. Representations and Warranties of AP Cyber. AP Cyber hereby represents and warrants to the Company as follows: (a) AP Cyber understands that this Warrant and the Warrant Shares are “restricted securities” (within the meaning of the Act) and have not been registered under the Act or any applicable state securities law and AP Cyber is acquiring this Warrant and the Warrant Shares as principal for its own account and not with a view towards, or for resale in connection with, the public sale or distribution thereof in violation of applicable securities laws, except pursuant to


 
LEGAL_AMERICAS # 602343320.8 - 9 - sales registered or exempted from registration under the Act. AP Cyber does not presently have any agreement or understanding, directly or indirectly, with any person to distribute any of this Warrant or the Warrant Shares in violation of applicable securities laws. AP Cyber has no present intent to effect a “change of control” of the Company as such term is understood under the rules promulgated pursuant to Section 13(d) of the 1934 Act. (b) AP Cyber is (a) either an “accredited investor” as that term is defined in Rule 501(a) of Regulation D promulgated under the Act or a “qualified institutional buyer” as defined in Rule 144A under the Act, and (b) a sophisticated institutional investor, experienced in investing in private securities transactions and capable of evaluating investment risks independently, both in general and with regard to all transactions and investment strategies involving a security or securities, including AP Cyber’s participation in the transactions contemplated by this Warrant and the MSA. (c) No inquiries or other due diligence investigations with respect to the Company, the Common Stock, this Warrant or the Warrant Shares issuable hereunder conducted by AP Cyber or its advisors, if any, or its representatives shall modify, amend or affect AP Cyber’s right to rely on the Company’s representations and warranties contained herein. AP Cyber understands that its investment in this Warrant and the Warrant Shares involves a high degree of risk. AP Cyber has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of this Warrant and the Warrant Shares. AP Cyber acknowledges and agrees that the Company does not make and has not made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth herein. (d) AP Cyber understands that this Warrant and the Warrant Shares are being offered and issued to it in reliance on specific exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the truth and accuracy of, and AP Cyber’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of AP Cyber set forth in this Section 9 in order to determine the availability of such exemptions and the eligibility of AP Cyber to acquire this Warrant and the Warrant Shares. AP Cyber further acknowledges and understands that this Warrant and the Warrant Shares may not be resold or otherwise transferred except in a transaction registered under the Act or unless an exemption from such registration is available. (e) AP Cyber understands that: (i) this Warrant and the Warrant Shares have not been and are not being registered under the Act or any state securities laws, and may not be offered for sale, sold, assigned or transferred unless (A) subsequently registered thereunder, or (B) the Holder shall have delivered to the Company (if requested by the Company) an opinion of counsel, in a form reasonably acceptable to the Company, to the effect that such Warrant or Warrant Shares to be transferred or assigned may be transferred or assigned pursuant to an exemption from such registration, or (C) the Holder provides the Company with reasonable assurance that such Warrant or Warrant Shares can be sold, assigned or transferred pursuant to Rule 144 promulgated under the Act (or a successor rule thereto) (collectively, “Rule 144”); (ii) any sale of this Warrant or the Warrant Shares made in reliance on Rule 144 may be made


 
LEGAL_AMERICAS # 602343320.8 - 10 - only in accordance with the terms of Rule 144, and further, if Rule 144 is not applicable, any resale of this Warrant or the Warrant Shares under circumstances in which the seller (or the person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the Act) may require compliance with some other exemption under the Act or the rules and regulations of the Securities and Exchange Commission promulgated thereunder; and (iii) neither the Company nor any other person is under any obligation to register this Warrant or the Warrant Shares under the Act or any state securities laws or to comply with the terms and conditions of any exemption thereunder. (f) AP Cyber understands that this Warrant and the Warrant Shares shall bear any legend as required by the “blue sky” laws of any state and shall bear a restrictive legend in substantially the following form (and a stop-transfer order may be placed against transfer of such share certificates): NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE [NOR THE SECURITIES FOR WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN] [HAS BEEN] REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 UNDER SAID ACT. (g) AP Cyber understands that no United States federal or state agency or any other government or governmental agency has passed on or made any recommendation or endorsement of this Warrant or the Warrant Shares or the fairness or suitability of the investment in this Warrant or the Warrant Shares nor have such authorities passed upon or endorsed the merits of the offering of this Warrant or the Warrant Shares. Section 10. Notices. All notices and other written communications provided for hereunder shall be given in writing and delivered in person or sent by overnight delivery service (with charges prepaid) or by facsimile transmission, if the original of such facsimile transmission is sent by overnight delivery service (with charges prepaid) by the next succeeding Business Day and (i) if to the Holder addressed to it at the address or fax number specified for such Holder in the Warrant Register or at such other address or fax number as the Holder shall have specified to the Company in writing in accordance with this Section 10, and (ii) if to the Company, addressed to it at One Commerce Square, 2005 Market Street, Suite 2400, Philadelphia, PA 19103, Attention: General Counsel, or at such other address or fax number as the Company shall have specified to the Holder in writing in accordance with this Section 10. Notice given in accordance


 
LEGAL_AMERICAS # 602343320.8 - 11 - with this Section 10 shall be effective upon the earlier of the date of delivery or the second Business Day at the place of delivery after dispatch. Section 11. Applicable Law. This Warrant shall be governed by and construed in accordance with the laws of the State of New York without giving effect to principles of conflict of laws. Section 12. Captions. The captions of the Sections and subsections of this Warrant have been inserted for convenience only and shall have no substantive effect. [Remainder of page intentionally left blank]


 
IN WITNESS WHEREOF, the undersigned have executed this Warrant as of the date first written above. DATAVAULT AI INC. By: _________________________________ Name: Nathaniel T. Bradley Title: Chief Executive Officer Attest:__________________ Secretary AP CYBER LLC By: _________________________________ Name: Daniel C. Gregory Title: Chief Executive Officer Docusign Envelope ID: A44EFB83-BCEE-864A-8087-E371435C734D


 
IN WITNESS WHEREOF, the undersigned have executed this Warrant as of the date first written above. DATAVAULT AI INC. By: _________________________________ Name: Nathaniel T. Bradley Title: Chief Executive Officer Attest:__________________ Secretary AP CYBER LLC By: _________________________________ Name: Daniel C. Gregory Title: Chief Executive Officer Docusign Envelope ID: E3ECDA9B-F896-8C66-8394-6F17F277EA1A


 
LEGAL_AMERICAS # 602343320.8 EXHIBIT A [To be signed only upon exercise of Warrant] To Datavault AI Inc.: Reference is made to the Warrant to Purchase Common Stock of Datavault AI Inc., dated as of July 22, 2026 (as may be amended from time to time in accordance with its terms, the “Warrant”). Terms used but not defined herein shall have the respective meanings ascribed to such terms in the Warrant. The undersigned, as the holder of the within Warrant (the “Holder”), hereby irrevocably elects to exercise the purchase right represented by such Warrant for, and to purchase thereunder, [ ] shares of Common Stock of the Company and herewith [makes payment of $[ ] therefor in full payment of the Exercise Payment] [surrenders to the Company shares of Common Stock having a Market Price of $[ ] in full payment of the Exercise Payment] [elects to receive a payment equal to the difference between (i) the Market Price on the date of exercise of the Warrant multiplied by [________] (the number of Warrant Shares for which the Warrant is being exercised) and (ii) [___________], which is the Exercise Price with respect to such number of Warrant Shares for which the Warrant is being exercised, in full payment of the Exercise Payment, payable by the Company to the Holder only in shares of Common Stock valued at the Market Price in accordance with the terms of the Warrant], and requests that the certificates for such shares of Common Stock (or, if applicable, the book entry in respect of such shares of Common Stock) be issued in the name of, and be delivered to [ ], whose address is [ ]. Dated: (Signature must conform in all respects to name of Holder as specified on the face of the Warrant) Address


 
LEGAL_AMERICAS # 602343320.8 EXHIBIT B [To be signed only upon transfer of Warrant] Reference is made to the Warrant to Purchase Common Stock of Datavault AI Inc., dated as of July 22, 2026 (as may be amended from time to time in accordance with its terms, the “Warrant”). Terms used but not defined herein shall have the respective meanings ascribed to such terms in the Warrant. For value received, the undersigned hereby transfers and assigns unto [ ] the right represented by the within Warrant to exercise the Warrant for [ ] shares of the Common Stock of Datavault AI Inc., and appoints [ ] as attorney to transfer said right on the books of Datavault AI Inc. with full power of substitution in the premises. Dated: (Signature must conform in all respects to name of Holder as specified on the face of the Warrant) Address In the presence of:


 
Page 1 of 18 Datavault – Available Infrastructure Master Purchase Order Agreement Between: AP Global Holdings LLC (d/b/a Available Infrastructure) ("Supplier") and Datavault AI Inc. ("Customer") Effective Date: ____________________ 1. PURPOSE AND BACKGROUND This Master Purchase Order Agreement (“Agreement” or “Master PO”) is entered into by and between Supplier and Customer for the purpose of establishing the formal, binding terms under which Supplier shall provide SanQtum™ infrastructure and cybersecurity services to Customer on a services-based delivery model. Supplier shall deploy, operate, manage, and maintain the SanQtum™ solution across up to one thousand (1,000) Units (roughly 335 clusters) located in up to one hundred (100) cities, pursuant to Release Purchase Orders issued under this Agreement. This Agreement defines the commercial framework, service model, payment structure, legal obligations, and operational procedures governing the provision of the SanQtum™ service. All Release Purchase Orders issued pursuant to this Agreement shall be governed by the terms herein. 2. DEFINITIONS 2.1 "Agreement" or "Master PO" means this document and all Exhibits, attachments, amendments, and Release Purchase Orders executed pursuant to it. 2.2 “Unit” means a single SanQtum Solution provides a base level of compute, storage and connectivity along with a cyber SanQtum zerotrust environment. 2.3 "Cluster" means a deployment containing three (3) SanQtum Solution units. 2.4 "Site" means a physical location for a SanQtum Solution unit designated by Customer. 2.5 "Release Purchase Order" or "Release PO" means a binding document issued by Customer authorizing deployment of the SanQtum™ service to one or more Sites. 2.6 "Deliverables" means all equipment, installation services, configuration activities, activation services, and validation tasks required to deploy the SanQtum™ service. Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D 1/4/2026


 
Page 2 of 18 2.7 " SanQtum™ Solution" means Supplier's proprietary managed platform, hardware, software, and associated Cloud and Network Services. 2.8 "Acceptance" means confirmation that the Services for a Site meet the requirements of this Agreement following the applicable acceptance period. 2.9 "Business Day" means any day other than a Saturday, Sunday, or federal holiday. 2.10 "Business Hours" means 9:00 AM to 5:00 PM Eastern Standard Time on Business Days. 3. SERVICE MODEL AND SCOPE 3.1 Product-as-a-Service Model Supplier shall provide the SanQtum™ Solution for each Site strictly as a managed service. Supplier shall retain title to all equipment, hardware, and infrastructure, including each SanQtum Solution, deployed in connection with the Services at all times. Nothing in this Agreement shall be construed as a sale of equipment, lease, bailment, or transfer of ownership, including any SanQtum Solution, to Customer. 3.2 Supplier Responsibilities Supplier shall: • Provide SanQtum™ gateway and storage equipment at each Site; • Install, configure, activate, and operate the SanQtum™ Solution; • Provide continuous monitoring, cybersecurity services, and platform management; • Perform maintenance, updates, and security patches; • Replace or repair Supplier-owned equipment as required to maintain service availability. • Sustain a 1Gbps circuit connection per location. 3.3 Exclusions Unless expressly set forth otherwise in a separate written agreement, Supplier shall not be responsible for: • Customer’s internal network design or instability; • Insufficient Customer bandwidth or upstream connectivity; • Customer misconfiguration or misuse; • Integration with non-Supplier hardware, software, or systems. • Conditions, restrictions, outages, or limitations imposed by third-party facility operators, landlords, or colocation providers. Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D


 
Page 3 of 18 3.4 Proof of Concept (PoC) 3.4.1 Proof of Concept Completion and Acceptance The Proof of Concept shall be deemed complete when Supplier has performed the evaluation, testing, and validation activities defined for the Proof of Concept and has delivered a written Proof of Concept completion summary or report to Customer (“PoC Completion Notice”). Customer shall have fifteen (15) calendar days following receipt of the PoC Completion Notice to review the Proof of Concept results and either: (a) provide written confirmation of acceptance of the Proof of Concept; or (b) provide written notice identifying, in reasonable detail, any material deficiencies specific to the stated Proof of Concept objectives. If Customer does not provide written notice of material deficiencies within the fifteen (15) day review period, the Proof of Concept shall be deemed accepted. Acceptance of the Proof of Concept confirms only that the Proof of Concept objectives have been completed and evaluated. Acceptance of the Proof of Concept does not constitute acceptance of production deployments, pricing for future Sites, or ongoing services, all of which remain subject to the pricing adjustment provisions of this Agreement and the issuance of applicable Release Purchase Orders. 3.4.2 Pricing and Adjustment(s) Based on Proof of Concept Findings Except as otherwise provided in Section 5.4 (Deposit Alternative to Proof of Concept Fee), the Proof of Concept shall be conducted prior to the issuance of any Release Purchase Orders under this Agreement. The Proof of Concept is intended to validate technical feasibility, deployment assumptions, operational requirements, and commercial pricing assumptions. Notwithstanding any pricing assumptions set forth in this Agreement, the Parties acknowledge that the Proof of Concept is intended to validate technical, operational, and commercial assumptions. If, as a result of the Proof of Concept, Supplier identifies material differences in scope, technical requirements, deployment complexity, security requirements, operational effort, or third-party costs (including but not limited to connectivity, power, facilities, or integration requirements), Supplier may propose reasonable adjustments to the pricing applicable to future Site deployments. Any such pricing adjustments shall be documented in writing and shall apply only to Sites ordered after completion of the Proof of Concept. Supplier shall not be obligated to deploy additional Sites at the initial pricing if the Proof of Concept demonstrates that such pricing is no longer commercially or technically viable. Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D


 
Page 4 of 18 4. SCALE AND DEPLOYMENT 4.1 Deployment Scale Customer may order deployment of SanQtum™ Solution units for up to 1,000 units in up to one hundred (100) cities within the 48 contiguous states of the United States of America. Actual deployment quantities shall be determined from time to time via Release Purchase Orders. 4.2 Site Selection Supplier shall identify and validate Sites based on feasibility, power availability, connectivity, safety, and operational suitability with respect to the SanQtum Solution units to be located thereat. 5. PRICING 5.1 Site Pricing The service fee for each Site shall be: USD $360,000 per Site (3 units), billed as a recurring service fee as set forth below. 5.2 Proof of Concept (PoC) Customer shall purchase an initial Proof of Concept for USD $250,000, payable 100% upon execution of this Agreement. The Proof of Concept shall include limited deployment, testing, and validation of the SanQtum™ Solution at one or more facilities or locations designated by Supplier as contemplated by Section 3.4 (Proof of Concept (PoC)) above. 5.3 PoC Credit Mechanism Upon issuance of a Release Purchase Order for the tenth (10th) Site, Supplier shall apply a USD $250,000 service credit against future service invoices. The PoC credit: • Is non-refundable; • May only be applied to service fees under this Agreement; • Has no cash value outside of applied credits. 5.4 Deposit Alternative to Proof of Concept Fee Notwithstanding the Proof of Concept fee described in this Agreement, Customer may elect to waive the upfront Proof of Concept payment by remitting a deposit of: • USD $12,000,000 Twelve Million Dollars • Within sixty (60) days of the Effective Date of this Agreement Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D


 
Page 5 of 18 Such deposit shall be applied as a prepayment for the first one hundred (100) SanQtum Solution units (and the related Sites) ordered under this Agreement, at a rate of USD $120,000 per Unit, and shall be credited against future service fees invoiced pursuant to applicable Release Purchase Orders. Upon Supplier’s receipt of the deposit in full and within the specified sixty (60) day period, the Proof of Concept fee shall be deemed waived, and no separate Proof of Concept payment shall be due. The deposit shall be non-refundable except as expressly provided otherwise in this Agreement and shall not obligate Supplier to deploy SanQtum Solutions to Sites beyond those ordered pursuant to executed Release Purchase Orders. Failure to remit the deposit within the sixty (60) day period shall result in the Proof of Concept fee remaining due in accordance with the Proof of Concept provisions of this Agreement 5.5 Final Pricing Pricing becomes fixed and binding upon execution of the corresponding Release PO, subject to the Proof of Concept provisions, approved change orders, and any other pricing adjustment mechanisms expressly set forth in this Agreement. 5.6 Taxes and Fees All prices are exclusive of taxes, duties, tariffs, and governmental charges. Customer shall be responsible for such charges unless legally exempt therefrom. 6. PAYMENT TERMS 6.1 Monthly Service Fees Each site consists of 3 SanQtum Solution units. For each SanQtum Solution unit deployed to a Site, Customer shall pay: • USD $10,000 per month per Unit • Three Units per Site • For a thirty-six (36) month term Total per-Site commitment: USD $360,000/year 6.2 Payment Schedule • Monthly invoices issued in advance; • Net thirty (30) days from invoice date; • Payments with respect to each SanQtum Solution unit at any Site shall begin upon such Site’s activation. 6.3 Post-Initial Term Services After the initial twelve (12) month term, continued operation of the SanQtum™ service shall require execution of a separate services agreement or renewal. Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D


 
Page 6 of 18 6.4 Late Payments Undisputed payments not received within ten (10) Business Days of the due date shall accrue interest at 1.5% per month or the maximum rate permitted by law. 6.5 Payment Disputes Customer shall provide written notice of any disputed amount within ten (10) Business Days of invoice receipt, which notice shall set out in reasonable detail the basis of such dispute. 7. DELIVERY, INSTALLATION, ACTIVATION, AND ACCEPTANCE Supplier shall retain title to all equipment, hardware, and infrastructure, including each SanQtum Solution, deployed in connection with the Services hereunder at all times. Nothing in this Agreement shall be construed as a sale of equipment, lease, bailment, or transfer, including with of ownership to Customer. 7.1 Supplier shall install and activate the SanQtum™ service at each Site. 7.2 Acceptance shall occur upon: • written confirmation by Customer; or • expiration of thirty (30) days after activation with no material defect notice; or • Customer use of the service in production. Customer may not unreasonably withhold, condition or delay acceptance 7.3 Installation and Activation • Supplier shall, with respect to each SanQtum Solution unit to be delivered to any Site hereunder: o Transport all equipment to the Site under Supplier-controlled logistics; o Perform all installation tasks; o Connect all required infrastructure interfaces; o Activate and configure the SanQtum Solution; o Validate the operational readiness of the system. 7.4 Site Completion Notice Upon completion of installation, activation, and validation, Supplier shall issue a Site Completion Notice, which shall constitute constructive delivery. 7.5 Acceptance Testing Customer shall have thirty (30) calendar days from the Site Completion Notice to conduct acceptance testing. Any defects identified in reasonable detail shall be remediated by Supplier as soon as reasonably practicable, and in no case later than thirty (30) calendar days from Supplier’s receipt of Customer’s notice of defect. Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D


 
Page 7 of 18 7.6 Rejection and Re-testing If Customer rejects the Deliverables during the acceptance testing period, Customer shall provide written notice specifying in reasonable detail all defects. Supplier shall have thirty (30) days to remedy the defects and re-submit for acceptance testing. Customer shall provide or make available to Supplier upon Supplier’s request, any and all information and documentation in the possession of, or available to, Customer evidencing or supporting the existence of such defects. Customer shall have an additional fifteen (15) days to conduct re- testing. Acceptance shall apply only to the corrected items and does not restart the entire 30-day acceptance period for non-defective Deliverables 7.7 Defect Resolution If Critical defects cannot be remediated within thirty (30) days, Customer may designate a replacement Site of equivalent scope and characteristics (“like-for-like”). All amounts paid for the original Site shall be carried forward as a non-refundable credit applicable solely to the replacement Site. No refunds shall be issued under this Section. The replacement Site shall be processed under a new Release PO or amendment, as applicable. 7.8 Optional Compute & Bandwidth Enhancements If Customer requires additional bandwidth or compute beyond the initial site and unit solution, additional capabilities can be provided with a monthly charge. 8. TERM AND TERMINATION 8.1 Term This Agreement shall remain in effect until all Deliverables have been accepted or the Agreement is otherwise terminated pursuant to this Section 8. 8.2 Termination for Cause Either Party may terminate this Agreement upon thirty (30) days’ written notice if the other Party materially breaches its obligations and fails to cure such breach within the notice period. Material breaches include, but are not limited to: • Failure by Customer to make any payments when due under or in connection with this Agreement; • Breach of confidentiality obligations herein; • Violation of applicable laws or regulations with respect to the subject matter of this Agreement. 8.2.1 Reciprocal Termination Supplier may terminate this Agreement or any outstanding Release Purchase Order upon ninety (90) days’ written notice if Customer fails to provide necessary environmental readiness, required cooperation, or other prerequisites reasonably required for Supplier to Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D


 
Page 8 of 18 perform installation or activation with respect to any SanQtum Solution unit, and such failure continues for more than thirty (30) days after written notice to Customer from Supplier. Failure by Customer to comply with the cooperation obligations set forth in Exhibit A shall constitute a material breach for purposes of this Section. 8.3 Termination for Convenience Customer may terminate this Agreement for convenience upon ninety (90) days' written notice. In such event, Customer shall remain liable for all amounts due under executed Release POs and for all work performed or materials procured by Supplier through the effective date of termination. 8.4 Effect of Termination In the event of termination: • Customer shall remain liable for all amounts due under executed Release POs; • Deposits shall not be refunded except in cases of material breach by Supplier; • Supplier shall deliver to Customer all completed work and materials paid for by Customer; • Both Parties shall return or destroy all Confidential Information of the other Party within thirty (30) days; • This Section 8.4 and Sections 9, 10, 11, 12, 15, 16, and 17 shall survive any termination of this Agreement. 9. WARRANTIES 9.1 Supplier warrants that: • All equipment provided shall be new (not refurbished), free from material defects in materials and workmanship, and conform to Supplier specifications; • Installation and activation services shall be performed in a professional and workmanlike manner in accordance in all material respects with industry standards; • Each SanQtum Solution unit delivered hereunder shall operate in accordance in all material respects with documented specifications when properly installed and maintained; • Supplier has the right to grant the licenses and provide the services contemplated herein; • The SanQtum Solution and its use as contemplated herein shall not infringe any third-party intellectual property rights. 9.2 Warranty Exclusions These warranties shall not apply to defects caused by: Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D


 
Page 9 of 18 • Misuse, abuse, or negligence; • Unauthorized modification or repair; • Operation outside environmental specifications; • Force majeure events; • Failure to follow Supplier's operating instructions. 9.3 Customer Warranties Customer warrants that: It has the authority to enter into perform its obligations under this Agreement; 9.4 Warranty Remedy Supplier's sole obligation and Customer's exclusive remedy for breach of warranty shall be, at Supplier's option, repair or replacement of defective equipment or re-performance of defective services. 9.5 Disclaimer EXCEPT AS EXPRESSLY SET FORTH IN THIS SECTION 9, SUPPLIER MAKES NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON- INFRINGEMENT. SUPPLIER DOES NOT WARRANT THAT THE SANQTUM SOLUTION WILL BE ERROR-FREE OR THAT OPERATION WILL BE UNINTERRUPTED. 10. LIMITATION OF LIABILITY 10.1 Liability Cap Supplier's aggregate liability under this Agreement with respect to any SanQtum Solution delivered and installed hereunder, whether arising from contract, tort, negligence, strict liability, or any other theory, shall not exceed the total amount paid by Customer to Supplier under the applicable Release PO giving rise to the claim. For claims not related to a specific Release PO, Supplier's liability shall not exceed the total amount paid by Customer to Supplier under this Agreement. 10.2 Exclusion of Consequential Damages NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, SPECIAL, OR EXEMPLARY DAMAGES, INCLUDING BUT NOT LIMITED TO LOST PROFITS, LOST REVENUE, LOSS OF DATA, LOSS OF USE, OR COST OF PROCURING SUBSTITUTE GOODS OR SERVICES, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 10.3 Exceptions • The limitations in this Section 10 shall not apply to: • • Either Party's breach of confidentiality obligations under Section 12; • Either Party's gross negligence or willful misconduct; or Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D


 
Page 10 of 18 • Customer's payment obligations. 10.4 Essential Purpose The Parties acknowledge that the limitations of liability set forth in this Section 10 are an essential element of the Agreement and that Supplier would not enter into this Agreement without these limitations. 11. INDEMNIFICATION 11.1 Supplier Indemnification Supplier shall indemnify, defend, and hold harmless Customer and its officers, directors, employees, and agents from and against any and all third-party claims, demands, losses, damages, costs, and expenses (including reasonable attorneys' fees) arising from or related to: • Personal injury or property damage caused by Supplier's negligence or willful misconduct; • Infringement or misappropriation of third-party intellectual property rights by the SanQtum solution; o Supplier’s indemnification obligations shall not apply to the extent that any claim arises from (i) modifications to the Deliverables made by Customer or its agents without Supplier’s authorization, (ii) Customer misconfiguration or misuse of the Deliverables, or (iii) integration, combination, or operation of the Deliverables with hardware, software, data, or systems not provided or approved by Supplier • Supplier's breach of this Agreement; or • Violation of applicable laws by Supplier or its personnel. 11.2 Customer Indemnification Customer shall indemnify, defend, and hold harmless Supplier and its officers, directors, employees, and agents from and against any and all third-party claims, demands, losses, damages, costs, and expenses (including reasonable attorneys' fees) arising from or related to: • Personal injury or property damage caused by Customer's negligence or willful misconduct; • Customer's use of the SanQtum solution in violation of this Agreement or applicable law; • Customer's breach of this Agreement; or • Modifications to the SanQtum solution made by Customer or its agents without Supplier's written consent. 11.3 Indemnification Procedures The indemnified Party shall: Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D


 
Page 11 of 18 • Promptly notify the indemnifying Party in writing of any claim; • Provide reasonable cooperation in the defense of the claim; • Allow the indemnifying Party to control the defense and settlement of the claim, provided that no settlement shall be made without the indemnified Party's consent if it requires an admission of liability or imposes obligations on the indemnified Party. 12. CONFIDENTIALITY 12.1 Definition of Confidential Information "Confidential Information" means all non-public information disclosed by one Party ("Disclosing Party") to the other Party ("Receiving Party"), whether orally, in writing, or by inspection of tangible objects, including but not limited to: • Technical data, specifications, and designs; • Business plans, financial information, and pricing; • Customer lists and business relationships; • Trade secrets and proprietary information; • This Agreement and its terms. 12.2 Obligations The Receiving Party shall: • Hold all Confidential Information in strict confidence; • Not disclose Confidential Information to any third party without prior written consent of the Disclosing Party; • Use Confidential Information solely for purposes of performing its obligations under this Agreement; • Protect Confidential Information using the same degree of care it uses for its own confidential information, but in no event less than reasonable care; • Limit access to Confidential Information to employees and contractors who have a legitimate need to know and who are bound by confidentiality obligations at least as protective as those herein. 12.3 Exceptions Confidential Information does not include information that: • Was publicly available at the time of disclosure or becomes publicly available through no breach of this Agreement; • Was rightfully in the Receiving Party's possession without confidentiality restrictions prior to disclosure; • Is independently developed by the Receiving Party without use of or reference to the Confidential Information; • Is rightfully obtained from a third party without confidentiality restrictions. Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D


 
Page 12 of 18 12.4 Required Disclosure If the Receiving Party is required by law, court order, or governmental authority to disclose Confidential Information, it shall: • Promptly notify the Disclosing Party of such requirement; • Cooperate with the Disclosing Party's efforts to seek a protective order or other appropriate remedy; • Disclose only the minimum amount of Confidential Information required. 12.5 Return of Confidential Information Upon termination of this Agreement or upon request, the Receiving Party shall promptly return or destroy all Confidential Information and certify such return or destruction in writing. 12.6 Duration The confidentiality obligations under this Section shall survive termination of this Agreement for five (5) years, except for information constituting trade secrets, which shall be protected for as long as such information remains a trade secret under applicable law. 13. Insurance 13.1 Supplier's Insurance Supplier shall obtain and maintain at its own expense during the term of this Agreement the following minimum insurance coverage: • Commercial General Liability Insurance: Minimum coverage of $2,000,000 per occurrence and $4,000,000 aggregate for bodily injury, property damage, and personal injury; • Workers' Compensation Insurance: Statutory limits as required by applicable law; • Professional Liability/Errors and Omissions Insurance: Minimum coverage of $2,000,000 per claim and aggregate; • Cyber Liability Insurance: Minimum coverage of $2,000,000 per claim and aggregate; 13.2 Customer's Insurance Customer shall obtain and maintain at its own expense during the term of this Agreement the following minimum insurance coverage: • Commercial General Liability Insurance: Minimum coverage of $1,000,000 per occurrence and $2,000,000 aggregate; • Property Insurance: Coverage for the SanQtum solution and equipment at full replacement value. 13.3 Insurance Requirements All insurance policies shall: Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D


 
Page 13 of 18 • Be issued by insurers with an A.M. Best rating of A- VII or better; • Name the other Party as an additional insured on general liability policies; • Include a waiver of subrogation in favor of the other Party; • Provide that coverage is primary and non-contributory; • Provide for thirty (30) days' advance written notice of cancellation or material change. 13.4 Certificates of Insurance Each Party shall provide the other with certificates of insurance evidencing the required coverage prior to commencing performance under this Agreement and upon renewal of any policy. 13.5 No Limitation Maintenance of insurance shall not limit either Party's liability or obligations under this Agreement. 14. FORCE MAJEURE 14.1 Definition "Force Majeure Event" means any event or circumstance beyond a Party's reasonable control, including but not limited to: • Acts of God, including earthquakes, floods, fires, storms, and other natural disasters; • War, terrorism, riot, civil unrest, or insurrection; • Epidemics, pandemics, or quarantine restrictions; • Government action, including embargoes, sanctions, or changes in law; • Labor disputes not involving the Party's own employees; • Failure of telecommunications, power, or other utilities not caused by the Party; • Cyberattacks, provided the Party has implemented reasonable cybersecurity measures. 14.2 Suspension of Performance Neither Party shall be liable for any failure or delay in performing its obligations under this Agreement to the extent such failure or delay is caused by a Force Majeure Event, provided that: • The affected Party provides prompt written notice to the other Party of the Force Majeure Event, including its expected duration and impact; • The affected Party uses commercially reasonable efforts to mitigate the effects of the Force Majeure Event and resume performance; • The obligations of the affected Party are suspended only for the duration of the Force Majeure Event. 14.3 Payment Obligations Customer's payment obligations shall not be excused by Force Majeure Events. Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D


 
Page 14 of 18 14.4 Termination If a Force Majeure Event continues for more than ninety (90) consecutive days, either Party may terminate this Agreement or the affected Release PO upon written notice to the other Party. In such event: • Customer shall pay for all work completed and accepted through the date of termination; • Supplier shall refund any amounts paid for work not performed; • Neither Party shall have further liability to the other except for obligations that accrued prior to termination. 16. DISPUTE RESOLUTION 15. DISPUTE RESOLUTION 15.1 Informal Negotiation In the event of any dispute, controversy, or claim arising out of or relating to this Agreement or the breach thereof (a "Dispute"), the Parties shall first attempt to resolve the Dispute through good faith negotiations between senior executives of each Party. Either Party may initiate such negotiations by providing written notice to the other Party. The senior executives shall meet within fifteen (15) Business Days of such notice and shall negotiate in good faith for a period of thirty (30) days. 15.2 Mediation If the Parties are unable to resolve the Dispute through informal negotiation, the Parties shall submit the Dispute to non-binding mediation administered by the American Arbitration Association ("AAA") or JAMS, as mutually agreed by the Parties. The mediation shall be conducted in accordance with the Commercial Mediation Procedures of the selected administrator. The mediation shall take place in a mutually agreed location. Each Party shall bear its own costs of mediation, and the Parties shall share equally the fees of the mediator. 15.3 Arbitration If the Parties are unable to resolve the Dispute through mediation within sixty (60) days of initiating mediation, either Party may submit the Dispute to final and binding arbitration administered by AAA or JAMS, as mutually agreed. The arbitration shall be conducted in accordance with the Commercial Arbitration Rules of the selected administrator, and the following provisions: The arbitration shall be conducted by a single arbitrator mutually agreed upon by the Parties, or if the Parties cannot agree, selected in accordance with the rules of the administrator; • The arbitration shall take place in a mutually agreed location; • The arbitrator shall issue a written decision including findings of fact and conclusions of law; Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D


 
Page 15 of 18 • The decision of the arbitrator shall be final and binding on both Parties; • Judgment upon the award may be entered in any court having jurisdiction; • Each Party shall bear its own attorneys' fees and costs, unless the arbitrator determines otherwise; • The Parties shall share equally the fees of the arbitrator and the administrator. 15.4 Exceptions Notwithstanding the foregoing, either Party may seek injunctive or equitable relief in any court of competent jurisdiction to protect its intellectual property rights, Confidential Information, or to prevent irreparable harm. 15.5 Confidentiality of Proceedings All negotiations, mediations, and arbitrations under this Section shall be confidential. Neither Party shall disclose the existence, content, or results of any such proceedings, except as required by law or to enforce any settlement or award. 15.6 Continued Performance Except for payment disputes or in the event of termination, the Parties shall continue to perform their obligations under this Agreement during the pendency of any Dispute resolution proceedings. 16. GENERAL PROVISIONS 16.1 Governing Law This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to its conflicts of law principles. 16.2 Entire Agreement This Agreement, including all Exhibits attached hereto, constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings, negotiations, and discussions, whether oral or written. 16.3 Amendments No amendment, modification, or waiver of any provision of this Agreement shall be effective unless in writing and signed by authorized representatives of both Parties. 16.4 Assignment Neither Party may assign this Agreement or any of its rights or obligations hereunder without the prior written consent of the other Party, except that either Party may assign this Agreement without consent in connection with a merger, acquisition, sale of substantially all assets, or similar corporate reorganization, provided that the assignee assumes all obligations hereunder. Any attempted assignment in violation of this Section shall be void. Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D


 
Page 16 of 18 16.5 Subcontracting Supplier may use subcontractors to perform services under this Agreement, provided that: • Supplier shall remain responsible for all services performed by subcontractors; • All subcontractors shall be bound by confidentiality and other obligations at least as protective as those in this Agreement; • Supplier shall provide Customer with notice of any subcontractors used for material services hereunder. 16.6 Independent Contractors The Parties are independent contractors. Nothing in this Agreement shall be construed to create a partnership, joint venture, employment, or agency relationship between the Parties. Neither Party has authority to bind the other or to incur any obligation on behalf of the other. 16.7 Notices All notices, requests, consents, and other communications under this Agreement shall be in writing and shall be deemed given: • Upon delivery if delivered personally or by nationally recognized overnight courier service; • Upon transmission if sent by email with confirmation of receipt; • Three (3) Business Days after mailing if sent by certified or registered mail, return receipt requested. Notices shall be sent to the addresses set forth in the signature block or to such other address as a Party may designate by written notice. 16.8 Severability If any provision of this Agreement is held to be invalid, illegal, or unenforceable, the validity, legality, and enforceability of the remaining provisions shall not be affected or impaired. The Parties shall negotiate in good faith to replace any invalid provision with a valid provision that achieves the original intent. 16.9 Waiver No waiver of any provision of this Agreement shall be effective unless in writing and signed by the Party against whom the waiver is sought. No waiver of any breach shall constitute a waiver of any other or subsequent breach. 16.10 Survival The following provisions shall survive termination or expiration of this Agreement: Sections 6 (Payment Terms to the extent amounts remain due), 9 (Warranties for the warranty period), 10 (Limitation of Liability), 11 (Indemnification), 12 (Confidentiality), 16 (Dispute Resolution), and 17 (General Provisions). Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D


 
Page 17 of 18 16.11 Counterparts This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. Electronic signatures shall be deemed original signatures for all purposes. 16.12 Interpretation • Headings are for convenience only and shall not affect interpretation; • "Including" means "including without limitation"; • References to "Sections" and "Exhibits" refer to sections and exhibits of this Agreement; • The singular includes the plural and vice versa; • “Days" means calendar days unless otherwise specified as Business Days. 16.13 Compliance with Laws Each Party shall comply with all applicable federal, state, local, and international laws, regulations, and ordinances in performing its obligations under this Agreement, including but not limited to export control laws, data protection laws, and anti-corruption laws. 16.14 Publicity Neither Party shall issue any press release or public statement regarding this Agreement or use the other Party's name, logo, or trademarks without the prior written consent of the other Party, except as required by law or regulation. The following Exhibits are incorporated into and made part of this Agreement: Exhibit A – Deployment Schedule & Customer Cooperation Signatures SUPPLIER: AP Global Holdings LLC (d/b/a Available Infrastructure) By: _____________________________ Name: ___________________________ Title: ____________________________ Date: ____________________________ CUSTOMER: Datavault AI Inc. By: _____________________________ Name: ___________________________ Title: ____________________________ Date: ____________________________ Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D CEO 1/4/2026 Daniel Gregory nate bradley CEO


 
Page 18 of 18 EXHIBIT A – DEPLOYMENT SCHEDULE & CUSTOMER COOPERATION A.1 Deployment Scheduling 1. Supplier shall coordinate deployment windows for each Site in collaboration with Customer. 2. Deployment schedules shall be mutually agreed in each Release PO; however, Customer acknowledges that delays in access or prerequisites may extend completion timelines. 3. Both parties agree to hold a workshop to refine State of Work and Deliverables, which may require adjustment to this agreement. A.2 Customer Cooperation Requirements Customer shall: 1. Respond promptly to Supplier requests for information, approvals, or coordination. 2. Avoid unreasonable delays in facilitating installation, validation, and activation activities. A.3 Failure to Cooperate If Customer fails to meet any cooperation obligation above and such failure materially impedes deployment: • Supplier may reschedule installation, and • Customer shall be responsible for any resulting delays, costs, or resource reallocations, and • If such failure persists beyond thirty (30) days after written notice, Supplier may terminate the affected Release Purchase Order pursuant to Section 8. Docusign Envelope ID: BB75D9BA-D86A-43F2-99EF-082D0FA9773D


 
1 BINDING TERM SHEET DATAVAULT AI INC. – SCILEX HOLDING COMPANY Dated: April 26, 2026 This binding term sheet (this “Term Sheet”) sets forth the principal terms upon which Scilex Holding Company, a Delaware corporation (“Scilex”), proposes to make an upfront cash contribution to Datavault AI Inc., a Delaware corporation (“Datavault” and, together with Scilex, the “Parties” and each, a “Party”), in exchange for the right to receive certain payments tied to revenues generated by Datavault’s quantum-ready edge network, on the terms and subject to the conditions set forth below (the “Transaction”). Term Description Parties Datavault: Datavault AI Inc., a Delaware corporation. Scilex: Scilex Holding Company, a Delaware corporation. Transaction At the closing of the Transaction (the “Closing”), Scilex will make an upfront cash contribution to Datavault in the amount of $120,000,000 (the “Upfront Payment”), and, in consideration therefor, Datavault will pay to Scilex the Scilex Payments (as defined below) on the terms set forth herein. Use of Proceeds Datavault will use the Upfront Payment exclusively to fully fund the deployment of Datavault’s quantum-ready GPU infrastructure across an estimated 100 cities in the United States (the “Quantum-Ready Edge Network”), including purchase 48,000 H200 GPUs from Available Infrastructures (with 24,000 H200 GPUs in stock at Available’s warehouse and the additional 24,000 H200 GPUs to be purchased at pre-fixed price per GPU. Total 48,000 GPUs have a current market value at approximately $2.4 billion), build-out, equipment, related working capital, and reasonable overhead expenses directly attributable thereto. It is projected by Available Infrastructures that the Quantum-Ready Edge Network has an annual revenue potential of $10 billion to $100 billion. The Upfront Payment is securitized by the total GPUs in stock and to be purchased until Scilex receives $180,000,000 from the Scilex Payments as described below.


 
2 Term Description Revenue Share From and after the Closing, Datavault will pay to Scilex an amount equal to: - 30% of all gross revenues recognized by Datavault attributable exclusively to the 100 city Quantum-Ready Edge Network (“Network Revenues”), payable until the aggregate amount of such payments received by Scilex equals $250,000,000 (the “Interim Cap”); - Once the Interim Cap is reached, 15% of Network Revenues, payable until the aggregate amount of such payments received by Scilex (when combined with amounts applied to the Interim Cap) equals $1,200,000,000 (the “Additional Cap”); and - Once the Additional Cap is reached, 5% of Network Revenues, payable during the lifetime of the GPUs purchased using the Upfront Payment (together with the payments toward the Interim Cap and the Additional Cap, the “Scilex Payments”). Network Revenues “Network Revenues” will be defined in the Definitive Agreement and is expected to mean all gross revenues recognized by Datavault in accordance with U.S. generally accepted accounting principles (“GAAP”) attributable to products, services, licenses, subscriptions, fees, and other amounts derived exclusively from or relating to the Quantum-Ready Edge Network, subject to such customary inclusions, exclusions, deductions, and adjustments (including for taxes, returns, refunds, chargebacks, and pass-through amounts) as may be agreed in the Definitive Agreement. Payment Terms Scilex Payments will be paid in U.S. dollars by wire transfer of immediately available funds to an account designated by Scilex, on a quarterly basis by fifteen (15) days after Datavault’s actual receipt of the applicable Network Revenues, accompanied by a written statement setting forth in reasonable detail the calculation of the applicable portion of Scilex Payments.


 
3 Term Description Reporting; Audit Rights Datavault will maintain books and records sufficient to determine Network Revenues and the calculation of Scilex Payments. Scilex will have customary audit rights, exercisable not more frequently than once per calendar year on reasonable prior notice and during normal business hours, with audit costs borne by Scilex; provided that, in the case of any underpayment in excess of 5% for the audited period, Datavault will reimburse Scilex for the reasonable costs of such audit and promptly pay the underpaid amount, together with interest at the prime rate plus 2%. Closing Subject to satisfaction or waiver of the Conditions to Closing (as defined below), the Parties anticipate that Scilex will fund the Upfront Payment in multiple closings with the final Closing will occur no later than December 31, 2026. Each closing will be executed with sufficient timeliness to support all payments required by Available Infrastructure prior to December 31, 2026. Conditions to Closing The Closing will be subject to the satisfaction or waiver of customary closing conditions for transactions of this type, including, without limitation: (i) negotiation, execution, and delivery of the Definitive Agreement; (ii) accuracy in all material respects of representations and warranties at signing and at the Closing; (iii) compliance in all material respects with covenants; (iv) receipt of all required corporate, regulatory, stockholder, and third-party consents and approvals; (v) absence of any law, order, or injunction prohibiting the Transaction; and (vi) the absence of any material adverse change with respect to Datavault or the Quantum-Ready Edge Network. Definitive Agreement The Parties will negotiate in good faith and use commercially reasonable efforts to enter into a definitive agreement (the “Definitive Agreement”) reflecting the terms set forth herein and containing such other representations, warranties, covenants (including customary affirmative and negative operating covenants of Datavault relating to the Quantum-Ready Edge Network), indemnities, conditions, termination rights, and other provisions as are customary for transactions of this type.


 
4 Term Description Due Diligence From the date hereof until the Closing or the earlier termination of negotiations, Datavault will provide Scilex and its representatives with reasonable access, during normal business hours and upon reasonable advance notice, to the books, records, properties, personnel, and advisors of Datavault as Scilex may reasonably request in connection with its due diligence review of Datavault and the Quantum-Ready Edge Network. Expenses Each Party will bear its own costs and expenses (including, without limitation, fees and expenses of counsel, accountants, financial advisors, and other advisors) incurred in connection with the negotiation, preparation, and execution of this Term Sheet, the Definitive Agreement, and the consummation of the Transaction, whether or not the Transaction is consummated. Public Announcements Neither Party will issue any press release or make any other public statement regarding this Term Sheet or the Transaction without the prior written consent of the other Party (such consent not to be unreasonably withheld, conditioned, or delayed), except as required by applicable law, regulation, or stock exchange rule, in which case the disclosing Party will, to the extent permitted, consult with the other Party in advance regarding the timing and content of such disclosure. Governing Law This Term Sheet, and any dispute, claim, or controversy arising out of or relating hereto (whether sounding in contract, tort, or otherwise), will be governed by and construed in accordance with the laws of the State of Delaware, without regard to its conflict of laws principles. Jurisdiction; Waiver of Jury Trial Each Party irrevocably submits to the exclusive jurisdiction of the Court of Chancery of the State of Delaware (or, if such court declines jurisdiction, the federal and state courts located in the State of Delaware) in connection with any dispute arising out of or relating to this Term Sheet. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT TO A TRIAL BY JURY IN ANY SUCH PROCEEDING.


 
5 Term Description Entire Agreement This Term Sheet, together with the Confidentiality Agreement, constitutes the entire agreement of the Parties with respect to the subject matter hereof and supersedes all prior agreements, understandings, negotiations, and discussions, whether oral or written, among the Parties with respect thereto. Amendment This Term Sheet may not be amended, modified, or supplemented except by a written instrument signed by both Parties. Counterparts This Term Sheet may be executed in one or more counterparts, each of which will be deemed an original and all of which together will constitute one and the same instrument. Signatures delivered by electronic transmission (including PDF or DocuSign or similar electronic signature platform) will be deemed original signatures for all purposes hereunder. IN WITNESS WHEREOF, the Parties have executed this Term Sheet as of the date first written above. DATAVAULT AI INC. By: _______________________________ Name: Title: SCILEX HOLDING COMPANY By: _______________________________ Name: Title:


 
DATAVAULT AI, INC. One Commerce Square, 24th Floor Philadelphia, PA 19103 BINDING LETTER OF INTENT April 29, 2026 CyberCatch Holdings, Inc. 4445 Eastgate Mall, Suite 200 San Diego, California 92121 Attention: Sai Huda, Chief Executive Officer Dear Mr. Huda: This binding letter of intent (the "LOI") is between Datavault AI, Inc ("Datavault"), a company incorporated and existing under the laws of state of Delaware, and CyberCatch Holdings, Inc., a company incorporated and existing under the laws of the Province of British Columbia ("CyberCatch" and together with Datavault, the "Parties"). The common shares of Datavault are listed on The Nasdaq Stock Market ("Nasdaq") and the common shares of CyberCatch are listed on the TSX Venture Exchange ("TSXV"). This letter of intent sets out the principal terms and conditions with respect to the proposed acquisition of CyberCatch by Datavault. 1. Description of the Transaction. The proposed transactions (collectively, the “Transaction”) will involve the parties entering into a definitive agreement (the “Agreement”) pursuant to which Datavault will, directly or indirectly, acquire from the shareholders of CyberCatch 100% of the issued and outstanding common shares of CyberCatch (being 26,766,269 common shares, the "CyberCatch Shares") by way of a plan of arrangement whereby the holders of CyberCatch Shares will receive the common shares in the capital of Datavault (the “Consideration Shares”). 2. It is contemplated that the Transaction will be completed by way of a three-cornered amalgamation structured as a court-approved plan of arrangement under the Business Corporations Act (British Columbia), pursuant to which CyberCatch will become a wholly-owned subsidiary of Datavault. The final structure for the Transaction will be determined following the advice of each of the parties' respective legal and tax advisors. The Consideration Shares to be issued pursuant to the Transaction are anticipated to be issued in reliance upon the exemption from the registration requirements of the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), provided by Section 3(a)(10) thereof, and exemptions from the registration and qualification requirements prescribed by applicable state securities laws. 3. Due Diligence. Each of Datavault and CyberCatch shall arrange for representatives of the other party to have such access to the books, records, documents, personnel, properties and facilities relating to its operations, as may be reasonably necessary for the other party to carry out a due diligence investigation. Each party shall use reasonable efforts to arrange for all relevant


 
legal, financial and technical data relating to its operations and its technology, as applicable, to be available to representatives of the other party. Upon completion of the Transaction, and without giving effect to any dilutive securities, the shareholders of CyberCatch will hold approximately [7.52]% of the equity of the Company (on an undiluted basis), and the existing shareholders of the Company will hold approximately [92.48]% of the equity of the Company (on an undiluted basis). A pro-forma capitalization table for the Company on a post-Transaction basis is attached hereto as Schedule “A”. 4. Consideration. Pursuant to the terms of the Agreement and as part of the plan of arrangement contemplated by the Transaction, the holders of CyberCatch Shares shall, upon closing of the Transaction (the “Closing”), receive 49,943,000 Shares common shares in the capital of Datavault, which is at an exchange ratio equivalent to 26,766,269 CyberCatch Shares valued at $3.73 USD ($5.11 CAD) per CyberCatch Share at a deemed price of $99,886,000 USD ($136,843,820 CAD). All outstanding dilutive securities of CyberCatch will be exchanged for shares of Datavault based on a cashless exercise basis at a deemed value of Datavault shares at a deemed price of $2.00 USD. 5. The Consideration Shares to be issued in connection with the Transaction will be issued pursuant to an exemption from registration under the U.S. Securities Act, anticipated to be Section 3(a)(10) thereof, and applicable state securities law exemptions. None of the Consideration Shares will contain any restrictive legends, provided the applicable conditions of Section 3(a)(10) are satisfied. None of the Consideration Shares have been or will be registered under the U.S. Securities Act, or under the securities laws of any state of the United States. 6. CyberCatch's Assets. Datavault will, through its ownership of CyberCatch, have the benefit of all such assets, business, revenues, intellectual property and other properties of CyberCatch. CyberCatch currently holds, and will at the time of Closing hold, all of the assets, intellectual property, business operations and other properties of CyberCatch, consistent in all material respects with the business and operations as described in CyberCatch's public disclosure record. 7. Documentation. The Parties will jointly prepare a draft of the Agreement incorporating the terms and conditions of this LOI and such other terms and conditions as are consistent herewith and are agreed to by the parties. The Agreement will contain such representations, warranties, conditions, covenants and indemnities as are customary in transactions of the type contemplated hereby. The Company will prepare the draft Agreement promptly after execution of this LOI. For clarity, the representations, warranties, conditions, covenants and indemnities included in the Agreement will be from the Company and CyberCatch, and the shareholders of CyberCatch will only be required to provide representations, warranties, conditions, covenants and indemnities, on a several and not joint basis, relating to their ownership of the CyberCatch Shares. 8. Conditions Precedent. The obligations of the Datavault and CyberCatch to proceed with the Transaction shall be subject to, among other things that may be contained in the Agreement, the following conditions being complied with or waived on or prior to the date of the Closing:


 
(a) receipt of the approval of the directors of Datavault and CyberCatch, respectively; (b) receipt of all necessary third-party approvals and consents to the Transaction, including any necessary court, regulatory or other approvals, including the approval of Nasdaq, the TSX Venture Exchange (“TSXV”) and any applicable notifications to or approvals from the United States Securities and Exchange Commission; (c) Datavault shall have confirmed that the Transaction does not require Nasdaq stockholder approval under applicable Nasdaq Listing Rules, or if required, such approval has been obtained; (d) receipt of a final order from the applicable court approving the plan of arrangement in respect of the Transaction, if applicable; (e) approval of the Transaction by the requisite majority of holders of CyberCatch Shares at a meeting of CyberCatch shareholders called for such purpose; (f) the results of due diligence investigations being satisfactory to Datavault and/or CyberCatch in all material respects, acting reasonably; (g) no material adverse change will have occurred in the business, results of operations, assets, liabilities, financial condition or affairs of Datavault or CyberCatch, financial or otherwise, between the date of signing this LOI and the Closing; (h) the representations and warranties of the respective parties contained in the Agreement will be deemed to have been made again on the Closing and will be true and correct in all material respects as of all relevant dates; (i) the existing management of CyberCatch continuing in such roles at CyberCatch, and new employment or consulting agreements with existing CyberCatch management, to be approved by the Company, will be entered into on or before Closing; (j) the Consideration Shares will be issued free and clear of any and all encumbrances, liens, charges, demands of whatsoever nature; (k) no person or corporation is entitled to a finder’s fee or other form of compensation from the Company with respect to the Transaction; and (l) material compliance by the respective parties with the terms of the Agreement. 9. Structure Terms. The Company will use its reasonable efforts to coordinate with Nasdaq and confirm that the Transaction will not require Nasdaq stockholder approval under applicable Nasdaq Listing Rules or, if required, to obtain such approval. 10. Post-Closing Management. The entire CyberCatch management team shall remain in place following Closing, with Sai Huda continuing as President of CyberCatch, reporting to the Chief Executive Officer of Datavault.


 
11. Publicity. Unless advised by counsel that such disclosure is required by law, including applicable disclosure requirements or TSXV and Nasdaq rules (in which case the party so advised will promptly notify the other party and permit the other party’s counsel to speak with the disclosing party’s counsel prior to announcement), under no circumstances will any party or their respective members, managers, shareholders, directors, officers, employees, affiliates or agents disclose the existence or terms of this LOI, or the Transaction contemplated thereby, except to their respective legal, financial and accounting advisors who have a need to know such information solely for the purposes of assisting their respective clients with regard to the Transaction. Without limiting the generality of the foregoing, no party shall make any press release or public announcement concerning the existence of this LOI or the Transaction without the prior written consent of the other party. Notwithstanding the foregoing, the parties are seeking that the Company promptly issue a news release disclosing this LOI and the parties agree to co-operate in good faith to prepare a joint press release mutually agreeable in form and substance. 12. Conduct of Business. From the date of the acceptance of this LOI until the earlier of the completion of the Transaction contemplated herein or the date this LOI is terminated in accordance with section 1414, the Company and CyberCatch will each operate their business in a prudent and business-like manner in the ordinary course and in a manner consistent with past practice. 13. Costs. All costs and expenses including legal fees and disbursements incurred in connection with the negotiation and preparation of this LOI and the Agreement and the consummation of transactions contemplated hereby and thereby shall be borne by the party that incurred same. 14. Termination. The obligations of the parties under this LOI shall terminate upon the earlier of: (a) execution of the Agreement; (b) the written agreement of the parties to terminate this LOI and the parties’ obligations hereunder; (c) notice of termination by any party if the Agreement has not been executed on or prior to May 30, 2026; or (d) the expiration of the Exclusivity Period (as defined below), provided that the provisions of sections 1111, 1313, 16(b) and 1818 shall survive termination. No compensation shall be payable to the other party upon a termination of this LOI. 15. Mutual Exclusivity. Each party will, and will cause its respective subsidiaries and its and their respective officers, directors, employees, representatives (including any financial or other advisor) and agents to, suspend any existing solicitation, encouragement, activity, discussion or negotiation with respect to any Acquisition Proposal (as hereinafter defined) with any person that has made, indicated any interest to make or may reasonably be expected to make, an Acquisition Proposal. As used herein, “Acquisition Proposal” means (other than the Transaction): any offer, proposal, expression of interest, or inquiry from any person (other than the other party hereto or any of its affiliates) relating to any merger, amalgamation, acquisition or sale, direct or indirect of the party. Commencing on the date hereof and ending on the earliest of (i) the date this LOI is terminated in accordance with section 1414; and (ii) [45 days] after the date of this LOI (the “Exclusivity Period”), each party will not, directly or indirectly, through any officer, director, employee, representative (including any financial or other advisor) or agent of the party or any of its subsidiaries: (a) solicit, initiate, facilitate or knowingly encourage (including by way of furnishing information or entering into any form of agreement, arrangement or understanding)


 
the initiation of any inquiries or proposals that could reasonably be expected to lead, in one transaction or a series of transactions, to an Acquisition Proposal; (b) participate in any discussions or negotiations with any person (other than the other party hereto or any of its affiliates) regarding an Acquisition Proposal; (c) approve, accept, endorse or recommend, or propose publicly to accept, approve, endorse or recommend, any Acquisition Proposal; (d) accept or enter into or publicly propose to accept or enter into, any agreement, understanding or arrangement or other contract in respect of an Acquisition Proposal; or (e) provide any confidential information to any third party. 16. Legal Effect. (a) Agreement to Negotiate in Good Faith. This LOI, when executed and delivered by the Company to CyberCatch, is binding and sets forth the parties’ mutual understanding with respect to the Transaction and the basis on which the parties will proceed forward as they negotiate the Agreement in good faith. (b) The parties each acknowledge that this LOI does not contain all matters upon which agreement must be reached in order for the Transaction to be agreed to or consummated, and therefore does not constitute a binding agreement or commitment with respect to the Transaction itself, provided however, that it is the intention of the parties that sections 4, 6, Error! Reference source not found., 8, 911 to 16(b) hereof, and the agreements and obligations of the parties set forth therein, will be legally binding upon and enforceable against the parties upon execution and delivery of this LOI. Except as set forth in the preceding sentence, a binding agreement or commitment with respect to the Transaction will result only from the execution of the Agreement, and neither this LOI, nor any draft of the Agreement, or any course of conduct, dealing or performance in respect thereto, will create any binding agreement or commitment on the part of any party with respect to the Transaction, and neither party will have any liability to the other party with respect to the Transaction until and unless the Agreement is prepared, executed and delivered by and between the parties. Any failure to conclude the Agreement, for whatever reason, other than breach of the obligation of a party to negotiate in good faith, will not result in any right of action by or claims for damages, expenses or equitable relief by either party. The parties hereto will be legally bound to proceed with the Transaction herein outlined only if and to the extent of, and in accordance with, the terms and conditions contained in the Agreement. 17. Entire Agreement. This LOI embody the understanding of the parties and supersede all prior agreements or understandings with respect to the subject matter hereof. 18. Governing Law. This LOI and the Agreement shall be governed by and construed solely in accordance with the laws of the Province of British Columbia without giving effect to the


 
conflicts of laws principles thereof and without reference to the laws of any other jurisdiction. The parties agree to submit to the exclusive jurisdiction of the courts of the Province of British Columbia, provided that nothing in this Agreement shall prevent either party from seeking injunctive relief in the courts of any competent jurisdiction. 19. Counterparts. This LOI may be executed in one or more counterparts and by facsimile or other electronic means, each of which shall be deemed to be an original, but all of which will constitute one and the same instrument. [Signature page follows]


 
If the foregoing is in accordance with your understanding, please communicate your acceptance by executing and returning a signed copy. This offer is open for acceptance until 5:00 pm Pacific Time on ______________, 2026. DATAVAULT AI, INC. By: Name: Nate Bradley Title: Chief Executive Officer Acknowledged, accepted and agreed to this ______________, 2026. CYBERCATCH HOLDINGS, INC. By: Name: Sai Huda Title: Chief Executive Officer


 
SCHEDULE “A” Pro-Forma Capitalization Table Holder Number of Shares Current Shareholders of Datavalt 614,179,104 Shares Shareholders of CyberCatch (Consideration Shares) 49,943,000 Shares CyberCatch Shareholder Ownership Post-Transaction Approximately [7.52%] Pro Forma Outstanding Shares (Undiluted) 664,122,104 Shares Number of Shares Issuable Existing Datavault AI, Inc. Options [To be confirmed] Existing Datavault AI, Inc. Warrants [To be confirmed] Datavault AI, Inc. Existing Shareholder Ownership Post-Transaction Approximately [92.48%] Error! Reference source not found. Total Shares Issued Post-Transaction (Fully Diluted) [TO BE CONFIRMED] Based on 614,179,104 shares outstanding and share price of USD $2.00 as at April 26, 2026.


 
LE G A L_ 49 31 88 99 .3 SC H ED U LE “ B” [N TD : I f r eq ui re d, in se rt C yb er C at ch sh ar eh ol de r c on sid er at io n al lo ca tio n ta bl e, re fle ct in g 26 ,7 66 ,2 69 C on sid er at io n Sh ar es to b e al lo ca te d am on g C yb er C at ch sh ar eh ol de rs . A c om pl et e sc he du le o f C yb er C at ch sh ar eh ol de rs a nd th ei r r es pe ct iv e sh ar e al lo ca tio ns to be p ro vi de d pr io r t o C lo si ng .]


 
Nathaniel T. Bradley, CEO One Commerce Square 2005 Market St, Ste 2400 Philadelphia, PA 19103 +1 (844) DATA-400 www.dvlt.ai Summary of Terms May 30, 2026 Except as expressly provided in the sections titled ‘Transaction Fees; Exclusive Provider,’ ‘Confidentiality; ‘Publicity,’ ‘Fees and Expenses,’ ‘Governing Law,’ and ‘Expiration,’ this term sheet is non-binding. The section titled “Transaction Fees; Exclusive Provider” section is fully binding on the Company and the Investor (as defined below) upon execution hereof. Issuer: Datavault AI Inc., a Delaware corporation (the “Company”). Investor: Investment Fund formed by Caprock Securities Pty Ltd or an affiliate. HELMEX FINANCIAL LLP. (“HMX”) and/or HELMEX GLOBAL LLP and/or one or more of its affiliates, designees or approved co-investors to invest and operate through the Investment Fund (collectively, the “Investor”). Amount of Financing The initial tranche (first tranche of a total of four successive tranches) is expected to represent a capital injection of the equivalent value by the Investor in the amount of $500,000,000 (the “Initial Tranche”). The Initial Tranche is intended to complete the first phase of the Investor's financial investment and acquisition of shares in the Company’s share as shall be set forth in the Definitive Agreements (as defined below) which terms this Term Sheet is directly related to and conditionate to. The parties intend the Initial Tranche to provide an immediately executable operational bridge toward the completion of the Transaction (as defined below), establish market credibility, and support the Company’s tokenization and exchange infrastructure strategy. The global transaction contemplates a total purchase price equivalent to $2,000,000,000 (the “Transaction”), which the Investor will inject as Preferred Units to be monetized, for the purchase of between a minimum of 1,000,000,000 to approximately 1,290,400,000 shares of common stock, par value $0.0001 per share, of the Company (“Common Stock”) and/or newly designated preferred stock, par value $0.0001 per share, of the Company (“Preferred Stock” and together with the Common Stock, the “Securities”), issued in four tranches of a minimum of 250,000,000 to approximately 322,600,000 shares of capital for $500,000,000 per tranche (each such tranche after


 
Nathaniel T. Bradley, CEO One Commerce Square 2005 Market St, Ste 2400 Philadelphia, PA 19103 +1 (844) DATA-400 www.dvlt.ai the Initial Tranche, the “Second Tranche,” “Third Tranche,” and “Fourth Tranche” together with the First Tranche, are collectively referred to as the “Tranches” and each, a “Tranche”). The capital stock to be issued to the Investor in the Initial Tranche shall be comprised of shares of Common Stock and/or Preferred Stock as will be defined in the Definitive Agreements to which this term sheet is subject. Type of Securities: Preferred Stock of the Company with the rights and preferences in favor of the Investor that will set forth in the Definitive Agreements. The Securities issued at the closing of each Tranche will be entitled to all rights accorded to holders of Common Stock or the same series of Preferred Stock, as applicable, subject to applicable securities laws and the Definitive Agreements. Notwithstanding the definition or classification of the shares whose acquisition is legally authorized, such acquired shares must necessarily confer upon [HMX / the Investor] the same political, economic, and corporate ownership rights in their entirety with respect to patents, intellectual property, and all other decision-making rights of control on the Board of Directors, by virtue of the Investor’s ownership interest. Type of Offering: Private placement of the Securities shall be exempt from registration under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D. Investor will be an accredited investor, qualified institutional buyer, or other eligible investor acceptable to the Company. The Definitive Agreements will include customary private placement representations. Considerati on: The purchase price per share of the Securities is expected to be from a minimum of $[1.55], to a maximum of $[2.00], subject to adjustment for recapitalizations, stock splits, stock dividends and similar transactions, and subject to agreement between the parties be reflected in the Definitive Agreements. The purchase price will be negotiated by the parties pursuant to arms-length negotiations as a result the transaction involving an investment of a majority position in the Company, the contemplated governance and other rights of the Investor, and the contemplated rights of the Investor related to the intellectual property of the Company.


 
Nathaniel T. Bradley, CEO One Commerce Square 2005 Market St, Ste 2400 Philadelphia, PA 19103 +1 (844) DATA-400 www.dvlt.ai At each closing, the applicable Investor will pay the purchase price by assigning, transferring and delivering to the Company Preferred Units, having an independently determined fair market equivalent value of $500,000,000 for the applicable tranche. No Investor will be required to assign, transfer or deliver the Preferred Units until the applicable closing date and concurrent receipt of evidence of issuance of the applicable Securities from the Company’s transfer agent in form and substance reasonably acceptable to such Investor. Transaction Fees; Exclusive Provider: The Company will contribute, as a binding obligation under this term sheet, the administrative, operational and structuring costs necessary to proceed with the structuring of the Investment Fund in an amount equal to 5% of the $500,000,000 Initial Tranche, or $25,000,000, which amount in respect of the Initial Tranche shall be paid by the Company in cash by wire transfer not later than June 1, 2026, to the account designated for such purpose by HMX at the regulated financial platform of CAPROCK SECURITIES PTY LTD, the Investment Fund Manager, a financial institution working under license and supervised primarily by the Australian Securities and Investment Commission (ASIC). The Definitive Agreements will provide that, to prepare the closing of each additional Tranche (by financially structured tranche of $500,000,000 each one), the Company will pay to the Investment Fund Manager Company an additional transaction fee in the aggregate amount of $25,000,000, with aggregate transaction fees not to exceed $100,000,000 across the closings of all Tranches; provided, that the additional $25,000,000 transaction fee payable by the Company with respect to the closing of the Second Tranche may be paid by the Company in cash, Bitcoin or combination thereof, with the form of such payment to be determined by the parties prior agreement. [The Investor opens the possibility to the Company to be beneficiary of 5% of the first monetization to access the fees of the second and successive later tranches. Said access is subject of an agreement that will compensate the Investor in a fair equivalent income, corresponding to the gain that the Company will obtain through the Investor’s approval set forth on the main final agreement to be completed between the parties.]


 
Nathaniel T. Bradley, CEO One Commerce Square 2005 Market St, Ste 2400 Philadelphia, PA 19103 +1 (844) DATA-400 www.dvlt.ai The Investor agrees that, from and after the date on which this term sheet is executed by both parties, all the Investor’s tokenomic projects, worldwide, will be exclusively handle through the Company, unless otherwise mutually agreed. Anticipated Timing; Closing Mechanics: The parties intend to execute this term sheet promptly, with an objective of signing no later than May 30, 2026. The Initial Tranche’s manufacturing and monetization process is targeted for 3–4 weeks on an aggressive basis and 6–8 weeks as the outside operational expectation, with the Initial Tranche and related definitive documentation targeted for completion by July 30, 2026. It is contemplated that the closing of the Initial Tranche would occur no earlier than the first Business Day and no later than the forty-fifth Business Day after execution of the Master Purchase Agreement, with each subsequent closing occurring no later than the forty-fifth Business Day after the prior closing. Conditions to Closing: The closing of each Tranche, excluding the Company’s costs set forth herein, will be subject to customary conditions, including satisfactory completion of due diligence by the parties; compliance, as well as the verification, if applicable, of the legal and administrative requirements of the SEC (USA), its associated regulators, Nasdaq, ASIC verifications, and, if necessary, banking regulators (ECB); execution of definitive transaction documents, including a Master Purchase Agreement and Registration Rights Agreement; accuracy of representations and warranties; performance of pre-closing covenants; absence of injunctions, trading suspensions, delisting threats or a Material Adverse Effect; receipt of all necessary consents and approvals, including stockholder approval; filing of necessary charter amendments; delivery of customary closing documents; payment of the applicable Transaction Fee described above; completion and acceptance of the independent valuation of the Preferred Units; and satisfaction of credit facility and collateral documentation requirements applicable to the Preferred Units. Notwithstanding the foregoing, the closing of (i) the Initial Tranche (excluding the cost to be borne in advance by the Company, as set forth herein, to cover the investment injection of the Preferred Units, equivalent to 5% of their par value), shall be subject to (a) the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and any EU or other foreign regulatory approvals in connection with the Transaction, (b)


 
Nathaniel T. Bradley, CEO One Commerce Square 2005 Market St, Ste 2400 Philadelphia, PA 19103 +1 (844) DATA-400 www.dvlt.ai conclusion of the Committee on Foreign Investment in the United States that the President of the United States has not taken action to block or prevent the Transaction and no requirements or conditions to mitigate any national security concerns have been imposed on the Company, and (c) the Company’s determination that it will be able to monetize the Preferred Units; and (ii) Tranche Two shall be subject to (a) the closing of the Initial Tranche, (b) the Company’s receipt of a fairness opinion for the Transaction by an independent investment bank selected by the Company in its sole discretion, (c) the Company’s determination of the accounting treatment of the Transaction, and (d) the Company’s determination that it will be able to monetize the Preferred Units. Use of Proceeds: Ideally, 90% of the net proceeds are to be used by the Company to fund real-world asset tokenization projects and service debt, and the remaining 10% of net proceeds may be used for general corporate purposes. This is subject to the discussions and final approvals between the parties. Registratio n Rights: At signing of the Definitive Agreements, the Company will execute a Registration Rights Agreement providing customary resale registration rights for the Shares. The Investor will hold such registration rights in the same proportion as the share volume of its stake, including the rights attached to the Common Stock and the Preferred Stock within the Company. Governance Matters: Upon the completion of the closing of each Tranche, the Investor shall have the right to designate one (1) director to the Company’s Board of Directors (each, an “Investor Designee”) and the Company shall take all necessary corporate action to cause such designees to be appointed to the Company’s Board of Directors (the “Board”) at or promptly following each such closing. [Upon the closing of the Fourth Tranche, the Investor shall have the right to designate the Chairman of the Board from the Investor Designees. The Investor designees must qualify as independent under applicable Nasdaq rules, and the Company will nominate Nathaniel Bradley and Brett Moyer for re-election through the 2028 annual meeting. Promptly following the closing of the Initial Tranche, the Company will form an investment committee comprised of the Company’s Chief Executive Officer, the Company’s Chief Financial Officer and one Investor designee, with


 
Nathaniel T. Bradley, CEO One Commerce Square 2005 Market St, Ste 2400 Philadelphia, PA 19103 +1 (844) DATA-400 www.dvlt.ai authority subject of the parties prior agreement to approve Company tokenization projects funded solely by the Company. Restrictions ; Put Option/Call Option The Securities will be subject only to restrictions required by applicable securities laws, the Registration Rights Agreement and any lock-up expressly agreed to by the Investor in the Definitive Agreements. The Investor and the Company agree to negotiate in good faith the terms and conditions of the put option/call option provisions set forth in the initial draft of the Master Purchase Agreement circulated by the Company to the Investor prior to the execution hereof. Definitive Agreements ; Representat ions: The investment will be made pursuant to a Master Purchase Agreement, including all necessary exhibits including the exhibit describing the units transfer and collateral documentation, the Registration Rights Agreement, a certificate of amendment to the Certificate of Incorporation of the Company, if necessary, a Certificate of Designation of Preferences, Rights and Limitations of the Preferred Stock, if applicable, any side letters, and other agreements, certificates, instruments and documents reasonably required in connection with the contemplated credit facility and the issuance of the Securities (collectively, the “Definitive Agreements”). The Definitive Agreements will include customary public-company PIPE representations, warranties, covenants, indemnification and specific performance provisions. Confidentia lity; Publicity: The existence and terms of this term sheet, the negotiations and the transaction will remain confidential except as required by law, SEC rules, Nasdaq rules or the Definitive Agreements to which this term sheet is subject. The Company will not publicly announce the transaction or disclose the name of the Investor, or any affiliate or adviser of the Investor without the prior written consent of the Investor, except to the extent required by law, SEC staff request or Nasdaq rules, and the Company will provide the Investor a reasonable advance opportunity to review and comment on any required disclosure to the extent legally permissible. Fees and Expenses: Each party shall be responsible for its own legal fees and expenses incurred in connection with the transactions contemplated herein, including the negotiation of this Term Sheet, other than the Transaction Fees discussed above.


 
Nathaniel T. Bradley, CEO One Commerce Square 2005 Market St, Ste 2400 Philadelphia, PA 19103 +1 (844) DATA-400 www.dvlt.ai Governing Law: This term sheet will be governed by, and construed in accordance with, the laws of the State of New York, without regard to conflicts-of-law principles that would require application of another jurisdiction’s laws, except to the extent mandatory principles of Delaware law apply. Expiration: The offer set forth in this term sheet will expire if not executed by the Company and the Investor prior to 5:00 p.m., New York City time, on May 30, 2026, unless extended in writing by the Investor in its sole discretion. The parties have signed this term sheet as of the date above written, as a reflection of their understanding of the principal terms of an investment. Datavault AI Inc. By: NATHANIEL BRADLEY Title: PRESIDENT HELMEX GLOBAL LLP By: CAMILO SANCHEZ RODRIGUEZ Title: PRESIDENT


 
Docusign Envelope ID: 2CDA1B49-7DA4-8521-8070-C47B50C36677 F6F98A69-7DA7-8C 7- 3 -F94D99B55B5C 1 BINDING TERM SHEET DATAVAULT AI INC. – SCILEX HOLDING COMPANY Dated: June 24, 2026 This binding term sheet (this “Term Sheet”) sets forth the principal terms upon which Scilex Holding Company, a Delaware corporation (“Scilex”), proposes to make cash or Scilex’s common stock or its subsidiaries’ publicly traded securities contribution to Datavault AI Inc., a Delaware corporation (“Datavault” and, together with Scilex, the “Parties” and each, a “Party”), in exchange for the Bitcoins (BTC) currently held in Datavault’s Biconomy digital wallet (the “Wallet”), on the terms and subject to the conditions set forth below (the “Transaction”). Term Description Parties Datavault: Datavault AI Inc., a Delaware corporation. Scilex: Scilex Holding Company, a Delaware corporation. Transaction At the closing of the Transaction (the “Closing”): 1. Total BTC purchase from Datavault’s Wallet in the amount of $50 million for 837 BTC. 2. Scilex will make the first payment in the amount of $30 million as soon as permitted for the BTC purchase from Datavault. 3. The remaining $20 million will be paid quarterly for the BTC purchases from Datavault, starting Q4-2026 with completion of all BTC purchased in the Wallet by December 31, 2028. 4. Payment of BTC shall be in cash or freely tradable Scilex common stock or its subsidiaries’ publicly traded securities or combination thereof at the discretion of Scilex. Definitive Agreement The Parties will negotiate in good faith and use commercially reasonable efforts to enter into a definitive agreement (the “Definitive Agreement”) reflecting the terms set forth herein and containing such other representations, warranties, covenants, indemnities, conditions, termination rights, and other provisions as are customary for transactions of this type.


 
Docusign Envelope ID: 2CDA1B49-7DA4-8521-8070-C47B50C36677 F6F98A69-7DA7-8C 7- 3 -F94D99B55B5C 2 Expenses Each Party will bear its own costs and expenses (including, without limitation, fees and expenses of counsel, accountants, financial advisors, and other advisors) incurred in connection with the negotiation, preparation, and execution of this Term Sheet, the Definitive Agreement, and the consummation of the Transaction, whether or not the Transaction is consummated. Public Announcements Neither Party will issue any press release or make any other public statement regarding this Term Sheet or the Transaction without the prior written consent of the other Party (such consent not to be unreasonably withheld, conditioned, or delayed), except as required by applicable law, regulation, or stock exchange rule, in which case the disclosing Party will, to the extent permitted, consult with the other Party in advance regarding the timing and content of such disclosure. Governing Law This Term Sheet, and any dispute, claim, or controversy arising out of or relating hereto (whether sounding in contract, tort, or otherwise), will be governed by and construed in accordance with the laws of the State of Delaware, without regard to its conflict of laws principles. Jurisdiction; Waiver of Jury Trial Each Party irrevocably submits to the exclusive jurisdiction of the Court of Chancery of the State of Delaware (or, if such court declines jurisdiction, the federal and state courts located in the State of Delaware) in connection with any dispute arising out of or relating to this Term Sheet. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT TO A TRIAL BY JURY IN ANY SUCH PROCEEDING. Entire Agreement This Term Sheet, together with the Confidentiality Agreement, constitutes the entire agreement of the Parties with respect to the subject matter hereof and supersedes all prior agreements, understandings, negotiations, and discussions, whether oral or written, among the Parties with respect thereto. Amendment This Term Sheet may not be amended, modified, or supplemented except by a written instrument signed by both Parties.


 
Docusign Envelope ID: 2CDA1B49-7DA4-8521-8070-C47B50C36677 F6F98A69-7DA7-8C 7- 3 -F94D99B55B5C 3 Counterparts This Term Sheet may be executed in one or more counterparts, each of which will be deemed an original and all of which together will constitute one and the same instrument. Signatures delivered by electronic transmission (including PDF or DocuSign or similar electronic signature platform) will be deemed original signatures for all purposes hereunder.


 
Docusign Envelope ID: 2CDA1B49-7DA4-8521-8070-C47B50C36677 F6F98A69-7DA7-8C 7- 3 -F94D99B55B5C 4 IN WITNESS WHEREOF, the Parties have executed this Term Sheet as of the date first written above. DATAVAULT AI INC. By: Name: Title: Nathaniel Bradley CEO SCILEX HOLDING COMPANY By: Name: Title: Henry Ji, PhD CEO


 

Exhibit 31.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Nathaniel Bradley, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Datavault AI Inc. (the “registrant”):
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures; and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 19, 2026
/s/ Nathaniel Bradley
Name:Nathaniel Bradley
Title:Chief Executive Officer
(Principal Executive Officer)


Exhibit 31.2
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Brett Moyer, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Datavault AI Inc. (the “registrant”):
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures; and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 19, 2026
/s/ Brett Moyer
Name:Brett Moyer
Title:Chief Financial Officer
(Principal Financial Officer)


Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Datavault AI Inc. (the “Company”) for the period ended June 30, 2026 (the “Report”), I, Nathaniel Bradley, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:
1.The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 19, 2026
/s/ Nathaniel Bradley
Name:Nathaniel Bradley
Title:Chief Executive Officer
(Principal Executive Officer)
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.


Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Datavault AI Inc. (the “Company”) for the period ended June 30, 2026 (the “Report”), I, Brett Moyer, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:
1.The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 19, 2026
/s/ Brett Moyer
Name:Brett Moyer
Title:Chief Financial Officer
(Principal Financial Officer)
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.